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ABSTRACT 
Colloidal Science of Ultrasound Contrast Agents 
Stephen Michael Dicker 
Advisor: Steven P. Wrenn, Ph.D. 
 
 
In this work, the behavior and properties of microbubble ultrasound contrast agents are 
measured and theoretically analyzed.  Among these measurements are the microbubble 
size distribution, inertial cavitation threshold, and resonance frequency.  The size 
distributions of populations of microbubbles are examined with a variety of different 
shell compositions.  The size distributions are very similar for all the shell compositions 
measured; they contained a monomodal peak with a nearly Gaussian distribution.  The 
mean size of the microbubbles did not change significantly for the compositional changes 
made in this study.  This same set of microbubble shell compositions is then analyzed for 
their resonance frequency.  This is accomplished by measuring the attenuation of a 
broadband chirp signal sent through a field of microbubbles and the frequency where the 
attenuation is the greatest the resonance frequency.  It is found that as PEG mole fraction 
and molecular weight increase, the resonance frequency decreases.  These shell 
compositions are then analyzed for their inertial cavitation threshold pressure and the 
results show that as PEG mole fraction increases, the inertial cavitation threshold 
increases.  With increasing PEG molecular weight, however, the cavitation threshold 
decreases.   
 
 
xvi 
 
With these experimental cavitation results, a predictive model is desired to explain the 
data theoretically.  Based on the colloidal science principles, a new model for the 
oscillation of thinly shelled microbubbles is explained.  For simple microbubble 
compositions, a predictive model can be applied for calculating material parameters of 
the microbubble shell.  This equation is shown to hold for the experimental cavitation 
data collected during the course of this work. 
 
Using the information gathered in the previous chapters, a novel contrast agent was 
designed.  The contrast agent is comprised of lipid microbubbles within the aqueous core 
of polymer shell microcapsules.  This combination has the benefit of added patient safety 
(through the aversion of cell death) while providing similar contrast to commercially 
available contrast agents.  The contrast agent accomplishes this by shielding the 
microbubbles from the incident sound pressure and preventing their expansion beyond 
the threshold radius.  The design of the contrast agent is also inherently a drug delivery 
vehicle which caters to both hydrophilic and hydrophobic drugs. 
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CHAPTER 1: A Brief History of Ultrasound Contrast Agents 
 
 
1.1 The Invention of Ultrasound 
 
As you’ve probably heard, the British luxury cruise ship R.M.S. Titanic struck a large 
iceberg on the evening of April 14th, 1912, and sunk just 3 hours later.  This was 
considered a great tragedy, and in order to avoid such future incident, Paul Langevin 
decided that ships of this nature needed a way to detect these types of scurrilous icebergs 
[1].  Langevin had previously been a student of the famous Pierre Curie (and illicit lover 
of Pierre’s more famous wife), and was well versed in one of Curie’s many discoveries, 
piezoelectricity.  His solution to the iceberg question was the invention of the hydrophone 
(along with Constantin Chilowski), a device which could produce high frequency sound 
above the range at which human ears can hear (above 20 kHz) and listen for reflections of 
the sound off of underwater geography, like icebergs [2].  Four years later, the 
hydrophone became quite popular and useful for detecting German U-boats tormenting 
conventional surface bound Allied ships [2].   This method of pulse echo location is the 
same which is used by bats and dolphins to guide their movements in the dark, and is the 
precursor to the modern ultrasound transducer. 
 
It wasn’t until the 1950’s when an esteemed Professor of Midwifery at Glasgow 
University, Ian Donald, used ultrasonic pulse echo location for medical techniques; more 
specifically for fetal imaging, it’s most prevalent use today [3].  However, this one 
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dimensional amplitude line (or “A-mode”) was not sufficient for any imaging purposes, 
as it only draws a line of the reflection intensity of the ultrasound signal.  As so, in 1962, 
Joseph Holmes, William Wright, and Ralph Meyerdirk invented the commonly used and 
stereotypical 2-D ultrasound system known as Brightness mode (or B-mode) ultrasound 
imaging system [4].  B-mode images are those most commonly seen in film and 
Facebook pictures of gestating children.  As recently as the early 2000s, 3-D ultrasound 
has become a reality (can also be considered as 4-D since the image can be watched in 
real time) and is commonplace in larger clinics and hospitals [1].   Today, ultrasound is 
an important tool in the clinical setting for both diagnostic imaging and a range of 
therapeutics (such as lithotripsy, cancer treatment, and cosmetic surgery [5, 6]). 
 
 
1.2 Clinical Ultrasound  
 
Ultrasound is simply defined as a mechanical vibration (otherwise known as sound) at 
frequencies above 20 kHz, the upper limit of human hearing [7].  This frequency of 
sound can be generated by the vibrations created by a piezoelectric material, such as lead-
zirconate-titonate (PZT) or polyvinylidene fluoride (PVDF) [1].  Piezoelectric materials 
are ideal for this technique as they can transform an electric signal into mechanical 
vibrations, therefore creating sound at a user defined pressure amplitude (akin to volume) 
and frequency (pitch).  Additionally, piezoelectric materials have backwards 
functionality; they can transform mechanical vibrations into an electric signal.  These 
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received signals can be used to build an ultrasound image.  For these reasons, the 
business end of an ultrasound system, the transducer, is made of a piezoelectric material. 
 
 
Figure 1.1: Sound spectrum. The audible sound spectrum is between 20 Hz and 20 kHz, with infrasound 
being below the audible range, and ultrasound above. 
 
The original application of ultrasound, finding icebergs underwater, is quite simple.  The 
primitive ultrasound transducer, or hydrophone, emits a quick burst of sound then listens 
for reflections of that sound from any objects in the sound’s path, and how long it takes 
from when the sound is emitted until it is detected.  These one dimensional Amplitude or 
A-mode scans simply display the magnitude (or amplitude) of the reflected sound being 
picked up by the hydrophone against the time between transmission and detection.  A-
mode “images” are reminiscent of submarine films, in which a tracer line scrawls across 
screen, beeping to indicate the presence of an enemy vessel. 
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Figure 1.2: Amplitude mode scan.  A typical A-mode line is shown, simply tracing the amplitude of the 
received signal (vertical axis) against the travel time of the pulse.  The spikes indicate strong 
reflections which are above a set threshold for detection.  Between the spikes is the level of 
noise [8]. 
 
In the scan from Figure 1.2, the tracer plots the pressure amplitude of the sound wave on 
the vertical axis against the total time from when the transducer emitted the sound to 
when it receives it (travel time).  Travel time is directly related to the distance an object is 
from the transducer (z): 
 
𝑡𝑡𝑟𝑎𝑣𝑒𝑙 = 2𝑧𝑐  
     (Equation 1.1) 
 
where c is the speed of sound in water (1500 m/s).  The distance is doubled because the 
sound needs to travel to and from the object it is reflecting off of.  Also of note from 
Figure 1.2 is the amplitude of the received signal.  The amplitude spikes indicate echoes 
coming from a certain distance from the transducer, which likely represent some real 
object detected underwater; whether it represents a fish, U-boat, or iceberg is 
indeterminate.  The steady, low values in A-mode are background noise, seen in Figure 
1.2 between the spikes and after the second spike. 
 
When sound is transmitted into a media, it propagates in the normal direction until the 
sound signal is lost to either reflection or attenuation [9-11].  Reflection is the rebound of 
the transmitted sound off an object in the sound’s path which can be picked up by the 
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transducer and translated into an image.  The amplitude of sound reflected from an object 
is determined by the comparison of the acoustic properties of the materials on either side 
of the object-water interface.  The acoustic properties can be summed up by the acoustic 
impedance (Z), measured in Rayleighs (or Rayls) named after the famous sound pioneer 
Lord Rayleigh: 
 Zi = ρici 
           (Equation 1.2) 
 
where ρ is the density of the material.  The amount of sound reflected off a given 
interface can then be determined with the reflective index (RI): 
 
𝑅𝐼 = |𝑍2 − 𝑍1|𝑍2 + 𝑍1  
     (Equation 1.3) 
 
where the subscripts 1 and 2 denote the materials on either side of the interface [1].  From 
Equation 1.3, it is obvious that materials with similar acoustic impedances will have a 
reflective index close to zero, meaning close no reflections.  Materials which have very 
dissimilar acoustic impedances (like water and submarine steel) will have a reflective 
index close to unity, indicating nearly total reflectance.  These reflections from interfaces 
are what build the trace in Figure 1.2, with the amount of reflected sound being related to 
the amplitude.  To solve the problem of sound reflection in diagnostic imaging, a gel 
matching layer is applied between the transducer and the patient’s skin.  This gel layer 
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has a similar acoustic impedance to human tissue in order to minimize reflections (tissue 
acoustic impedance = 1540 m/s) [1].  Without this matching layer, the sound would be 
transmitted into a thin air layer between the transducer and skin, then reflect substantially 
off the air-skin interface (Zair = 400 Rayl, Ztissue = 1.5 MRayl; RI (air-tissue) = 0.999).  If 
this were the case, only 0.1 % of the transmitted signal would pass through the air-skin 
interface and be available for imaging. 
 
These reflections are again employed when adding a dimension to the ultrasound image, 
and moving into Brightness, or B-mode.  Through the use of array transducers (multiple 
element), two dimensional images can be generated by compiling the information 
gathered from the multiple transducer elements.  In this mode, each transducer element 
(typically at least 64 elements) builds a line propagating longitudinally through the 
adjoining media.  The quintessential B-mode image of a fetus is shown below in Figure 
1.3. 
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Figure 1.3: Brightness mode fetal ultrasound.  B-mode image of an 18 week old fetus (the author’s 
nephew, David Dempsey) taken with a curved array transducer is displayed.  Different 
materials translate into a grayscale based on the magnitude of their reflection coefficient 
(white = bone, tissue = grey, amniotic fluid, blood = black). 
 
The image of the fetus is easily recognizable because of the acoustic impedance 
difference between the materials shown in the image.  Sound propagates from the 
transducer (top of the image) downwards towards the bottom of the image.  The 
trapezoidal shape of the image matches the shape of the transducer array (in this case a 
curved array).  As the echoes are received by the transducer, an image can be built based 
on the travel time from when the sound pulse was emitted to when the echo was received, 
and the magnitude of the echo (as in A-mode).  Modern ultrasound systems have 
sufficient computer processing speed to update these images in real time (25 – 30 frames 
per second) [1]. 
 
The colors on the grayscale represent the magnitude of the reflections from the various 
material interfaces.  Black represents the materials which have the least reflection (blood, 
or amniotic fluid), the grays are materials which have some degree of reflection (tissue, 
organs), and white represents the greatest reflection (bone, air).  The skull is clearly 
recognizable in white, along with the ribs of the fetus.  The black streaks traveling 
through the fetus’ head are acoustic shadows, areas in which all the sound has already 
been reflected (in this case most likely by the skull) and no signal is received, thus no 
image is compiled.  In clinical settings, a thin gel matching layer is applied to the 
patient’s skin to avoid small air pockets between the skin and the ultrasound transducer 
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from reflecting the signal. The majority of human tissue has a very similar acoustic 
impedance to water (1.5 MRayl for water, 1.6 MRayl for tissue), as does the matching 
layer gel (1.5 MRayl). 
 
The other mechanism by which a sound signal is lost is through attenuation of the signal 
by the media it is travelling through.  Total attenuation is basically the losses in the signal 
due to sound adsorption and irregularities in the material the sound is propagating 
through.  Attenuation (measured in dB per MHz per cm) is dependent on both the travel 
distance of the sound and the sound frequency. For both dependences, the total amount of 
sound attenuated increases for higher frequencies and travel distances.  Given the 
frequency, all sound will be attenuated by a certain distance from the transducer and will 
be worthless for pulse echo location.  The attenuation coefficient (measuring the degree 
of attenuation per MHz per cm) changes depending on the material the sound is traveling 
through.  For example, the attenuation coefficient is very low in water, with a value of 
0.002 dB/(MHz cm), increases to 0.14 dB/(MHz cm) for blood, and to 3.54 dB/(MHz 
cm) for bone [1].  For this reason, sound propagates the farthest through water without 
being completely attenuated of the three materials listed above.  The heterogeneous 
nature of human tissue leads to unpredictable non-linearity in the signal, along with 
additional incidences of signal scattering and reflection [12]. 
 
Besides losses and reflections in tissue, ultrasound imaging also suffers from inherent 
flaw which limits the usefulness of the technique.  It is well known that the sound 
frequency (f) is equal to the speed of sound (c) divided by the wavelength (λ): 
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𝑓 = 𝑐
𝜆
 
         (Equation 1.4) 
 
The problem is the well known trade-off between ultrasound image resolution and 
penetration depth.  The image resolution is related to the wavelength of the sound wave, 
such that the smaller the wavelength, the better the resolution (smaller objects can be 
resolved). Since wavelength is inversely proportional to the frequency of the sound, the 
higher the selected imaging frequency, the higher the image resolution will be.  However, 
attenuation of the signal through tissue also rises (at 0.5 dB/ (MHz cm)) with the increase 
of frequency, limiting the image adequacy at higher penetration depths.  Therefore, there 
is some optimal ultrasound frequency to give the best image depending on the penetration 
depth required.  This optimum frequency depends on the several clinical variables, such 
the size of the object being imaged and patient weight (lower frequencies required for 
increased depth through adipose).  Most clinical ultrasound machines have at least three 
transducers for achieving optimal resolution depending on the penetration depth and 
resolutions required for the specific application and circumstance. 
 
 
1.3 Ultrasound Contrast Agents 
 
Current ultrasound imaging techniques have the advantage of being a relatively safe, 
inexpensive, and non-invasive diagnostic tool when compared to other imaging 
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modalities like computed axial tomography (CAT), magnetic resonance imaging (MRI), 
and X-ray [1].  However, ultrasound imaging suffers in image resolution and depth of 
view compared to these techniques and is therefore inadequate for many diagnostic 
scenarios.  For example, it is difficult to resolve small blood vessels, such as 10 µm 
diameter capillaries [7, 13], because of their size coupled with the acoustic similarities 
between blood and tissue.  To aid in overcoming this issue, ultrasound contrast agents are 
employed to enhance the picture quality of ultrasound images in situations such as the 
one mentioned above. 
 
1.3.1  Ultrasound Contrast Agent History 
The first use of ultrasound contrast agents occurred in 1968 by cardiologists Raymond 
Gramiak and Pravin Shah [14].  Gramiak and Shah noted that when injecting agitated 
saline solution into a heart chamber during echocardiology, a so-called cloud of echoes 
could be resolved from the chamber, which is perturbed and dissipates with subsequent 
heart beats.  This cloud of echoes can be attributed to the reflection of the ultrasound 
signal from gas pockets in the injected saline solution created during agitation.  The 
reflections are simply caused by the mismatch in the acoustic impedance between air and 
blood, and thus the ultrasound contrast agent was born.  However, this technique suffered 
because of the short lifespan of the contrast agent, as the agitated gas within the saline 
quickly dissolves in the larger volume of blood.  On the other extreme, if too much air is 
added into the bloodstream an embolism can develop, and more than 20 ml of air can be 
fatal [15, 16].  Therefore, small, stable gas bubbles are ideal for increased bubble lifetime 
and avoiding emboli.   
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As ultrasound technology developed, so did the need for effective and safe contrast 
agents.  In 1982, the first commercially available contrast agent, Echovist, was released 
by Berlex Canada.  To stabilize the micron sized gas bubbles, the interface of the 
microbubbles is coated with galactose granules.  In this way the air bubbles will resist 
dissolution in the bloodstream and retain a size smaller than that of the smallest capillary 
(10 µm) [17].  The first FDA approved contrast agent used in the US was Albunex (since 
discontinued) in 1994, which was only approved for echocardiology (Albumin shell with 
encapsulated air).  Since their commercial inception, ultrasound contrast agents have 
grown significantly in their medical utility.  Besides being integral in echocardiology, 
they are of particular interest in cancer diagnosis, specifically in their ability to 
distinguish between benign, fluid-filled cysts, and malignant, vascular tumors [6, 18].  
Outside the realm of diagnostic imaging, microbubbles were also being evaluated as drug 
delivery vehicles (their ability to trigger drug release preferentially when under 
ultrasound will be discussed later in this chapter).  However, this microbubble research 
renaissance was to be ended by an FDA black box warning on ultrasound contrast agents. 
 
In October 2007, the FDA issued a black box warning (like those found on cigarettes) for 
all contrast agents listing a litany of potential contraindications of contrast agent use.  
Whether this warning was deserved was to be a matter of much debate in Washington 
and abroad.  It was reported that several patients who had been administered an 
ultrasound contrast agents reported complications on the day after imaging occurred, with 
at least one of these instances being a fatality [19].  Naturally, regulatory agencies like 
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the FDA reacted quickly by issuing the black box.  In Europe, Bracco’s SonoVue was 
withdrawn from the market because of European regulator’s concerns over possible 
respiratory distress caused by the dissolved heavy gas [19].  However, more recent 
studies have shown that these measures may have been an overreaction.  First, it is 
unclear whether use of ultrasound contrast agents was the cause of the complications and 
death.  These effects could have been from the ultrasound itself, some other non-related 
factor, or most likely the pre-existing heart condition they required an echocardiograph 
for.  Secondly, and more convincingly, it has been reported that the safety records from 
echocardiography indicate only a 1:500,000 fatality risk, which is lower than that for the 
other imaging modalities mentioned earlier [20, 21]. 
 
 
Figure 1.4: Optison boxed warning.  This FDA regulated black box warning appears on GE 
Healthcare’s Optison as of January 2012. 
 
Regardless of deservedness, the 2007 black box warning severely crippled the ultrasound 
contrast agent industry.  Many outdated and startup manufacturers were forced to fold, 
and even a current industry leader – GE Healthcare’s Optison – was temporarily removed 
from the market.  Through the lobbying effort of healthcare professionals, in particular 
Philadelphia’s own Dr. Barry Goldberg, some of the warnings were relaxed only a year 
later in 2008, albeit not totally removed [22].  Although only present for a year, the 
effects of the black box warning were felt even by the largest manufacturers, and to date 
only three have weathered the warning: GE Healthcare’s Optison, Lantheus’ Definity, 
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and Bracco’s SonoVue (although SonoVue is in the European market).  A fourth 
manufacturer, Acusphere, currently has an ultrasound contrast agent in the pipeline, 
which is expected to be commercially available as soon as it gains FDA approval.  Most 
recently, in October 2011, Lantheus won another major victory for the industry by further 
removing contraindications from the packaging of Definity [22].  While the industry was 
crippled for almost 4 years from the FDA warning, it is finally beginning to regain favor 
from doctors and researchers alike in the advancement of medical imaging and drug 
delivery.  Today, ultrasound contrast agents are still only FDA approved for 
echocardiology, however abroad (especially in Europe and South America) contrast 
agents are approved for a wide range of diagnostic applications [22].  The commercial 
use of microbubbles as drug delivery vehicles has yet to be accepted, although it can be 
anticipated in the near future with the state of research towards that end [6]. 
 
1.3.2 Microbubble Chemistry 
The importance of stability has been at the forefront of ultrasound contrast agent 
technology development.  Since 1982, contrast agents have gone through developmental 
“generations” in their pursuit of increased stability [12].  Michiel Postema and Georg 
Schmitz compiled a comprehensive list of the current state of the microbubble contrast 
industry in 2006 (adapted and updated in Table 1.1) [12].  As evident from Table 1.1, the 
ultrasound contrast agent industry has suffered significantly since 2006 due to the black 
box warning.   
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Table 1.1: Ultrasound contrast agent market overview. Adapted from Postema and Schmitz [12]. 
Product 
Name Manufacturer Shell Material Gas 
Mean 
Diameter 
(µm) 
Current 
Availability 
Albunex 
Molecular 
Biosystems 
Albumin Air 4.3 No 
Levovist, 
Sonovist 
Schering AG 
Lipid/galactose, 
cyanoacrylate 
Air 2-3 No 
Definity 
Lantheus 
Medical 
Imaging 
Lipid/surfactant C3F8 1.1 - 3.3 Yes 
Echogen Sonus Pharm. Surfactant C5F12 2 – 5 No 
Imagent 
Alliance 
Pharm. 
Lipid/surfactant C6F14 6 No 
Optison GE Healthcare Albumin C3F8 2.0 – 4.5 Yes 
Quantison Upperton Ltd. Albumin Air 3.2 No 
SonoVue Bracco Lipid SF6 2.5 Yes 
AI-700 
(Imagify) 
Acusphere 
Polylactic co-
glycolic acid 
C4F10 2 Pipeline 
Cardiosphere 
Point 
Biomedical 
Polylactic acid Air 3 No 
Sonozoid GE Healthcare Lipid/surfactant C4F10 2.4 – 3.6 Japan only 
 
 
The first generation, as typified by Echovist, is defined by a coated microbubble with 
encapsulated air.  The coatings of the first generation of microbubble contrast agents 
were typically sugars or proteins [1, 12].  The main drawback of this first generation of 
contrast agents was the relatively high solubility of air in the bloodstream (0.0292 vol/vol 
in water) [23].  To further improve stability, the second generation of contrast agents was 
comprised of microbubbles which encapsulate a lower solubility gas, such as 
perfluorocarbons or sulfur hexafluoride (SF6).  Many of these inert gasses have water 
solubility of an order of magnitude lower than air (0.007 vol/vol in SF6) [23].  The 
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microbubble coatings also became more stabile with the introduction of phospholipid and 
polymer shells, and often a blend of both.  This type of microbubble contrast agent is the 
most prevalent in the industry today, and is therefore the focus of the experiments, 
simulations, and discussions in this dissertation.  
 
 
Figure 1.5: Microbubble schematic cross-section.  The cartoon shows a phospholipid monolayer 
microbubble encapsulating a gas core with some percent of the lipids functionalized with 
polyethylene glycol (PEG) polymer. 
 
As shown in the cartoon in Figure 1.5, the microbubbles synthesized in this study (which 
are a close analog of SonoVue or Definity) contain only three species.  First, the 
microbubble shell encapsulates a gas core, which for this work (and SonoVue) is SF6.  
The monolayer phospholipid shell surrounding the core needs to be in the gel phase in 
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order to successfully encapsulate the gas.  The lipid chemistry that best satisfied the 
condition of a gel phase at room (or body) temperature are those whose fatty acid chains 
are completely saturated – that is, the fatty acid chains contain only single bonds.  Double 
bonds in the fatty acid chains of phospholipids decrease the melting point and the packing 
efficiency of the membrane, both of which are unfavorable for gas encapsulation [24].  
The benefit of using phospholipids as the coating for microbubbles is their ability to self-
assemble because of their molecular structure.  The hydrophilic head group will always 
seek to align itself close to the aqueous, while the hydrophobic fatty acid tail groups will 
seek to shield themselves from the water.  In the case of a microbubble, the tail groups 
can minimize their free energy by coating the gas interface.  The lipid used most 
predominately in phospholipid shelled microbubbles is Distearoyl phosphatidylcholine 
(DSPC), a molecule with two fatty acid chains of 18 single bonded carbons, with a 
choline head group (as seen in Figure 1.6).   
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Figure 1.6: Distearoyl phosphatidylcholine molecule.  2-D and 3-D molecular models of DSPC as 
shown.  Like all phospholipids, it contains a hydrophilic head group (choline) a 
phosphate/glycerol linker, and a hydrophobic tail group (two stearic acids). 
 
To further increase the stability of the microbubble, some fraction of the monolayer lipids 
can be functionalized with a hydrophilic polymer.  Most commonly, the polymer selected 
for these purposes is some form of Polyethylene glycol (PEG).  PEG is preferable 
because of its relatively high hydrophilicity amongst polymers, and because of its 
biocompatibility.  PEG increases the stability of microbubbles simply by the steric 
repulsion of the PEG chains protruding from two different microbubbles, which keeps the 
bubbles from coalescing.  The same effect aids microbubble longevity in the 
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bloodstream, and the PEG repels macrophages employed in the reticuloendothelial 
system from breaking down the microbubbles [7, 25, 26]. 
 
 
Figure 1.7: Polyethylene glycol repeating unit.  PEG has a molecular formula of C2nH4n+2On+1, where n 
is the number of repeat units.  
 
The percentage of lipid functionalized PEG in the membrane and (to a lesser extend) the 
molecular weight of the PEG influence the surface properties of the polymer.  At 
relatively low PEG functionalization, the polymer has space sufficient to exhibit a more 
random structure (with one end grafted to the lipid), better known as the mushroom 
regime.  As PEG functionalization increases, the polymer strands begin to feel the 
presence of the others in the membrane and begin to straighten and stand upright, normal 
to the membrane [27].  This densely packed formation is known as the brush regime.  
Both polymer configurations are displayed below in Figure 1.8. 
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Figure 1.8: PEG membrane configurations.  At low functionalization percentages, defined by 
Backmann [27] as when the distance between two polymer grafting points is approximately 
greater than twice the polymer radius, the PEG polymer is free to spread out to its natural 
radius of gyration in the mushroom regime.  When the distance between two polymers is less 
than twice the polymer radius, the two strands begin to repulse each other and therefore 
straighten into the brush regime. 
 
As shown in Figure 1.8, the PEG configuration transitions from mushroom to brush 
regime when the distance between two PEG strands drops below twice the polymer 
radius.  At this point the strands are repulsing one another, since the PEG strands have a 
stochastic position, with their probable positions shown in Figure 1.8 as green 
hemispheres [27].   
 
This combination of encapsulated low solubility heavy gas, a gel phase lipid monolayer, 
and a percentage of the membrane lipid functionalized with PEG leads to a stable 
ultrasound contrast agent. 
 
 
1.4 Microbubble Cavitation 
 
When microbubbles are exposed to an ultrasound field, they will begin to oscillate 
radially to the “tune” of the sound.  That is, the microbubbles are feeling the alternating 
positive and negative pressures imposed by the sound wave.  Microbubbles are 
sufficiently small that the entire microbubble will always experience the same acoustic 
21 
 
pressure; it is a point charge to the ultrasound wave (i.e. for 3 MHz ultrasound traveling 
through water, the wavelength will be 500 µm, much larger than a 1 µm bubble) [28].  
Therefore, during the positive portion of the wave, the microbubble will experience 
increased external pressure, and begin to contract.  On the negative portion of the 
pressure cycle, the microbubble will be experience a negative external pressure and will 
expand.  These oscillations are made possible by the compressible gas core, where other 
microstructures may feel the vibrations from the sound wave; few will be affected as 
dramatically as bubbles.  This oscillatory phenomenon is generally referred to as 
cavitation. 
 
1.4.1 Stable Cavitation 
Cavitation can be broken down into two categories, based on the outcome of the 
oscillations.  Stable cavitation can be defined if linear microbubble oscillations are 
sustained indefinitely under an unchanging ultrasound field.  Linear oscillations are those 
in which the positive and negative responses of the microbubble are equal in magnitude 
(to match the ultrasound sine wave signal).  In this case, as depicted in Figure 1.9 
(adapted from Chomas [29]), the microbubble contracts under positive pressure and 
expands under negative pressure indefinitely. 
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Figure 1.9: Stable cavitation.  The microbubble size responds to the incident acoustic wave in two ways, 
as imaged by Chomas [29] and redrawn by Szabo [1].  The speed of the oscillations is 
determined by the frequency of the sound wave, and the magnitude of the oscillations is 
dependent on the pressure amplitude of the sound wave. 
 
Sustained stable cavitation occurs at low pressure amplitudes, specifically those below 
the inertial cavitation threshold pressure.  Altering the frequency of ultrasound also has 
an effect on the dynamic radius of the microbubble.  As frequency increases, the effects 
of the microbubble shell cause the response of the microbubble to lag behind the 
frequency of the incident sound [30, 31].  Because of this lag, the microbubble never has 
sufficient time during a single cycle to reach the size dictated by the maximum pressure 
amplitude of the sound wave.  That is to say, while the microbubble is decreasing in 
radius in response to the positive pressure, it begins to experience the negative pressure 
portion of the cycle before it has fully responded to the positive pressure portion, and 
therefore begins to grow (again lagging behind the incident sound wave).  This lag can be 
attributed partially to the dampening effect from the mass of the shell [32].  At lower 
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frequencies, the microbubble will have sufficient time to fully respond to the oscillations 
from the incident sound wave and grow to their full potential. 
 
As a result of the oscillating microbubble, the surrounding fluid is also pulled towards 
and pushed away from the bubble in a process known as microstreaming.  
Microstreaming is the first example of the microbubble’s ability to influence its 
environment as a result of oscillation.  The effects of microstreaming have been shown 
by Wu to transiently open cell membranes to which a microbubble has been tethered, in a 
process known as sonoporation [33].  Wu also reports that the shear stress induced on a 
cell bilayer from the microstreaming of a tethered microbubble to be as high 10 kPa [34].  
In the scope of microbubble cavitation bio-effects, microstreaming is a minor 
contribution as compared to those from inertial cavitation. 
 
1.4.2 Inertial Cavitation 
When microbubble oscillations become sufficiently large in magnitude, they can undergo 
a violent collapse known as inertial cavitation.  In the event of inertial cavitation, a 
microbubble grows too large during its negative pressure expansive phase that it 
implodes on itself in the subsequent positive pressure rarefactional phase.  This implosion 
is accompanied by a large local increase in temperature and pressure, suggested by Szabo 
to be up to 5000 K and 100 MPa respectively [1].  Along with these local effects, a 
shockwave is generated by the imploding bubble, which can impart a large positive 
pressure on nearby structures.  This phenomenon was first observed in naval research, as 
the speed at which boat propellers spin causes gas voids to form and subsequently 
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collapse behind the propeller blades.  The negative pressure behind the blades was 
sufficient to nucleate these gas voids, which then inertially cavitated as they returned to 
the hydrostatic pressure, causing damage to the propeller (as seen in Figure 1.10). 
 
 
Figure 1.10: Screw propeller cavitation damage.  Evidence of the power of inertial cavitation is 
obvious at the bottom of the image.  
 
The criterion for the onset of inertial cavitation is a matter of some debate in the 
ultrasound field.  Initially it was thought by most groups and published in The Acoustic 
Bubble [35] (otherwise known as The Acoustic Bible, in some circles) that this inertial 
cavitation criteria was the bubble reaching approximately twice its initial radial, R = 2R0.  
This idea is especially popular amongst groups who are able to measure the size of an 
oscillating bubble, using high speed photography techniques which are capable of 
recording 10 million images per second [29, 36].  They note that when a bubble reaches 
twice its resting size during the expansion phase, it will generally collapse on the 
subsequent rarefactional phase, as demonstrated in Figure 1.11 (again from Chomas 
[29]).  Other groups suggest that criteria for inertial cavitation should be related to the 
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bubble wall velocity, or the kinetic energy [37].  More specifically, a suitable cavitation 
threshold might be defined as when the bubble wall speed exceeds the speed of sound in 
the surrounding media (the definition of the onset of a shockwave). 
 
 
Figure 1.11: Inertial cavitation streak image.  This streak image, generated by Chomas [29], shows the 
radius of the microbubble as a function of time during sonication.  In the first image, the 
microbubble is at its resting radius, R0, and ultrasound has yet to be applied.  As ultrasound 
is applied, at approximately 0.6 µs, the positive pressure phase causes the bubble to 
contract.  At 0.9 µs, the bubble has fully expanded in response to the negative pressure peak 
of the incident ultrasound, which upon inspection is greater than twice the resting radius.  
On the subsequent positive pressure phase, the microbubble undergoes an implosion, 
displayed at starting at 1 µs.   
 
The streak image by Chomas clearly shows a microbubble, initially at rest, undergoes a 
growth phase followed by a fragmentation, collapse, and destruction.  As this process is 
quite chaotic, the outcome of the destruction is somewhat nebulous.  While it is obvious 
from Figure 1.11 that the bubble is destroyed, it is difficult to ascertain whether its 
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disappearance can be attributed to a high energy collapse (like inertial cavitation), or 
rather a fragmentation or dissolution. 
 
The onset of high energy inertial cavitation is the suspected cause of the many of the 
negative bio-effects associated with contrast enhanced ultrasound imaging [20].  
Microbubbles which inertially cavitate while tethered to cells are likely to cause cell 
death.  Those which are inertially cavitate in the bloodstream also have a chance to cause 
hemolysis [20].  As these results are unwanted during an ultrasound scan, ultrasound 
vendors coined a variable to aid clinicians in avoiding unwanted adverse effects.  The 
mechanical index (MI) is defined as: 
 
𝑀𝐼 = 𝑃𝑁𝑃
�𝑓
 
     (Equation 1.5) 
 
where PNP is the peak negative pressure of the incident sound wave (in MPa) and f is 
center frequency of the incident sound (in MHz).  In practice, it is only FDA approved to 
operate a clinical unit under an MI of 1.9 [38].  Quite evidently, the mechanical index is 
an empirical parameter with odd units which is used as a rough guideline for avoiding 
inertial cavitation and unwanted adverse effects.  In general, the MI illustrates two factors 
which influence the likelihood of the onset of inertial cavitation; an increase in the 
acoustic pressure leads to larger oscillations of the microbubble (thus approach the 
cavitation threshold), and a decrease in the frequency allows longer times for 
microbubbles to nucleate and grow in response to the negative pressure they are under 
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(also approaching sizes near the threshold).  This is quite a simplistic approach to 
avoiding adverse bio-effects, and therefore a better understanding of the parameters 
which affect the onset of cavitation is highly desirable, and is discussed at length in 
Chapter 3. 
 
However, in some cases the onset of inertial cavitation is favorable.  These cases are 
generally confined to the realm of drug delivery.  Cavitation can aid drug delivery in two 
ways.  First, as discussed previously, the cavitating microbubble can cause reversible 
pores to open in the membrane of a cell, therefore better allowing drug present in the 
cell’s environment to enter through these pores; a process known as sonoporation [39, 
40].  Secondly, the microbubbles themselves can act as the drug carriers.  In these cases, 
a hydrophobic drug can be added to the surfactant shell of the microbubble and as the 
microbubble ruptures, the small pieces of the shell can be more easily taken up by the 
cells [15, 41, 42].  This strategy would be especially effective against cancer cells, as they 
are known to have a so-called “leaky” vasculature in which to trap microbubble 
fragments containing the drug [25, 41, 43].  Both the potentially positive and negative 
effects related to inertial cavitation make it and its onset topics of interest for 
pharmacologists and clinicians alike. 
 
 
1.5 Microbubble Dynamic Radius 
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These cavitation effects were being felt as early as the turn of the 20th century.  With the 
growing popularity of the steam engine as the main use of propulsion for warships and 
other naval vessel and the advent of the gas turbine, ship propellers were being driven 
faster than ever.  The screw propeller (from Figure 1.10) in particular was almost 
exclusively used with these forms or propulsion.  However, as discussed earlier, these 
types of propellers were easily damaged just by normal use as the result of inertial 
cavitation.  This problem is precisely what attracted a prominent thinker of the time to 
analyze the phenomenon in detail: John William Strutt, otherwise known as Lord 
Rayleigh. 
 
In 1917, Lord Rayleigh was 75 years old and had accomplished more than many 
scientists combined in a lifetime (and in fact Rayleigh would be dead just 2 years later).  
His greatest achievements to date included the explanation of why the sky is blue 
(Rayleigh scattering) and discovering the element argon (for which he won the Nobel 
Prize).  He would add to his long list of credentials by expounding - along with the 
contributions of four others - the most fundamental equation of bubble motion, still in use 
today (albeit with many modifications). 
 
1.5.1 The Rayleigh-Plesset-Neppiras-Noltingk-Poritsky Equation 
The Rayleigh-Plesset-Neppiras-Noltingk-Poritsky equation, or RPNNP as it is 
affectionately known [44], is the basis for the understanding of bubble oscillations.  Lord 
Rayleigh  originated the equation to describe the collapse of an empty cavity in an 
incompressible fluid (to mimic those collapsing behind propeller blades) [45].  Along 
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with Lord Rayleigh, the next 3 contributors to the equation, Milton Spinoza Plesset in 
1949 [46], Ernest Neppiras and B.E. Noltingk in 1950 and 1951 [47, 48], were all 
interested in modeling the microbubble size phenomenon.  Neppiras and Noltingk were 
the first to study the oscillations of naked (with no shell) microbubbles under the 
influence of ultrasound [48].  However each of the first four contributors derived this 
non-linear bubble motion equation, starting from a simple energy balance.  A brief 
schematic of the process is show below in Figure 1.12. 
 
 
Figure 1.12: Microbubble oscillation in a liquid.  The initial microbubble radius R0, is changing with 
the R (or R(t)) in response to an incident ultrasound wave with pressure P(t).  PI is the 
internal pressure of the bubble, PL is the pressure directly outside the bubble, P0 is the 
hydrostatic pressure, and P∞ is the pressure far away from the bubble. 
 
The initial energy balance of the system is simple.  The work of a microbubble expanding 
(or contracting) can be equated to the kinetic energy of the fluid being moved by the 
microbubble. 
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�𝑃𝑑𝑉 = 12𝑚𝑣2 
    (Equation 1.6) 
 
where P is pressure, V is bubble volume, m is the mass of liquid being moved, and v is 
the velocity at which it is moving.  In Equation 1.6 the left hand side represents the PV 
work of the bubble, and the right hand side is the kinetic energy of the fluid being 
displaced (assuming expansion).  The volume on the left and the mass on the right can 
then be rewritten as a function of the bubble radius, R, and the velocity on the right as a 
function of the radial position, r, starting at the outside of the bubble, R. 
 
�(𝑃𝐿 − 𝑃∞)4𝜋𝑅2𝑑𝑅 = 12𝜌��𝑑𝑟𝑑𝑡�2 4𝜋𝑟2𝑑𝑟 
  (Equation 1.7) 
 
where PL is the pressure directly outside the bubble, P∞ is the pressure far away from the 
bubble, R is the dynamic bubble radius, ρ is the density of the liquid, and r is the radial 
position outside the bubble, and 𝑑𝑟
𝑑𝑡
 is the bubble wall velocity, and will be written as ?̇?.  
To simplify the equation, r can be rewritten as a function of R from a simple mass 
balance.  If the liquid is incompressible, then the conservation of mass result can be 
written as in Equation 1.8. 
 
𝑟2̇ = 𝑅4𝑅2̇
𝑟4
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     (Equation 1.8) 
 
Now substituting Equation 1.8 into Equation 1.7 and solving the integral on the right 
hand side only between R and infinity,  
 
�(𝑃𝐿 − 𝑃∞)4𝜋𝑅2𝑑𝑅 = 2𝜋𝜌𝑅4𝑅2̇ 
       (Equation 1.9) 
 
To remove the integral on the left, the derivative of both sides of the equation can be 
taken with respect to R.  Taking the derivative of the right hand side gives Equation 1.10: 
 
(𝑃𝐿 − 𝑃∞)4𝜋𝑅2 = 2𝜋𝜌�3𝑅2𝑅2̇ + 𝑅3 �𝑑𝑅2̇𝑑𝑅 �� 
 (Equation 1.10) 
 
The dR term in the denominator of the final term on the right can be equated ?̇?dt (by the 
definition of ?̇?.  Now taking the derivative of 
𝑑𝑅2̇
𝑑𝑡
, 
 (𝑃𝐿 − 𝑃∞)4𝜋𝑅2 = 2𝜋𝜌�3𝑅2𝑅2̇ + 2𝑅3?̈?� 
         (Equation 1.11) 
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where ?̈? is the second derivative of bubble radius with respect to time (bubble wall 
acceleration). Finally, P∞ can be equated to P0 plus the ultrasound pressure function, P(t), 
and the equation can be quickly rearranged to its familiar form: 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌 (𝑃𝐿 − 𝑃0 − 𝑃(𝑡)) 
                         (Equation 1.12) 
 
However, PL is a quantity which is practically impossible to measure, and therefore it is 
easier to recast it in terms of the pressure inside the bubble, PI, and the Laplace pressure:  
 
𝑃𝐼 = 𝑃𝐿 + 2𝜎𝑅  
                                             (Equation 1.13) 
 
where σ is the surface tension.  Next, both immeasurable pressures should be removed 
from the equation.  If the process is adiabatic, then PVγ is constant (where γ is the 
polytropic index).  Therefore, the initial state of the equation can be equated to the state 
of the equation at any time t.   
   
𝑃𝑉𝛾 = 𝑃𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑉0𝛾 
                                             (Equation 1.14) 
 
�𝑃𝐿 + 2𝜎𝑅 � �43𝜋𝑅3�𝛾 = �𝑃0 + 2𝜎𝑅0� �43𝜋𝑅03�𝛾 
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                     (Equation 1.15) 
 
𝑃𝐿 = �𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 − 2𝜎𝑅  
                                 (Equation 1.16) 
 
By combining Equation 1.16 and Equation 1.12, the final form of the equation is arrived 
at (as derived by Neppiras and Noltingk [48]):  
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 − 2𝜎𝑅 − 𝑃0 − 𝑃(𝑡)� 
         (Equation 1.17) 
 
Elegant as this solution is, it is somewhat incorrect.  First, the solution is quite unstable 
and only holds for small oscillations in R (low pressures, below 100 kPa).  Another 
inherent flaw becomes obvious when P(t) becomes zero after some time, t (as if the 
ultrasound is shut off), the bubble oscillations persist undampened beyond when P(t) 
becomes zero.  Figure 1.13 show the shape of the pressure function, P(t), used throughout 
this work (although at varying amplitudes).  Its characteristic is the 4 cycle sine wave, 
followed by 2 µs of rest (to allow the radius to return to rest).  Figure 1.14 shows the 
dynamic response of the microbubble radius (normalized by the resting radius), as 
predicted by Equation 1.17 (when ρ is 998 kg/m3, P0 is 10.13 kPa, σ is 0.051 N/m, γ is 
1.07, and R0 is 1 µm). 
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Figure 1.13: Incident pressure function.  The incident pressure function here and throughout this work 
is characterized by a 4 cycle sine wave pulse, followed by 2 µs of rest.  Here, the pressure 
amplitude is 100 kPa, although this is varied significantly throughout this work. 
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Figure 1.14: Microbubble dynamic response as predicted by Rayleigh’s equation.  The 
microbubble’s predicted change in normalized radius over time is shown here to be non-
linear response to the 100 kPa pressure function shown in Figure 1.13 (as expected).  
However, the radial oscillations persist even after the pressure function is zero, indicating a 
flaw in the equation.   
 
This undamped oscillation issue was fixed quickly however by the fifth and final 
contributor to the equation in 1952, made by Poritsky [49].  Poritzky derived an equation 
for the same situation, although instead of approaching the derivation with an energy 
balance, Poritsky used a common fluid dynamics relationship, the Navier-Stokes 
equation.  From this derivation, he arrived at the same result, with an added term.  This 
term amounts to the viscous losses in pressure as attributed to the notion that the liquid 
has some viscosity (which they do).  Therefore, with its final addition, the complete 
RPNNP equation is as follows in Equation 1.18: 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 − 2𝜎𝑅 − 4𝜇?̇?𝑅 − 𝑃0 − 𝑃(𝑡)� 
         (Equation 1.18) 
 
where µ is the viscosity of the liquid.  A simulation of the complete RPNNP equation, as 
seen in figure below, shows that if P(t) becomes zero, the bubble radius with dampen 
back to its initial value.  Figure 1.15 show the response predicted by the RPNNP with the 
same P(t) and input parameters (with µ = 0.001 Pa s) as used to generate Figure 1.14. 
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Figure 1.15: Microbubble response predicted by the RPNNP equation.  With the same P(t) and input 
parameters as used to generate Figure 1.14, the RPNNP equation proves superior as the 
viscous losses term dampens the oscillations of the bubble after the pressure is reduced to 0 
(at about 2 µs). 
 
The RPNNP equation does operate under a set of assumptions however, which are as 
follows [50, 51]: 
 
 1. The bubble is always spherical. 
 2. Uniform conditions exist within the bubble. 
3. The acoustic wavelength is large compared to the bubble size (such that 
the whole bubble always experiences the same pressure. 
4.  No body forces are accounted for (such as gravity or electromagnetism). 
5. Bulk viscous effects are ignored. 
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6. The surrounding liquid is incompressible, but the bubble gas is not. 
7. The density of the surrounding fluid is far greater than that of the gas. 
8. The gas content of the bubble is always constant. 
9. The vapor pressure of the gas is always constant.   
10. The bubble oscillations are adiabatic. 
11. The bubble has no coating (nothing between the gas and liquid). 
 
Although all these assumptions are not entirely sound, it has been the work of many 
groups since the 1950s to account for many of these shortcomings of the RPNNP 
equation.  The one focus in particular, especially in the past two decades, has been in 
accounting for an oscillating microbubble which does have a coating or shell, as is the 
case with ultrasound contrast agents.  Several of such equations will be presented in the 
following chapters, along with proposed model for microbubble dynamic radius from a 
colloidal and membrane science viewpoint.  All of these equations however, find their 
roots in the RPNNP equation. 
 
 
1.6 Dissertation Summary 
 
This dissertation will focus mainly on five topics: the effect of varying the shell 
composition on the size of microbubbles, cavitation phenomenon, and resonance 
frequency, along with the design of a microbubble oscillation model and the design and 
implications of a novel ultrasound contrast agent.  As the size distribution of a population 
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of microbubbles significantly influences its cavitation and resonance behavior, it will be 
discussed briefly in Chapter 2.  Chapter 3 focuses on the development of a technique to 
measure inertial cavitation and the influence of shell composition on the cavitation 
threshold of microbubbles.  This behavior will also be modeled with a RPNNP-like 
equation in such a way to better understand cavitation phenomena.  Chapter 4 will briefly 
discuss various proposed models for microbubble dynamic radius, along with the 
development of a new model to describe the oscillations as a function of colloidal 
parameters.  Chapter 5 introduces the effect of changes in shell composition on the 
resonance frequency of microbubbles, along with a technique for measuring resonance 
frequency experimentally and a theoretical explanation.   
 
Using the information in the preceding chapters, Chapter 6 describes the design of a 
novel contrast agent with the focus of contrast longevity, patient safety, and potential 
dual functionality as a drug delivery vehicle.  Techniques developed in previous chapters 
will be used to analyze the new contrast agent, such as cavitation measurements and 
acoustic response data.  Additionally, an equation to describe microbubble oscillations 
for the new contrast agent is developed.  The final chapter, 7, reviews the significant 
findings of this work and attempts to project the future direction of research relating to 
these studies. 
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CHAPTER 2: Microbubble Size Distributions 
 
 
2.1 Introduction 
 
As evident from equations like the RPNNP, the size of a bubble is important to 
understand as it determines the point at which the bubble will cavitate [52, 53].  The real-
time size of a microbubble under an ultrasound field is non-linear and chaotic (very 
sensitive to initial conditions), and it is most often preferred to consider the initial, or 
resting radius of the microbubble instead.  The resting radius (R0 in the equations herein) 
greatly influences the response of the microbubble to the ultrasound field, and can 
determine the likelihood of cavitation (if the threshold is related to R/R0).  As a 
simplifying assumption in some RPNNP-like equations, the microbubble size is taken to 
be a constant [54, 55].  In the case of analyzing the theoretical behavior of a single 
microbubble, this can be of some merit.  However, when analyzing a large population of 
microbubbles like those present in ultrasound contrast agents, the microbubble size is 
often highly varied. 
 
In real scenarios, the synthesis or manufacturing procedure will set the resting size of a 
microbubble.  Small scale techniques, such as microfluidics, have the advantage of great 
sensitivity and can consistently synthesize microbubbles with very uniform sizes [56].  
Larger scale techniques, such as those employed by Bracco and Lantheus in the 
production of their respective contrast agents, do not have the luxury of a perfectly 
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uniform size in their formulations.  In the case of Definity, for example, a previously 
prepared mixture of dissolved lipid and heavy gas are sealed and vigorously mixed at the 
time of injection.  This mixing process creates stable microbubbles between 1.1 – 3.3 µm 
in diameter, as reported by Lantheus [12].  The shape of the distribution of these sizes is 
roughly Gaussian.  Successful techniques such as these can produce a large quantity of 
microbubbles in a short time at high concentrations.  Again,   the trade off is the apparent 
distribution of sizes.  In microbubble populations like Definity, SonoVue, and those 
synthesized in this work, it is important to bear the size distribution in mind the when 
comparing experimental results with theoretical models.  This chapter presents the 
method in which the microbubbles used in this study are synthesized along with a novel 
image segmentation program for measuring the size distribution of microbubble contrast 
agents, and the resulting size distributions of the microbubble compositions discussed 
herein. 
 
 
2.2 Microbubble Synthesis and Image Segmentation 
 
2.2.1 Materials 
The lipid 1,2-Distearoyl-sn-Glycero-3-Phosphocholine (DSPC) and Polyethylene Glycol 
(PEG) functionalized lipid 1,2-Disteroyl-sn-Glycero-3-Phosphoethanolamine-N-
[Methoxy(Polyethyleneglycol)-2000], ammonium salt (DSPE PEG 2000) were purchased 
from Avanti Polar Lipids (Alabaster, AL).  The 1000, 3000 and 5000 g/mole molecular 
weight DSPE PEG functionalized lipids were also supplied by the above.  Sulfur 
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Hexafluoride (SF6) gas was purchased from Airgas (Allentown, PA).   All other reagents 
used were of analytical grade. 
 
2.2.2 Microbubble Preparation 
Preparing phospholipid shelled microbubbles is a simple self-assembly process.  A lipid 
film containing various mole% of the gel phase lipid DSPC (85 – 99 mole%) and a PEG 
functionalized lipid (1 – 15 mole%) is deposited onto a 20 ml scintillation vial from stock 
solutions dissolved in chloroform by N2 spin drying followed by 2 hours in vacuum.  A 
matrix of the shell compositions analyzed in this chapter (and in the following chapters) 
is gathered in Table 2.1, along with the mass of lipid and PEG functionalized lipid mixed 
to synthesize them. 
 
Table 2.1:  Matrix of studied shell compositions. The masses (in mg) of materials used to 
synthesize the microbubbles of the various shell compositions are displayed in the matrix. 
%mole 
PEG 
DSPE PEG 
5000 DSPC 
DSPE PEG 
3000 DSPC 
DSPE PEG 
2000 DSPC 
DSPE PEG 
1000 DPSC 
1 1.11 52.09 0.74 53.47 0.56 54.16 0.36 54.90 
2.5 2.53 45.97 1.75 49.70 1.34 51.23 0.88 52.94 
5 4.41 38.55 3.19 44.27 2.51 46.83 1.71 49.84 
7.5 5.86 32.94 4.41 39.70 3.55 42.94 2.48 46.95 
10 7.01 28.56 5.45 35.80 4.47 39.48 3.20 44.25 
12.5 7.95 25.04 6.35 32.43 5.30 36.39 3.88 41.70 
15 8.74 22.15 7.14 29.49 6.04 33.59 4.52 39.31 
 
The dried film containing the materials listed above is then rehydrated with aqueous 
phosphate buffered saline (PBS) solution (pH 7.4) by sonicating the sample at low 
frequency (Hielscher UP200S Ultrasonic Processor, Hielscher Ultrasonics, Teltow, 
Germany) for approximately 3 minutes at 20% amplitude.  This has the dual effect of 
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dissolving the lipid mixture in solution and raising the temperature above that of the 
DSPC gel phase transition temperature, 55 oC.  The rehydrated solution is then cooled 
and aliquoted out into 2 ml serum vials and sealed.  1.5 ml of the dissolved lipid solution 
is added to each vial, as this is determined to be the optimal gas-to-aqueous ratio to result 
in the most concentrated microbubble sample.   
 
The head space air is then evacuated from the vial and replaced with the fluorinated 
heavy gas, SF6.  Finally the vials are vigorously shaken using the Vialmix shaker 
(Lantheus Medical Imaging) in order to disperse the gas phase.  During this step, the head 
space gas is broken down into small enough fragments that it will be preferentially coated 
by the lipid and PEG functionalized lipid.  The new lipid/PEG coating stabilizes the 
microbubble such that it will remain stable even when exposed to the atmosphere for at 
least 3 days (see Chapter 6 for in depth analysis of contrast agent shelf life).  The 
resultant microbubbles are allowed to settle at room temperature for 30 minutes; however 
long term storage should occurs at 2-8 oC.  These techniques successfully produce stable 
microbubbles with a 1-2 µm diameter.  
 
2.2.3 Microbubble Size Determination 
As evident from the oscillatory nature of these microbubbles under a sound field and the 
inertial cavitation criteria put forth previously, the resting size of a microbubble is an 
important parameter to measure.  Microbubbles are difficult to measure with dynamic 
light scattering (DLS) as they are on the larger end the acceptable measurement range (10 
– 1000 nm), and they do not obey Brownian motion, a necessary criteria for measuring 
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the size.  The gold standard for measuring microbubble size distributions is the Coulter 
Counter (Beckmann-Coulter, Brea, CA).  However, in the absence of such a device and 
on a budget, microscope image processing techniques can be employed to accurately 
measure size distributions of microbubbles. 
 
The size distribution of the population of microbubbles was determined by a MATLAB 
(Mathworks, Natick, MA) image segmentation program.  Samples of the selected shell 
compositions are separately prepared by the same method listed above and diluted 10 
times to aid the analysis of the program, since overlapping or clustered microbubbles 
cause anomalous results.  First, four images are recorded from each of four samples 
prepared of a given shell composition (resulting in 16 images per shell composition).  
The images are recorded with an optical Carl Zeiss Axioskop 2+ microscope (Carl Zeiss 
AM, Oberkochen, Germany).  An example of a typical microbubble image (magnified by 
a 100X objective) is displayed below in Figure 2.1 for a shell composition of 95 mole% 
DPSC, 5 mole% DSPE-PEG 2000. 
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Figure 2.1: Typical microbubble micrograph.  This micrograph is a good representation of a typical 
microbubble population.  This sample has a shell composition of 95 mole% DPSC and 5 
mole% DSPE-PEG 2000.  The black circles in the plane of view will be the microbubbles 
which will be analyzed.  
 
The goal of the image segmentation software is to correctly identify dark circles of any 
size and measure their diameter.  First, the software finds the difference between an 
image which has microbubbles (sample image), and a reference image taken with the 
same objective in the presence of just water.  In this way, any imperfections in the lens 
and constant background color can be removed.  The program then converts the image 
into a binary color scheme using threshold manipulation, as well as inverting the colors.  
The colors are inverted in order to remove the white halo from the outside of the 
microbubbles (deemed not to be part of the measurable microbubble).  Figure 2.2 shows 
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the inverted binary image displayed in Figure 2.1, where the microbubbles have been 
converted into the white circles. 
 
 
Figure 2.2: Inverted binary microbubble micrograph.  The micrograph from Figure 2.1 has been 
modified using threshold manipulation to convert it to a binary image (black and white only).  
Additionally, the image is inverted so that black microbubbles become white domains.   
 
With this image, the program traces the edge of the white domains and fits them with 
polygons with a shape fitting algorithm.  The program then determines the radii by 
measuring the vertices of the polygons.  The polygons themselves are nearly circular and 
are a very close match to the actual radius of the microbubbles being images.  The 
outlines polygons can be mapped back onto the original image to illustrate this point.  In 
Figure 2.3 below, the outlines are traced in blue over the original image being analyzed 
from Figure 2.1. 
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Figure 2.3: Polygon outlined microbubbles.  The blue outlines of the polygons built from Figure 2.1 are 
overlaid on the original micrograph from Figure 2.2.  This image illustrates the accuracy of 
the microbubble image segmentation software as the actual edges of the microbubbles are 
closely traced by the blue polygons.  
 
The blue polygons here very closely outline the microbubbles from the initial 
micrograph.  The software indentifies all sizes of microbubbles, as long as they have 
enough contrast to the background media (basically determined by the focus of the 
microscope).  The main drawback of the software is that the microbubbles need to be at a 
dilution such that microbubbles are not coming into contact with one another, as this can 
obscure the size results.  By indentifying the vertices of the polygons, the program can 
calculated the diameters of the imaged microbubbles.  By employing widely available 
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MATLAB software, this method is cheap and simple procedure for measuring the size 
distribution of a population of microbubbles. 
 
 
2.3 Size Distribution 
 
As discussed in the previous section, the size distribution of a population of microbubbles 
can be determined from an image segmentation technique.  In Section 2.2.3, a population 
of microbubbles with a shell composition of 95 mole% DPSC, 5 mole% DSPE-PEG 2000 
is imaged and run processed with MATLAB.  From the image generated in Figure 2.3 
(along the 15 additional images taken of this shell composition), the microbubble size 
distribution data can be collected and analyzed.  By analyzing 16 separate images, the 
program can collect the sizes of over 200 microbubbles per shell composition.  A 
histogram of the size distribution is then generated for all the microbubbles analyzed for 
the aforementioned shell composition, shown in Figure 2.4. 
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Figure 2.4: Size distribution histogram.  This histogram describes the size distribution of a population 
of over 200 microbubbles analyzed with a shell composition of 95 mole% DPSC and 5 
mole% DSPE-PEG 2000.  For this population, the mean radius is approximately 1 µm, and 
the distribution is nearly Gaussian.  However, the histogram contains more microbubbles 
larger than the mean than microbubbles smaller than the mean.   
 
The size histogram from this shell composition has a mean radius of about 1 µm and a 
standard deviation of 1.6 µm.  The distribution has one mode and is nearly Gaussian, 
however with more microbubbles of relatively higher size than of lower size.  This 
process can then be repeated for the entire set of shell compositions described in Table 
2.1.  The data collected for the mean values of diameter and the respective standard 
deviations for this set of shell compositions is shown in Figure 2.5. 
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Figure 2.5: Microbubble mean diameter as a function of shell composition.  The size distributions of a 
set of shell compositions detailed in Table 2.1 is determined with the image segmentation 
method.  DSPE-PEG compositions of 1, 2.5, 5, 7.5, 10, 12.5, and 15 mole% and PEG 
molecular weights of 1000 [x], 2000 [○], 3000 [□], and 5000 [∆] g/mole are studied.  The 
mean value for the diameter does not significantly change over the span of studied shell 
compositions.  Additionally, the standard deviations of the size distributions are very large in 
comparison to the change in mean diameter. 
 
From Figure 2.5, it is clear the standard deviations in the microbubble size are large (on 
average 1.5 µm).  It is also clear that the average diameter only ranges from about 1 – 1.5 
µm, regardless of the shell composition.  While it is possible to observe that the mean 
diameters are increasing with increasing PEG composition, it is not a statistically 
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significant change due to the size of the standard deviation.  Therefore, this data shows 
that the size distribution of a population of microbubbles is largely insensitive to changes 
in microbubble shell composition (or at least the changes made for this study, systems of 
DSPC and 1 – 15 mole%, DSPE-PEG 1000 – 5000 g/mole).  
 
These results are somewhat curious; however, as it might be expected that mean diameter 
should increase as molecular weight increases from 1000 to 5000.  Theoretically, the 
thickness of the shell could vary to some degree based on the change in molecular 
weight.  The length of one repeat unit of PEG is 3.9 Å [57], and the number of repeat 
units presented here varies from 22 (for PEG 1000) to 113 (for PEG 5000), assuming the 
molecular weight of a PEG repeat unit is 44 g/mole.  These values amount to a maximum 
difference of 35 nm between the length contribution of PEG 1000 and PEG 5000.  This 
difference is very small compared to the average diameter of the microbubbles (between 
1 and 1.5 µm).  Additionally, the length of 35 nm assumes that the chains stand straight 
up, normal to the monolayer.  This is certainly not the case; their geometry is a function 
of the composition in the monolayer, and therefore the packing density (this 
conformational change is discussed at length in Chapter 3).  It is also possible that the 
PEG chains are invisible to the optical microscope, and are therefore neglected by the 
image segmentation software.  It is unlikely that this is the case, but if so a technique 
which does not use optics to record size would be preferred (like DLS).   
 
As 85 to 99 mole% of the bilayer is comprised of the same material (DSPC) for all the 
shell compositions studied, these results make sense.  Additionally, all shell compositions 
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display the same shape reported for 95 mole% DPSC and 5 mole% DSPE-PEG 2000 
sample (monomodal with near-Gaussian profile), but were not included here for brevity.  
In fact the resting size of a self assembled microbubble should be generally set by the 
Laplace pressure [58]: 
 
∆𝑃 =  2𝜎
𝑅0
 
(Equation 2.1) 
 
where ∆P is equal to the difference in the pressure inside and outside of the bubble at 
equilibrium.  Because this pressure difference should be constant for a microbubble at 
equilibrium, the only factor influencing the shape is the surface tension, σ.  As discussed 
later in Chapter 4 and thoroughly in other works [36, 59], the difference in the surface 
tension for a bubble at rest (not under ultrasound) between any of the shell compositions 
described here is negligible.  However small the differences in the size distributions may 
be, the measured distributions will be used in the models presented in the following 
chapters for accuracy. 
 
 
2.4 Incorporation into Subsequent Chapters and Conclusion 
 
As mentioned previously, the size distribution of microbubbles is of importance 
throughout this work.  Although the variations in the distributions are small between the 
different microbubble shell compositions studied, the shape of the distributions as a 
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whole greatly affect microbubble behavior.  In Chapter 3, the size distribution of the 
microbubble populations is shown to influence the speed of the onset of inertial 
cavitation.  In Chapter 5, the size distribution affects the shape the resonance peak of 
microbubble populations.  Additionally, these measured size distributions will be used 
when simulating theoretical models in order to better describe the experimental data.  In 
these studies, weighed averages of the size distributions will be employed (weighting 
based on the measurement occurrence fraction at a give radius).   
 
In this chapter, the size distributions of microbubble populations were measured for a set 
of shell compositions to be used in the remainder of this work.  This set of compositions 
was defined, the microbubble preparation technique was detailed, and novel image 
segmentation software based in MATLAB for measuring microbubble size distributions 
was presented.  Finally, it is shown that the size distributions of the microbubble samples 
measured are monomodal and nearly Gaussian, and display statistically insignificant 
changes between shell compositions.  
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CHAPTER 3: Microbubble Inertial Cavitation Threshold Pressure 
 
 
3.1 Introduction 
 
While the ultrasound image exceeds other imaging modalities such as X-ray, magnetic 
resonance imaging (MRI), and computed axial tomography (CAT) in safety, portability, 
and cost, it lags in image resolution and contrast.  One way the ultrasound image quality 
can be improved during investigation of the blood circulation or perfusion imaging is the 
use of ultrasound contrast agents.  These contrast agents are gas spheres stabilized by a 
surfactant coating the gas/liquid interface [12, 60, 61]. While air is sometimes used as the 
gas, a heavier gas can be chosen to maximize the stability of the microbubble in an 
aqueous environment.  These stable gases (most commonly fluorinated compounds) are 
typically denser, have lower water solubility, and diffuse slower than air [1].  The gas-
stabilizing shell can also be made from a variety of materials, including lipids, polymers, 
fatty acids, and proteins such as albumin [1].  One advantage to using amphiphilic 
molecules such as phospholipids is their ability to self-assemble around a gas sphere by 
orienting their hydrophobic tail groups toward the gas and their hydrophilic head groups 
toward the aqueous media.  Along with the surfactant, an additional molecule is often 
added to the shell to enhance stability.  This additional stabilizer is usually a hydrophilic 
polymer material which has been functionalized, or covalently bonded, to a lipid or fatty 
acid [26, 62, 63].  Accordingly, the polymer will face radially outward from the gas 
surface and protrude into the aqueous media.  The advantage of this type of polymer is 
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twofold, namely to prevent the coalescence of groups of microbubbles by steric 
hindrance, and to convey the property of stealth in vivo, so as to avoid elimination by 
reticuloendothelial phagocytic cells [26]. 
 
Recently, attention has turned to the use of microbubbles as possible vehicles for drug 
delivery.  In many of these applications the drug is incorporated into the microbubble 
shell material [41, 64].  The mechanism of release for these vehicles takes advantage of a 
microbubble’s acoustic response in the presence of a sound field, better known as 
cavitation.  At relatively low pressure amplitudes, a microbubble will expand and 
contract in response to the alternating negative and positive pressures to which it is 
subjected.  When these oscillations in microbubble radius can be sustained, the 
phenomenon is known as stable cavitation.  At relatively high pressure amplitudes, 
however, the microbubble oscillations increase in amplitude and become non-linear; that 
is, the changes in radius during expansion and contraction are no longer equivalent.  At a 
certain pressure, termed the inertial cavitation threshold pressure, the microbubble 
becomes sufficiently large during its expansion phase that it implodes and fractures upon 
the subsequent rarefaction [28, 29, 60, 65].  This implosion associated with inertial 
cavitation produces a shockwave, a local increase in temperature, and loud broadband 
noise [28, 63, 66-68].  The temperature increase and shockwave have been shown to 
cause damage to nearby microstructures, including cells [63, 69].  The mechanical index 
(MI) has been defined to assist ultrasound technicians in avoiding unwanted detrimental 
health effects.  The MI is defined as the peak negative pressure (PNP) divided by the 
square root of the driving frequency of ultrasound (in MPa and MHz, respectively) and is 
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used to quantify the potential danger of an ultrasound scan; in clinical settings the MI 
must be maintained below a value of 1.9 [38].   
 
On the other hand, inertial cavitation effects might be beneficial for drug delivery 
applications [12, 63, 70].  Depending on the application of interest, one may therefore 
wish to either achieve or to avoid inertial cavitation, and this requires knowledge of the 
inertial cavitation threshold pressure for a given population of microbubbles.  Moreover, 
this chapter will show that the inertial cavitation threshold will vary with microbubble 
shell architecture (such as membrane composition and microstructure) and will therefore 
allow for some degree of control over when a microbubble will undergo inertial 
cavitation.   
 
It is therefore necessary to understand which physical properties govern the inertial 
cavitation pressure and how.  While the dynamic behavior of a microbubble in the 
presence of a sound field is well described [28, 67], an experimental inertial cavitation 
threshold pressure is not well defined for varying shell composition.  A commonly 
accepted condition for inertial cavitation is when a microbubble expands to twice its 
resting radius during rarefaction, as this equips the microbubble with sufficient kinetic 
energy to implode upon contraction [35].  Given that the amplitude of the microbubble 
oscillations (and cavitation pressure threshold) is governed by microbubble shell 
elasticity and viscosity, so too then must the inertial cavitation threshold.  It is therefore 
anticipated that changes in microbubble elasticity and viscosity, as accomplished by 
changes in shell composition, can be used to set the inertial cavitation threshold. 
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3.2 Inertial Cavitation Detection 
 
3.2.1 Materials 
The lipid 1,2-Distearoyl-sn-Glycero-3-Phosphocholine (DSPC) and Polyethylene Glycol 
(PEG) functionalized lipid 1,2-Disteroyl-sn-Glycero-3-Phosphoethanolamine-N-
[Methoxy(Polyethyleneglycol)-2000], ammonium salt (DSPE PEG 2000) were purchased 
from Avanti Polar Lipids (Alabaster, AL).  The 3000 and 5000 molecular weight DSPE 
PEG functionalized lipids were also supplied by the above.  Sulfur Hexafluoride (SF6) 
was purchased from Airgas (Allentown, PA).   All other reagents used were of analytical 
grade. 
 
3.2.2 Microbubble Preparation 
A lipid film containing various mole% of DSPC and a PEG functionalized lipid is 
deposited onto a 20 ml scintillation vial from stock solutions dissolved in chloroform by 
N2 spin drying followed by 2 hours in vacuum.  The dried film is then rehydrated with 5 
ml of aqueous phosphate buffered saline (PBS) solution (pH 7.4) by sonicating the 
sample (Hielscher UP200S Ultrasonic Processor, Hielscher Ultrasonics, Teltow, 
Germany) for approximately 3 minutes at 20% amplitude.  This has the dual effect of 
dissolving the lipid mixture in solution and raising the temperature above that of the 
DSPC gel phase transition temperature, 55 oC.  The rehydrated solution is then cooled 
and aliquoted out into 2 ml serum vials and sealed.  The head space air is then evacuated 
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from the vial and replaced with the fluorinated heavy gas, SF6.  Finally the vials are 
vigorously shaken using the Vialmix shaker (Lantheus Medical Imaging) in order to 
disperse the gas phase.  The resultant microbubbles are allowed to settle at room 
temperature for 30 minutes, however long term storage should occurs at 2-8 oC.  These 
techniques successfully produce stable microbubbles with a 1-2 µm diameter. The size 
distribution of the population of microbubbles was determined by a MATLAB 
(Mathworks, Natick, MA) image segmentation program described in Chapter 2.  Samples 
of the selected shell compositions are separately prepared by the same method listed 
above and diluted to aid the analysis of the program, since overlapping or clustered 
microbubbles cause anomalous results.  The program then detects circles imaged by an 
optical Carl Zeiss Axioskop 2+ microscope (Carl Zeiss AM, Oberkochen, Germany) and 
reports the diameter distribution of the sample.  To limit the size distribution of 
microbubbles, a sample is centrifuged (Beckman-Coulter Allegra-64R, Palo Alto, CA) at 
3600 rpm for 5 minutes, and the liquid phase is collected for testing. 
 
3.2.3 Cavitation Detection Technique 
A home-built high voltage pulser, described in previous work [66, 71], is used to drive a 
2.25 MHz, 7.5 cm focus ultrasound transducer (Olympus NDT, Waltham MA).  Another 
2.25 MHz transducer is set at 90o to the transmitter and receives the acoustic response of 
a sample insonified by the transmitting transducer, such that the foci of the two 
transducers will overlap.  The foci of the spherically focused transducers are cigar 
shaped, with a 1 mm diameter, shown in the field simulation in Figure 3.1. 
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Figure 3.1: Field simulation of a transducer.  An acoustic field simulation from MATLAB for the 2.25 
MHz spherically focused (at 7.5 cm) Olympus transducers is displayed.  Regions which have 
the deepest red are the areas at which the transducers output will be most intense, and blue 
areas where the output is the weakest, or non-existent.  Both axes describe a distance in space, 
and the scales for both are in meters. 
 
If the transducers are positioned at 90o to one another, it is easy to imagine that the cigar 
shaped foci form a cross, where the overlapping region is a cube with a volume of 1 mm3. 
Both transducers are housed within a 15 liter tank filled with de-ionized water, the setup 
of which is shown in Figure 3.2.   
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Figure 3.2:  Cavitation detection experimental set-up. The cavitation detection system consists of two 
2.25 MHz spherically focused ultrasound transducers set at 90o relative to each other, one 
transmitting and the other used to receive (not drawn to scale).  The overlapping focal region 
of the transducers is approximately 1 mm3, located within a larger sample chamber (latex cot).  
Raw acoustic data is used to generate acoustic spectrograms, and inertial cavitation is detected 
by the determination of the amplitude of the phase inverted signal. 
 
The pulser is capable of delivering peak negative pressures of up to 3 MPa, as calibrated 
using a needle hydrophone [72]. The received signal is filtered to reduce noise by a 5 
MHz low pass filter (Minicircuits, Brooklyn NY) and amplified by +26 dB (Panametrics 
NDT, Waltham MA) before being digitized by an oscilloscope (Cleverscope Ltd., 
Auckland NZ).  The oscilloscope can resolve 100 MHz sample frequency.  The 
schematic is shown in Figure 3.3. 
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Figure 3.3: Cavitation detection schematic.  A home built pulser (designed and synthesized by Michał 
Mleczko) drives one 2.25 MHz transducer.  A second 2.25 MHz transducer receives the 
signal, which is then low pass filtered at 5 MHz, amplified by +26 dB, digitized by an 
oscilloscope, and recorded by MATLAB.  MATLAB also informs the pulser when to pulse, 
and the oscilloscope when to receive. 
 
The transmitting transducer creates pulse trains consisting of 4 pulses of 4 cycles each 
with 80 µs between pulses.  Every other pulse is inverted to allow for phase inversion in 
signal processing.  The total experiment consists of 600 pulse trains, which are 
transmitted at a repetition frequency of 5 Hz.  The experiment is repeated for set peak 
negative pressure amplitudes between 50 kPa and 2 MPa, and for PEG molecular weights 
between 2000 and 5000 with PEG concentrations ranging between 1 and 15 mole%.  The 
sample chamber consists of a latex cot (Duro-Med Industries, Valencia, CA) positioned 
so that the overlapping foci are within the cot.  Latex is used in order to minimize sound 
reflection from the walls of the sample chamber.  Previously prepared microbubbles are 
T
R +26 dB
5 MHz
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added to the sample chamber such that the dilution is six million times the initial 
concentration.  This dilution is based on the assumption that one billion microbubbles per 
milliliter exist in the initial microbubble solution, and such that if well mixed one bubble 
will be sampled in the focus for every six pulse trains.  The selection of this dilution is 
discussed in detail in Section 3.3.  The sample chamber is stirred by a magnetic stir plate 
at 600 rpm set under the tank.  For each new pressure amplitude, a fresh concentration of 
bubbles is added to the sample chamber, and each composition is repeated in triplicate in 
order to ensure at least one hundred microbubbles are analyzed for statistical 
significance. 
 
The received signal is then processed by a MATLAB program.  For each pulse train 
collected the program determines first whether a microbubble is found, and secondly if a 
microbubble is found, whether or not it is destroyed.  To determine whether a bubble is 
found, a phase inversion technique is used where the waveforms from the first and 
second pulses are added together.  Since the waveforms from the first and second pulse 
are inverse of one another, any linear response will be added to zero.  This is the case for 
the walls of the sample chamber.  The responses of the front wall to the first 2 pulses (one 
positive and one negative 4 cycle sine wave) are shown below in Figure 3.4.  As 
displayed, the responses are equal and opposite for this linear oscillator, and their 
addition results in zero signal (or just noise). 
 
62 
 
 
Figure 3.4: Phase inversion technique.  The received waveforms of only the response of the front wall 
of the latex sample chamber for the first two pulses (first positive [blue], and second negative 
[green] 4 cycle sine wave) are displayed.  It is easy to see from the graph that the responses of 
these pulses are equal in magnitude and opposite in phase, and their sum will equal zero.   
 
Non-linear oscillations, like those given off by cavitating microbubbles, will not be 
cancelled and show a significant response.  The program then determines a median and 
max value for the addition of the first two pulses.  If the max/median of the addition of 
the first two pulses is greater than the empirically determined detection threshold, than a 
bubble is determined to be found.  To determine whether the bubble was destroyed, the 
program similarly adds the third and fourth pulses.  The addition of the third and fourth 
pulses is then subtracted from the addition of the first and second pulses.  In this way, the 
program can determine in what condition a bubble found in the first set is in the second 
set.  If this subtraction is greater than the empirically determined destruction threshold, 
than that bubble is determined to be destroyed.  Sample pulse trains which specify both 
63 
 
these conditions are shown in the figures below (bubble found and not destroyed in 
Figure 3.5, bubble found and destroyed in Figure 3.6). 
 
 
Figure 3.5: Conditions for an undestroyed microbubble.  Acoustic spectrograms (left) and phase 
inverted waveforms (right) are displayed for 3 conditions: phase inversion of the first 2 pulses 
(top), phase inversion of the second 2 pulses (middle), and the difference between the 2 pulse 
sets (bottom).  In this example, a microbubble is found in the top row, as well as the second 
row; therefore it is automatically determined in the bottom row that the found microbubble 
has not been destroyed.  Acoustic spectrograms are displayed as a frequency index versus a 
time index, and the waveforms are a voltage versus a time index. 
64 
 
 
Figure 3.6: Conditions for a destroyed microbubble.  As in Figure 3.5, acoustic spectrograms (left) and 
phase inverted waveforms (right) are displayed for 3 conditions: phase inversion of the first 2 
pulses (top), phase inversion of the second 2 pulses (middle), and the difference between the 2 
pulse sets (bottom).  Here, a microbubble is found in the top row, however only noise is 
present in the second row; therefore it is automatically determined in the bottom row that the 
found microbubble has been destroyed.  Acoustic spectrograms are displayed as a frequency 
index versus a time index, and the waveforms are a voltage versus a time index. 
 
In each row of the preceding figures, the MATLAB program asks a question.  In the first 
row, it asks whether a microbubble is detected in the focus or not (top row).  
Microseconds later, it again asks whether a microbubble is detected (middle row).  
Finally, in the last row, the program asks whether a bubble found in the top row has been 
destroyed in the second row (only if yes to the first question).  Both these questions are 
determined by empirically determined threshold values of the max signal divided by the 
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mean signal of the waveform.  In Figures 3.D and 3.E, the max/mean values of each row 
are displayed above their respective acoustic spectrogram.  If the max/mean value of the 
phase inverted signals (top or middle row) is greater than 10, than a bubble is considered 
to be found.  Additionally, if the difference of the inversions (bottom row) has a 
max/mean value greater than 7, than the found microbubble is considered to be 
destroyed.  While these values may seem arbitrary, it is clear from the above figures that 
there exist clear cases of microbubble detection or the lack thereof.  Depending on the 
acoustic pressure, the max/mean values reported for found microbubbles can drop as low 
at 7.5; however, even at the highest acoustic pressures studied here, the max/mean value 
for noise (or no microbubble found) never reaches higher than 3.5.  Taken together, these 
results lend credibility to the selection of the max/min threshold values for detection and 
destruction.  This method can generally be referred to as the double passive cavitation 
identification technique.  
 
To ensure a microbubble cannot travel across the focus during the a single pulse train, the 
speed of mixing must be set such that a microbubble cannot cross the 1 mm focus within 
a single pulse train (0.3 ms), but will have sufficient time to clear the focus in the time 
between pulse trains (0.2 s).  The mixing speed is therefore set to 600 rpm (in a 1 cm 
radius sample chamber, where the bubbles travel rotationally) to ensure the max distance 
travelled by a microbubble within a single pulse train does not exceed 50 µm, which is 
far less than the overlapping foci distance of 1 mm.  Based on this speed, the bubble can 
theoretically travel a distance of 125 mm in 0.2 seconds, far greater than the length of the 
overlapping foci.  However, adjacent pulse trains with microbubbles found are excluded 
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from the processing to remove the possibility of the same microbubble being analyzed 
twice.  In this way the program determines how many microbubbles are destroyed out of 
how many microbubbles are detected. 
 
 
3.3 Microbubble Acoustic Response 
 
The pulser described earlier can also be used to measure the acoustic response of the 
microbubbles during sonication.  To measure the acoustic response, the magnitude of the 
voltage received by the transducer is analyzed over a period of sonication time.  This 
method is somewhat more rudimentary than the technique described earlier to measure 
inertial cavitation; however it can be used as a tool to define certain parameters of the 
experiment.  One such parameter is the optimal concentration of microbubbles within the 
sample chamber for inertial cavitation detection, discussed in brief in the previous 
section.  For this study, the concentration of microbubbles can be varied from relatively 
low concentrations (20 million times dilutions in PBS) to relatively high concentrations 
(up to only 100 times dilution of the initial microbubble formulation).  The results of this 
dilution experiment, preformed at acoustic pressure of 500 kPa over a period of 140 
seconds, are shown in Figure 3.7.  The pressure is selected to create a high enough signal 
to noise ratio in the microbubble response without destroying an excess of microbubbles.  
The time of sonication is selected to match the time of sonication planned for the 
cavitation detection study. 
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Figure 3.7: Acoustic response of various microbubble concentrations.  The raw acoustic response in 
volts of microbubble dilutions of 500k, 3MM, 6MM, 10MM, and 20MM times dilution are 
recorded over a period of 140 seconds (or 600 waveforms at 5 Hz pulse repetition frequency).  
The higher concentrations – 500k and 3MM times dilution – exhibit multiple scattering 
effects at early times.  At the lowest concentration – 20MM times dilution – the signal to 
noise ratio very low.  The intermediate concentrations – 6MM and 10MM times dilution – are 
most suitable for the cavitation detection studies. 
 
In the relatively higher concentrations, 500k and 3MM times dilution, the voltage 
response increases first before decreasing.  This is counter intuitive because the acoustic 
response is expected to decrease as sonication time increases; that is to say, as more 
microbubbles are being destroyed, the acoustic response of the sample is decreasing.  
This initial increase is due to the effects of multiple scattering and the inability of tightly 
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packed microbubbles to oscillate adequately.  After a sufficient number of microbubbles 
have been destroyed, the acoustic response can then reach its maximum value, and begin 
to drop again as more microbubbles are destroyed.  This multiple scattering effect is 
undesired; especially because it is preferred to only analyze a microbubble during 
approximately once every fifth pulse (to avoid measuring the same bubble on multiple 
occasions).  On the other hand, at the lower concentration – 20 MM times dilution – 
throughout the experiment the acoustic response barely comes beyond the noise level.  
This is simply because such a small amount of microbubbles are being analyzed.  For the 
purposes of this work, this low concentration is not enough give a sufficient signal to 
noise ratio, and does not analyze enough microbubbles over the course of the experiment 
to be statistically significant.  Therefore, the intermediate concentrations, 6 MM and 10 
MM times dilutions, will be adequate for the cavitation detection studies.   
 
Even at these concentrations, there still exist some sequential pulse trains in which a 
microbubble is identified by the cavitation software.  Analyzing a microbubble in every 
waveform is unwanted, as any given microbubble should only be analyzed once.  This 
concentration theoretically allows a microbubble only to appear in the focus in one of 
every six pulse trains.  While in practice this is not exactly true, adjacent pulse trains in 
which a bubble is detected are discarded to avoid the possibility of recording the response 
from the same microbubble. 
 
3.4 Transducer Calibration 
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Before the measurements of microbubble percent destruction can be attempted, it is 
important to determine at what peak negative pressures (PNP) the microbubbles are 
experiencing.  This is not a simple task however, as the input to the piezoelectric 
transducer is a set voltage programmed into the pulser (SchaumSchläger).  The properties 
of the transducer material determine how it converts voltage into mechanical vibrations 
and the sound wave.  A hydrophone needle is used measure the acoustic pressure of the 
sound wave inside the transducer focal region.  The hydrophone has a sensitivity of -276 
dB re 1 V/µPa at the transducer frequency of 2.25 MHz (as sensitivity is a function of 
frequency).  So to calibrate the transducer, the voltage output of the pulser can be varied 
between 0 and 255 Volts (peak to peak).  The hydrophone, positioned in the transducer 
focus, picks up the response of the signal (also in voltage), which can then be converted 
to pressure by the sensitivity.  By this method, a curve can be fit to the experimental data 
to describe the acoustic pressure of any possible voltage input from the pulser.  The 
results of the transducer calibration are shown in Figure 3.8, below. 
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Figure 3.8: 2.25 MHz transducer calibration.  The input set voltage of the pulser is converted into 
acoustic pressure using a needle hydrophone with a sensitivity of -276 dB re 1 V/µPa at 2.25 
MHz.  The peak negative pressure of the signal in the transducer focus has a linear region at 
low set voltages, then reaches an asymptote at approximately 3.2 MPa.  The data is described 
by an empirical 4th order polynomial equation which can be used to describe the acoustic 
pressure at any pulser set point. 
 
The data above in Figure 3.8 is linear in the region of interest, 0 – 2 MPa (or 0 – 45 set 
volts).  However for future work with the Olympus transducer it is best to characterize 
the entire range of pulser set voltages with an empirical equation describing the 
calibration data.  The empirical 4th order polynomial equation is listed below for 
reference in Equation 3.1: 
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PNP = -7.165*10-10(Vs4) + 1.016*10-6(Vs3) - 3.961*10-4(Vs2) + 5.941*10-2(Vs) + 4.799*10-2 
                                                                                                                                 
(Equation 3.1) 
 
where PNP is the peak negative pressure in MPa, and Vs is pulser set voltage in V.  While 
Equation 3.1 is purely empirical, it describes the measured data quite well, and has an R² 
value of 0.998.  With this calibration curve and equation, the inertial cavitation behavior 
of microbubbles can be studied as a function of acoustic peak negative pressure (as well 
as varying shell composition). 
 
 
3.5 Cavitation Threshold Pressure as a Function of Shell Composition 
 
This section details the measurement of microbubble cavitation threshold pressures, and 
the effects of altering microbubble shell composition.  Specifically, the microbubble shell 
composition will be altered by a change in the functionalized PEG mole fraction and 
molecular weight.  The inertial cavitation data as an overall percent of a microbubble 
population destroyed is reported as a function of increasing peak negative pressure.  The 
percent of microbubbles destroyed divided by total microbubbles measured is determined 
for each of the samples as described in the previous section.  Each sample is sonicated at 
peak negative pressures of 50, 100, 225, 350, 500, 600, 800, 1000, 1250, 1750, and 2000 
kPa.  For a given sample, the percentage of destroyed microbubbles was measured, along 
with 95% confidence intervals for at each of the pressures listed above.  Results were 
plotted in the form of destruction profiles (% destroyed versus peak negative pressure) 
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fitted with a cumulative Gamma distribution.  For all samples, the destruction threshold 
increased sigmoidally similar to Figure 3.9, which gives results for the 1 mole% DSPE 
PEG 2000, 99 mole% DSPC system.   
 
 
Figure 3.9: Representative bubble destruction curve.  Graph of percent bubble destruction with 
increasing acoustic peak negative pressure (PNP).  Results shown are for a contrast agent 
consisting of 99 mole% DPSC and 1 mole% DSPE-PEG2000 functionalized lipid.  No 
cavitation is observed at PNP less than 0.4 MPa, which is defined as the inertial cavitation 
threshold value, PT0.  PT50 and PT100 are therefore defined as the pressures required to 
cavitation 50 and 100 percent of the microbubble population, and for this sample are 0.85 
MPa and 1.5 MPa, respectively.  Between the measured values, the cavitation destruction 
profile is fit with a cumulative Gamma distribution with 95% confidence intervals. 
 
The destruction profiles were used to identify three peak negative pressure thresholds for 
each sample: PT0, defined as the pressure at which inertial cavitation first occurs, PT50, 
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defined as the pressure which yields 50% fractional destruction, and PT100, defined as the 
pressure at which the sample is fully cavitated.  For example, in Figure 3.9 the values of 
PT0, PT50, and PT100 are 0.4, 0.85, and 1.5 MPa, respectively.  The Gamma distribution is 
simply used as a consistent and unbiased method of providing a smooth curve through 
and between data points. 
 
Results for tests pertaining to PEG compositions of 1, 2.5, 5, 7.5, and 10 mole% (PEG 
molecular weight 2000) are shown together in Figure 3.10A. It is observed that the 
microbubbles require higher peak negative pressure to cavitate as the mole fraction of 
PEG in the formulation increases (PT50 values of 0.85, 0.88, 0.93, 1.19, and 1.26 MPa are 
recorded for PEG concentrations of 1, 2.5, 5, 7.5 and 10 mole%, respectively). This trend 
also holds when the PEG molecular weight is changed to 3000 and 5000 (Figure 3.10B, 
C, respectively).   
 
 
A 
74 
 
 
 
 
Figure 3.10:  Influence of PEG molecular weight and composition on cavitation thresholds.  Graphs 
report percent bubble destruction with increasing acoustic peak negative pressure.  Systems 
include: A DPSC/DSPE-PEG2000 system containing DSPE-PEG2000 concentrations of 1, 
2.5, 5, 7.5, 10 mole%, with acoustic pressure ranging from 50 kPa to 2 MPa.  The data is fit 
to a cumulative Gamma distribution with 95% confidence intervals. The varying 
concentrations of PEG all exhibit the same increasing sigmoidal trend with increasing 
acoustic pressure.  However, as the concentration of PEG increases, more pressure is 
C 
B 
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needed to cavitate a similar fraction of microbubbles. B DSPC/DSPE-PEG3000 system 
containing DSPE-PEG3000 concentrations of 1, 2.5, 5, 7.5, 10 mole%.  Similar trends to 
Figure 3.10 A are observed. C DSPC/DSPE-PEG5000 system containing DSPE-PEG5000 
concentrations of 1, 2.5, 5, 7.5, 10 mole%.  Similar trends to Figure 3.10 A, B are observed. 
 
As with Figure 3.9, the results of Figure 3.10A-C were used to identify PT0, PT50, and 
PT100 values for each sample. Figure 3.11 shows how PT50 varies with PEG mole fraction 
for each of the PEG molecular weights used.  Here, one notes a slight decrease in PT50 for 
increasing PEG molecular weight.  The vertical dashed lines at 4 and 8 mole% represent 
literature values corresponding to phospholipid membrane phase behavior.  4 mole% 
represents the mole fraction of PEG-lipid where the surface phase changes from 
mushroom regime to brush regime, and 8 mole% corresponds to the PEG-lipid saturation 
limit in a lipid membrane (for PEG 2000) [26, 73, 74].  Changes in PEG molecular 
weight shift these transitions slightly. 
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Figure 3.11: PT50 cavitation pressure dependence on PEG molecular weight and composition.  The 
mean cavitation threshold pressure, or PT50, is plotted for each of the systems in Figure 3.10 
A, B, C against the concentration of their respective molecular weights of PEG.  Each of 
the three molecular weights of PEG (2000[♦], 3000[■], and 5000[▲]) show a sigmoidal 
increase in inertial cavitation pressure as the concentration of PEG increases.  The 
inflection points of each molecular weight are at approximately 4 mole% and 8 mole%.  
Additionally, as molecular weight of PEG is increased, the mean cavitation threshold 
pressure decreases slightly.  The transition at around 4 mole% is reported in literature as the 
point at which lipid functionalized PEG transitions from the mushroom configuration phase 
to the brush configuration phase.  The transition at 8 mole% is also reported in literature as 
the composition at which PEG-lipid membranes are saturated with functionalized PEG [26, 
73, 74]. 
 
To attempt to identify the cause of the change in cavitation threshold pressure, the resting 
microbubble size of all the samples was also measured.  Figure 3.12 B shows a sample 
size distribution for a population of microbubbles from the 90 mole% DSPC / 10 mole% 
DSPE-PEG2000 system.  A destruction curve for this population is measured, and then 
the population is the centrifuged to limit size polydispersity.  The centrifuged sample size 
distribution is presented in Figure 3.12 C.  Before centrifugation the mean microbubble 
radius is 0.71 µm, and the variance of the radii is 0.122 µm; after centrifugation the mean 
radius is 0.49 µm, with a variance of 0.052 µm.  Figure 3.12 A shows the comparison of 
the destruction curves for the sample before and after centrifugation.   
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Figure 3.12: Cavitation threshold variance as a function of microbubble size polydispersity for the 
90 mole% DSPC / 10 mole% DSPE-PEG2000 system.  A Cavitation destruction curves 
for two different populations of microbubbles.  The steeper curve belongs to a population 
which is centrifuged at 3600 rpm for 5 minutes (○) and the more gradual curve to a freshly 
prepared sample of microbubbles (x).  The value of PT50 for both curves is the same for both 
populations, 1.2 MPa.  The size distributions from the two populations are shown: B The 
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size distribution of a freshly produced population of microbubbles.  The mean radius is 0.71 
µm +/- 0.35 µm.  C The size distribution for the same sample in Figure 3.12 B after 
centrifugation.  The mean radius is 0.49 µm +/- 0.22 µm.   
 
The onset of cavitation in the centrifuged sample is much more sudden than before 
centrifugation, and the curves intersect at their PT50 values.   A comprehensive study of 
the resting diameter distribution as a function of PEG composition and molecular weight 
is described in Chapter 2.  The microbubble size shows no statistically significant change 
throughout the samples.  The size distribution is fairly constant between 0.5 and 2.5 µm, 
with a mean diameter of approximately 1 µm. 
 
 
3.6 Simulating Inertial Cavitation Thresholds 
 
To add to the credibility of the measured cavitation threshold values, the experimental 
behavior is compared with simulated predictions.  These predictions consist of solving 
the modified version of the Herring equation (itself a modification of the well-known 
Rayleigh-Plesset equation (Equation 1.17)) [75], which describes pressure amplitude as a 
function of microbubble resting radius, to find the pressure amplitude which satisfies the 
criteria for cavitation at a given microbubble resting radius.  Since the microbubbles used 
in this work are not monodisperse in radius, the theoretical threshold pressure calculated 
as a function of resting radius is superimposed onto the measures size distributions.  
Then, for each experimental pressure tested, the fraction of microbubbles whose radii 
correspond to a pressure threshold less than the applied (experimental) pressure is 
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identified.  The microbubble fractions identified in this fashion serves as the prediction 
for comparison with the measured microbubbles destruction profiles.   
 
3.6.1 The Herring Equation 
Conyers Herring was an American physicist working with the National Defense Research 
Committee (NDRC) during the Second World War.  Herring’s work to this point had 
little to do with microbubble cavitation phenomenon (in fact it was in solid state physics), 
until he was assigned to the subsurface warfare division of the NRDC, and he was forced 
to take a closer look at Lord Rayleigh’s work.  In 1941, Herring made his modification to 
Rayleigh’s equation [76], which consisted of taking into account that the surrounding 
fluid is not completely incompressible by adding an extra term to Equation 1.12: 
   
𝑅?̈? + 32𝑅2̇ = 1𝜌 �𝑃𝐿 − 𝑃0 − 𝑃(𝑡) + 𝑹𝒄 𝑷?̇?� 
                   (Equation 3.2) 
 
where c is the speed of sound in the surrounding liquid and 𝑃?̇? is the first derivative of the 
pressure outside the bubble with respect to time (also note this equation does not include 
Poritsky’s viscous damping term as Herring’s work was 10 years its prior).  Since PL is 
described previously in Equation 1.16, its derivative can be taken and rearranged to give: 
 
𝑃?̇? = 1𝑅 �−3𝛾?̇? �𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 + 2𝜎?̇?𝑅 � 
                       (Equation 3.3) 
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Therefore substituting Equation 3.2 into Equation 3.3 yields the final version of the 
Herring equation [76] (with some algebraic rearrangement and the addition of Poritsky’s 
viscous damping term, for posterity). 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 �1 − 3𝛾?̇?𝑐 � − 2𝜎𝑅 �1 − ?̇?𝑐� − 4𝜇?̇?𝑅 − 𝑃0 − 𝑃(𝑡)� 
  (Equation 3.4) 
 
3.6.2 Morgan’s Modification of the Herring Equation 
Since the development of equations like the RPNNP and Herring’s equation, many 
subsequent modifications have been made to both, especially towards incorporating the 
effect of the microbubble surfactant shell.  Karen Morgan has made one such 
modification famous in 2001 by adding shell properties into the derivation of Herring’s 
equation [54].  Specifically, Morgan added the effects of the elastic modulus and shell 
viscosity into the Herring equation.  The addition of shell material properties such as 
these is of interest to this study because such parameters are needed to better describe the 
changes in the microbubble shell composition.  The Morgan model is therefore selected 
to simulate the cavitation destruction profiles, with the shell properties mentioned above 
as tuning parameters.  The Morgan modification of the Herring equation [54] is shown 
below in Equation 3.5: 
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� − 12𝜇𝑠ℎ𝜀 ?̇?𝑅(𝑅 − 𝜀) − 𝑃0 − 𝑃(𝑡)� 
Equation 3.5 
 
where R is the instantaneous radius of the bubble, ?̇? and ?̈? are the first and second 
derivative of the bubble radius with respect to time, ρ is the density of the surrounding 
media, P0 is the hydrostatic pressure, σ is the interfacial tension, Ro is the mean 
microbubble resting radius, χ is the shell elastic modulus, γ is the polytropic gas constant, 
c is the outside media speed of sound, µ is the viscosity of outside media, µsh is the shell 
viscosity, ε is the shell thickness, and P(t) is the driving pressure function (the same 
shape as previously defined).  The values for ρ, P0, σ, γ, µ, and c will be constant for a 
system of invariable shell lipid, encapsulated gas, and surrounding media.  However, the 
interest of this study will be to vary the relevant shell material properties, χ and µsh. 
 
The Morgan modification of the Herring equation can be solved numerically to determine 
a cavitation threshold curve with respect to resting radius.  In this way, the amplitude of 
P(t) is increased and the Morgan equation is differentially solved for R until the 
amplitude which gives R = 2R0 with the given parameters is located, where 2R0 is an 
acceptable estimate of the size a microbubble must reach for it to inertially cavitate [70, 
77].  R0 is then increased iteratively and the process of finding the amplitude of P(t) 
which gives R = 2R0 is repeated for each new R0.  The peak negative pressure of P(t) 
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which solved the equation is plotted against their respective R0 steps to create a cavitation 
threshold plot.  The lowest trough of this pressure curve is known as the optimal size and 
pressure for bubble cavitation [38, 65].  Overlaid with this pressure curve is the measured 
size distribution of the shell compositions analyzed.  This is necessary to take into 
account the range of microbubble sizes found in order to analyze a real sample with a 
polydisperse population, which will correspond to a distribution of cavitation pressures.  
Therefore, to generate a plot of fraction of bubbles destroyed, steps of pressure are 
iterated to determine what percentage of the overall occurrence of the overlaid size 
distribution is above the pressure curve.  The percentage of the size distribution is 
therefore correlated to the fraction of microbubbles destroyed at its respective pressure. 
In this way, by altering shell viscosity and elasticity parameters within physically 
relevant ranges, the experimental results can be fit with a theoretical comparison based on 
the Morgan modification of the Herring equation. 
 
Therefore, the experimental data recorded in Figure 3.10 A-C is modeled with the 
Morgan modification of the Herring Equation.  Again, the interest of this study lies in 
altering shell material properties to model its behavior and thus χ and µsh will be 
variables, while the other parameters listed in Table 3.1 will be constant.  
 
Table 3.1:  Modified Herring equation model parameters. 
Hydrostatic pressure P0 10130 Pa 
Resting radius R0 1 µm 
Media density ρ 998 kg m-3 
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Interfacial tension coefficient σ 0.051 N m-1 
Polytropic gas exponent γ 1.07 
Speed of sound in media c 1500 m s-1 
Media viscosity µ 0.001 Pa s  
Shell thickness ε 1 nm 
 
For the purposes of this study, the pressure function will be a single 4 cycle sine wave, 
displayed in Chapter 1.  The Herring equation is then numerically solved for R and the 
amplitude of the 4 cycle sine wave in P(t) is increased incrementally until the amplitude 
value which results in R = 2R0 is found.  R0 is then increased iteratively from 0.1 µm to 3 
µm in steps of 0.1 µm, and the process of finding the amplitude of P(t) which gives R = 
2R0 is repeated for each new R0.  The peak negative pressure of P(t) which solved the 
equation will be plotted against their respective R0 solutions to create a cavitation 
threshold plot, an example of which is given in Figure 3.13.   
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Figure 3.13: Herring equation optimal cavitation size.  Graph of the theoretical cavitation pressure 
and relative occurrence related to resting radius of microbubbles.  The Morgan solution 
pressure curve is generated by solving the Morgan modification of the Herring equation at a 
range of amplitudes of the pressure function for the point when the instantaneous radius is 
equal to 2 times the resting radius (solid line). The lowest point on the pressure curve is 
related to the optimum resting radius for microbubble cavitation.  The size distribution for a 
population of microbubbles comprised of 99 % mol DSPC and 1 % mol DSPE-PEG2000 is 
overlaid (dashed line).          
 
Also overlaid in Figure 3.13 is a sample size distribution measured earlier for each of the 
shell compositions analyzed.  Now it is of interest to generate the sigmoidal curve of 
fraction of bubbles destroyed against increasing peak negative pressure.  To accomplish 
this, steps of pressure are taken to determine what percentage of the overall occurrence of 
the size distribution is above the Morgan equation curve at a given pressure.  This 
percentage above the curve is therefore correlated to the fraction of microbubbles 
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destroyed in the measured cavitation threshold destruction curves and overlaid in the 
results (example in Figure 3.14).   
 
 
Figure 3.14: Theoretical Herring model comparison with experimental data.  A sample of the 
modified Herring equation theoretical model (x line) compared to experimental results 
(solid line) from a cavitation experiment of the 90 % mol DSPC, 10 % mol DSPE-
PEG2000.  The theoretical model displayed was created using the parameters in Table 1, 
and with χ = 6 N m-1, µsh = 4 Pa s. 
 
In this way the shell material properties can be altered; χ between 1-13 N m-1, and µsh 
between 0.1-5 Pa s to match the experimental results with a theoretical model based on 
the Morgan modification of the Herring equation.  The range of relevant χ and µsh values 
are plotted as theoretical fractional destruction as a function of peak negative pressure in 
the sensitivity plot shown in Figure 3.15.   
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Figure 3.15: Range of relevant χ and µsh values.  Graph shows of the range of theoretical values of the 
elastic modulus (χ) in N m-1 and the shell viscosity (µsh) in Pa s.  The cavitation destruction 
curves show that the fraction destroyed decrease with increasing χ and µsh at a single 
pressure.  The graph was built with the following data sets (in descending order): χ=1, 
µsh=1; χ=5, µsh=1; χ=5, µsh=5; χ=10, µsh=1; χ=10, µsh=5; and χ=10, µsh=10 [N m-1, Pa s]. 
 
Taking this sensitivity study a step further, theoretical cavitation profiles can be 
determined in this manner for a large range of input parameters, χ and µsh.  For the 
purposes of this study, the input parameters will range from 0 – 8 N/m in elastic modulus, 
and 0 – 8 Pa s in shell viscosity.  Although this is a rather large range (especially in shell 
viscosity), this should provide a better picture of how the cavitation threshold 
theoretically changes with material parameter alterations.  Figure 3.16 displays all the 
theoretically calculated inertial cavitation thresholds (PT) as a function of the input 
parameters entered into the Morgan’s modification of the Herring equation used to solve 
for the cavitation threshold.   
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Figure 3.16: Theoretically determined inertial cavitation thresholds.  Theoretical inertial cavitation 
thresholds displayed here are calculated using Morgan’s modification of the Herring 
equation (Equation 3.5) using a range of input parameters – shell viscosities of 0 – 8 Pa s, 
and elastic modulus of 0 – 8 N/m.  In general, increasing the shell viscosity drastically 
increases the cavitation threshold pressure, and increasing the elastic modulus slightly 
increases the cavitation threshold pressure. 
 
Figure 3.16 shows that the cavitation threshold pressure increases with both increasing 
shell viscosity and elastic modulus.  Both of these effects stiffen the membrane, which 
subsequently will cause the microbubble to require more pressure to inertially cavitate.  
While all these theoretical cavitation thresholds are correct for the given input 
parameters, it is desirable to find which set or sets of input parameters determine the 
88 
 
cavitation threshold pressure which most closely matches the measured cavitation 
thresholds. 
 
To solve this problem, not only the values of inertial cavitation threshold pressure, but the 
shape of the modeled and measured cavitation profiles should be compared.  In addition 
to the model determining the cavitation threshold pressure for each set of input 
parameters, it also builds theoretical cavitation profiles, an example of which is shown in 
Figure 3.14.  A simple Cartesian norm is applied to find the difference in the shapes of 
the modeled and measured curves: 
 
𝑒 = ��(𝐹𝑡𝑖 − 𝐹𝑒𝑖)2 + (𝐹𝑡𝑖+1 − 𝐹𝑒𝑖+1)2 + ⋯  
  (Equation 3.6) 
 
where e is the error between the measured and modeled cavitation profiles, Ft is the 
fraction destroyed at a given pressure from the theoretical cavitation profile, and Fe is the 
fraction destroyed at a given pressure from the measured cavitation profile.  For a given 
shell composition system, the squared error between the modeled cavitation profiles and 
a single experimental profile (for the given system) is calculated and plotted as a function 
of the input parameters in Figure 3.17.  Because a two parameter fit is employed in 
solving Morgan’s modification of the Herring equation, a unique solution does not exist.  
In fact, there exists a line of input parameters that will satisfy the criteria for matching the 
modeled and measures inertial cavitation thresholds.  Figure 3.17 shows the squared error 
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results for a shell composition comprised of 99 mole% DSPC and 1 mole% DSPE-
PEG2000. 
 
 
Figure 3.17: Error surface for a given shell composition.  The graph displays the values of the squared 
error (calculated from Equation 3.6) as a function of the input parameters (0 – 8 Pa s in 
shell viscosity, and 0 – 8 N/m in elastic modulus) for a microbubble population comprised 
of 99 mole% DSPC, 1 mole% DSPE-PEG 2000.  The lowest values of the squared error are 
tied to the input parameters which give the best agreement between the modeled and 
measured cavitation profiles, represented in this figure by the solid pink line. 
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For each shell composition, an error surface like the one displayed in Figure 3.17 can be 
computed.  In this error surface, the values of the input parameters which have the lowest 
error value between measured and modeled are highlighted in pink.  For this shell 
composition, the pink line therefore represents the best fit input parameters for the 
Morgan modification of the Herring equation.  Extending this technique to other PEG 
mole fractions in the PEG 2000 set, a plane of best fit input parameters can be built.  This 
plane can be assembled simply by calculating the best fit lines for each of the PEG mole 
fractions (2.5, 5, 7.5, and 10 mole%), and interpolating between the lines in the input 
parameter space.  This plane of best fit input parameters is displayed below in Figure 
3.18 for systems of varying compositions of DSPC and DSPE-PEG 2000. 
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Figure 3.18: Plane of best fit input parameters.  Lines of best fit input parameters for PEG 2000 
compositions of 2.5, 5, 7.5, and 10 mole% (remainder DSPC) are plotted together.  The 
input parameter space between the measured PEG compositions is interpolated with least 
squares.  As PEG 2000 composition increases, shell viscosity and elastic modulus increases 
(while holding the other respective input parameter constant).  
 
The plane in Figure 3.17 is created using least squares interpolation.  The best fit plane 
also provides some insight into behavior of the input parameters as a function of 
microbubble shell composition.  As PEG 2000 composition increases in the monolayer, 
so do the values of both shell viscosity and elastic modulus (if the other parameter is held 
constant).  This plane successfully predicts the values of the selected input parameters, 
shell viscosity and elastic modulus, for any composition of DSPC / DSPE-PEG 2000 
microbubbles.  Additionally, this plane can be reproduced for any microbubble 
composition system simply by inputting the measured inertial cavitation thresholds. 
 
 
3.7 Conclusions 
 
The results of this work show unequivocally that the microbubble inertial cavitation 
threshold is sensitive to changes in microbubble shell composition.  This is not 
surprising, but until now the result has not been demonstrated for the given systems 
experimentally.  Perhaps more importantly, the results are well-described by a model that 
quantifies cavitation in terms of rigorous membrane properties, name elasticity and shell 
viscosity.  Accordingly, this work suggests that using shell composition to tune the 
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microbubble inertial cavitation pressure to a desired value is feasible in the range 0.76 – 
1.26 MPa. 
 
The ability to tune the microbubble inertial cavitation threshold is of potential 
significance, given the importance of cavitation concerning safety during imaging.  That 
is, by tuning the inertial cavitation pressure to a relatively high value, one could improve 
the safety of an ultrasound contrast agent formulation without compromising 
performance.  Moreover, it is likely that tuning the microbubble cavitation pressure could 
improve efficacy in applications involving microbubbles as actuators or delivery vehicles 
as occurs in sonoporation and drug/gene delivery.    
 
Taking full advantage of microbubble cavitation threshold tunability requires a solid 
understanding of the extent to which various physical properties influence the threshold 
value.  Several aspects of this work therefore warrant further discussion.  First is the fact 
that all destruction profiles generated exhibit a sigmoid shape.  This is simply due to the 
fact that the microbubbles used here were not monodisperse, which is true for nearly all 
microbubble samples, including commercial formulations.  The only reported 
monodisperse microbubble formulations reported are those prepared by microfluidic 
techniques [78].  For a monodisperse microbubble population, one would expect the 
destruction profile to exhibit step change.  That is, one would expect a single threshold 
pressure, below which no microbubbles cavitate inertially and above which all 
microbubbles cavitate inertially.  The fact that the percentage of microbubbles 
undergoing inertial cavitation rises gradually with pressure reflects the polydispersity of 
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the samples.  Figure 3.12 demonstrates this effect clearly; centrifuging a formulation 
therefore decreases the polydispersity significantly from a variance of 0.122 to 0.052 µm, 
leading to a much sharper transition.  Accordingly, the polydispersity should be borne in 
mind when discussing cavitation thresholds.  It should be further noted that the 
polydispersity just mentioned relates primarily to the sizes of microbubbles rather than to 
any variations in shell composition.  A natural question then arises, namely what is the 
influence of size on the cavitation threshold? In other words, if the size polydispersity is 
what accounts for the breadth in cavitation observed at a given shell composition, then 
could changes in size be what causes the observed shifts in the overall destruction 
profiles as one changes shell composition?  The short answer is no; size polydispersity 
affects the breadth of a given microbubble destruction profile but does not account for 
shifts in destruction profiles among samples.  This is demonstrated clearly by Figure 2.5, 
which shows that microbubble sizes are largely insensitive to the various shell 
compositions used herein.  Thus, the observed changes in cavitation threshold must be 
due to some feature of the microbubble other than size that is sensitive to compositional 
changes. 
 
The obvious candidate is the shell membrane physical properties.  Evidence supporting 
this view is the result obtained when the cavitation data is plotted as threshold pressure 
versus PEG mole fraction for each of the three PEG molecular weighs used.   The 
threshold pressure is largely insensitive to PEG compositional changes until a mole 
fraction of approximately 4.5 mole%, a value which coincides with the published 
transition of PEG 2000 from a so-called mushroom to a brush configuration, shown in 
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Figure 3.11.   Above this transitional composition, the threshold rises sharply with 
additional PEG.  The cavitation threshold becomes insensitive to PEG composition once 
again above approximately 8 mole%, a value which corresponds to the published 
saturation value of PEG 2000 in PEG-lipid membranes [26, 73, 74].  At mole fractions 
exceeding the saturation limit, excess PEG functionalized lipids are thought to self-
assemble into micellar structures, which would not be echogenic or detected by the pulse 
inversion technique applied in this study [79, 80].  Thus, the cavitation results correlate 
well with known lipid membrane phase behavior.   Moreover, these results occur 
irrespective of the PEG molecular weight used.  On the other hand, the PEG molecular 
weight does influence only the extent of cavitation achieved in the various regions of 
composition space.  Taken together, these results point to change in membrane stiffness 
as the primary parameter controlling the inertial cavitation threshold. 
 
To test this idea, a well-known model that accounts for microbubble shell stiffness in the 
presence of a sound field is invoked, namely the Morgan modification of the Herring 
equation.  This model explicitly accounts for two properties of the shell, namely the shell 
viscosity and the elastic modulus, and describes dynamic microbubble radius as a 
function of applied pressure.  However, the equation does not explicitly identify an 
inertial cavitation pressure.  The approach was to invoke a commonly used criterion for 
cavitation put forth by Leighton [35], namely that the microbubble must expand to twice 
its resting radius during rarefaction so as to possess sufficient kinetic energy to implode 
on the successive contraction.  Solving the Morgan modification of the Herring equation 
for this criterion gives the expected pressure for inertial cavitation for a given resting 
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microbubble radius.  Given the aforementioned size polydispersity of the samples, the 
solution as a function of microbubble radius can be coupled with the measured resting 
radii for the samples so as to give predicted destruction profiles.  Strictly speaking, the 
predictions are not best fits of the data (as this would require computation beyond the 
scope of this study); nevertheless, the model predictions agree with the experimental 
results using reasonable values of membrane elasticity and viscosity.  The values 
presented of the elasticity and shell viscosity are examples of a set of parameters which 
fit the experimental data, however they are not unique solutions, and for this reason a 
range of values are presented in Figure 3.15.    It is therefore concluded that the tunability 
of microbubble inertial cavitation thresholds has been experimentally demonstrated using 
shell composition and that experimental results agree with a well established model of 
microbubble physics.  
 
The sensitivity of inertial cavitation threshold to changes in shell viscosity and elasticity 
makes shell composition (here, polyethylene glycol (PEG) molecular weight and 
composition) a potential tuning parameter for microbubble-based ultrasound contrast and 
drug delivery applications.  Microbubble shell composition can be used to adjust the 
inertial cavitation threshold so as to either avoid or achieve cavitation at a given operating 
pressure.  This idea was tested by measuring the inertial cavitation threshold for 
populations of phospholipid-shelled microbubbles suspended in aqueous media, and 
using this method to quantify the influence of shell composition on the inertial cavitation 
threshold.  The experimental cavitation data was fit with Morgan’s modification of the 
Herring equation, using shell viscosity and elastic modulus as the tuning parameters.  In 
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conclusion, the design and synthesis of microbubbles with a prescribed inertial cavitation 
threshold is feasible using PEG molecular weight and mole fraction as tuning parameters. 
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CHAPTER 4: Colloidal Model for Microbubble Oscillations 
 
 
Since Lord Rayleigh’s derivation of his famous equation, many modifications have been 
made to improve the accuracy of the model for predicting microbubble oscillations.  For 
example, Poritsky famously accounted for the viscous losses to the surrounding fluid to 
be included as the last ‘P’ in the RPNNP (designation by Lauterborn [44]); and Herring 
accounted for the compressibility in the surrounding liquid by adding the mach number 
�
?̇?
𝑐
�.  Since then, many subsequent additions have been made to the Rayleigh’s equation, 
most of which incorporating Poritsky’s (RPNNP-like) or Herring’s modification, or both.  
All of these modifications can trace their derivation to the addition of a term into energy 
balance, which Rayleigh initially stated as the work of the expanding bubble is equal to 
the kinetic energy of the fluid is it pushing away.  In this section, some of the more 
famous modifications are examined and their influence on theoretical microbubble 
oscillations is displayed. 
 
 
4.1 Significant Microbubble Dynamics Models  
 
4.1.1 Naked Microbubble Models 
Naked microbubbles, or microbubbles without a surfactant shell, were the main focus of 
most of the research up until the 1980s and 1990s.  This includes the most famous of 
these equations, the RPNNP equation (Equation 1.18), along with the Herring equation 
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(Equation 3.4).  Note that Equation 3.4 is actually the ‘modified’ Herring equation as 
Poritsky’s viscous losses term has been added to it in order to show the progression of the 
equation from its inception by Lord Rayleigh.   
 
At low acoustic pressures (and therefore small oscillations), both the RPNNP and the 
modified Herring equation behave similarly.  This is because both equations are identical 
with the exception of Herring’s addition of terms including 1 minus the Mach number.  
When the microbubble oscillations are small, the wall velocity (?̇?) is much smaller than 
the speed of sound in the liquid (c), and thus the term approaches unity.  However, as the 
acoustic pressure is increased above 100 kPa, the difference in the equations is very 
noticeable.  Figure 4.1 shows the response of the microbubble (both both in non-
dimensional radius and Mach number) predicted by both naked models at two acoustic 
pressures, 50 kPa and 200 kPa (with the shape of the 4 cycle pulse shown earlier in 
Figure 1.13).  
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Figure 4.1: RPNNP and modified Herring model comparisons.   The RPNNP model (black line) and 
modified Herring model (blue line) simulations are compared.  The simulations in the first 
column have an incident pressure of 50 kPa, and the second column has an incident pressure 
of 200 kPa.  The first row displays the response of the non-dimensional radius (R/R0) and the 
second row displays the response of the non-dimensional wall velocity (or Mach number; (?̇?/
𝑐)). 
 
In the top row of Figure 4.1, the non-dimensional radius response, it is observed that at 
the low pressure (50 kPa), there exists almost no difference between the RPNNP and 
modified Herring models.  However, as the pressure increases (to 200 kPa) these 
differences become more pronounced; the modified Herring equation successfully 
dampens the microbubble oscillations, while the RPNNP predicts unstable oscillations 
with a maximum R/R0 of 4 (far greater than predicted cavitation thresholds).  The same 
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phenomenon is noticed in the Mach number plots, where the speed of the microbubble 
wall quickly becomes much larger than the speed of sound in the RPNNP predication as 
the pressure is increased.   
 
If the pressure is increased even more than displayed here (to values above 500 kPa), 
both models become unstable.  It is accepted that models like these can only approximate 
very small microbubble oscillations.  Additionally, neither of these equations have 
accounted for the possibility of a microbubble shell, as this would not have been of 
interest in the 1950s when both these researchers were interested in underwater bubbles.  
This is no longer the case, as modelers have taken an interest in predicting the behavior 
of ultrasound contrast agents. 
 
4.1.2 Thinly Shelled Microbubble Models 
Since the mid 1980s and the inception of the ultrasound contrast agent, microbubble 
models have begun to attempt to understand the response of shelled microbubbles.  As 
before, these models add additional damping terms into the energy balance in order to 
explain the effect of the shell on microbubble oscillations.  The following section will 
analyze three of such equations which make modifications to the RPNNP or Herring.  
Although there are many more models which describe microbubble oscillations for both 
shelled and shell-less systems, these three models are selected because they will help to 
explain the justification for the presented colloid model for microbubble oscillation 
described in Section 4.2.  One of the first of these modifications was made by Nico de 
Jong in 1994 [81], where the shell stiffness parameter  (Sp) is taken into effect.   
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4.1.2.1  de Jong Model 
de Jong’s modification to the RPNNP was simply to add the effect of the stiffness of the 
shell into the energy balance by introducing the shell stiff parameter (Sp).  Although the 
shell stiffness parameter is empirical and mainly used in fitting, it is the first important 
step in accounting for the stiffness of the microbubble shell.  Note that the de Jong model 
has an extra term which describes the overall damping of the system from a variety of 
media, δ (viscous, acoustic, and thermal).  These damping effects were originally 
proposed by Eatock and Nishi in 1984 [82], but their equation is not included here for the 
sake of brevity.  The Eatock and Nishi modification is simply the RPNNP with the 
addition of the damping term: −𝛿𝜔𝜌𝑅?̇?.  As it is cumbersome to express these models in 
terms of all of their modifiers, this work names them by their final editor (i.e. de Jong’s 
model is really de Jong’s modification of Eatock and Nishi’s modification of Poritsky’s 
modification of Rayleigh’s equation).  Modifications beyond the Herring or RPNNP 
equations will be displayed in bold.  The de Jong model can be written as [1, 81]: 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 − 2𝜎𝑅 − 4𝜇?̇?𝑅 − 𝜹𝝎𝝆𝑹?̇? − 𝟐𝑺𝒑 � 𝟏𝑹𝟎 − 𝟏𝑹� − 𝑃0
− 𝑃(𝑡)� 
(Equation 4.1) 
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where δ is the total damping, ω is the center frequency, and Sp is the shell stiffness 
parameter.  de Jong’s addition of the all encompassing Sp parameter was the first step in 
the development of a shelled microbubble model, although this is not a well defined 
parameter, and is often cited as being set to values of 1 – 5 N/m [28, 63, 70, 81].  A more 
rigorous model defining microbubble oscillations would include one or more well 
defined shell material properties, as can be seen in the following sections.  However, to 
show the initial difference between a naked microbubble model and a thinly shelled 
microbubble model, Figure 4.2 displays the response of a microbubble to the same 
incident sound wave as in Figure 4.1, at pressure of 50 and 200 kPa.  The microbubble is 
modeled using both the de Jong equation (red line) and its predecessor, the RPNNP 
equation (again, black line) for both its normalized radius and wall velocity.  As before, 
the following constants are used for a microbubble in an aqueous environment: ρ is 998 
kg/m3, P0 is 10.13 kPa, σ is 0.051 N/m, γ is 1.07, µ is 0.001 Pa s, and R0 is 1 µm.  
Additionally, the de Jong’s equation parameters are: ω is 2.25 MHz, Sp is 1 N/m, and δ is 
0.06 (as from his works and that derived from Medwin [10, 81]). 
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Figure 4.2: RPNNP and de Jong model comparison.  The predictions of microbubble dynamic radius 
and wall velocity are simulated using both the RPNNP (again, black line) and de Jong’s 
model (red lines).  The simulations in the first column have an incident pressure of 50 kPa, 
and the second column has an incident pressure of 200 kPa.  The first row displays the 
response of the non-dimensional radius (R/R0) and the second row displays the response of 
the non-dimensional wall velocity (or Mach number; (?̇?/𝑐)). 
 
The de Jong model predicts oscillations of a lower magnitude than the RPNNP.  This is 
to be expected as the Eatock damping term and shell stiffness term both increase the 
resistance of the microbubble to oscillation.  These modification terms, along with any 
other credible additions to naked microbubble models, serve to increase the damping of 
the system and decrease the magnitude of the oscillations.  However, the weakness of the 
de Jong model is in characterizing the shell with the shell stiffness parameter, a fitting 
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parameter which has no value in a predictive model.  Future models would attempt to 
expound on this by introducing rigorously defined physical properties instead of the shell 
stiffness parameter.  
 
4.1.2.2 Morgan Model 
Karen Morgan’s modification of the shelled microbubble oscillation equation contains 
the terms derived by both Poritsky and Herring [49, 54, 76].  The Morgan equation is 
used to simulate the cavitation profiles and attempt to explain the experimental cavitation 
results in Chapter 3, and is displayed in Equation 3.5.  This model, derived in 2000, is a 
significant advance in microbubble physics as it incorporates well defined material 
properties of the shell, the elastic modulus (χ) and shell viscosity (µsh), as opposed to de 
Jong’s fitting parameter, Sp. 
 
Again, Morgan’s equation includes the addition of terms which describe the shell and 
serve to dampen the oscillations of the bubble.  Since the Morgan equation represents an 
even more stable example of a microbubble dynamics model, its response to the incident 
sound wave should be examined at even higher pressure amplitudes.  Figure 4.3 shows 
the response of a microbubble’s non-dimensional radius to incident pressure amplitudes 
of 50, 200, 500, and 1000 kPa.  The oscillations become increasingly non-linear as the 
incident pressure amplitude increases, as well as becoming greater in magnitude.  The 
magnitude of the oscillations varies from 1.07 to 7.5 between 50 kPa and 1 MPa.  In these 
simulations, χ and µsh are constant at 1 N/m and 0.63 Pa s, respectively.  
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Figure 4.3: Morgan model predictions.  The predictions of microbubble non-dimensional radius are 
simulated using for the Morgan model at four pressure amplitudes.  The simulations have 
incident pressure amplitudes (top left to right) or 50, 200, 500, and 1000 kPa.  In general, the 
oscillations grow larger and more non-linear as the pressure is increased. 
 
Observing the non-dimensional radius R/R0 is important because as discussed earlier it 
contains insight into the onset of inertial cavitation (suggested by Leighton to be when 
R/R0 = between 2 and 2.3 [35]).  In the case that the inertial cavitation threshold pressure 
is 2, than the Morgan model predicts cavitation somewhere between 200 and 500 kPa (a 
thorough study of the cavitation predications of the Morgan equation are discussed in 
Chapter 3).  However, some groups have suggested that the onset of inertial cavitation 
should be related to the kinetic energy of the bubble, and therefore the non-dimensional 
wall velocity of the bubble (or Mach number, ?̇?/𝑐).  Figure 4.4 displays the Mach number 
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as a function of the same incident pressures as Figure 4.3.  It is suggested by Vaughan 
that the inertial cavitation threshold is a Mach number of 1 [37].  In this case, the Morgan 
model predicts cavitation based on the Mach number between 500 kPa and 1 MPa. 
 
 
Figure 4.4: Morgan model predictions of the Mach number.  The predictions of microbubble non-
dimensional wall velocity are simulated using for the Morgan model at four pressure 
amplitudes.  The simulations have incident pressure amplitudes (top left to right) of 50, 200, 
500, and 1000 kPa.  The velocity change becomes non-linear with increasing incident 
pressure, until the speed becomes spectrum-like, with very larger compression velocity 
(negative velocity) compared to the expansion velocity. 
 
Morgan adds two terms to the Herring equation to account for the effect of both the 
elastic modulus and shell viscosity, which are: 2𝜒
𝑅
�
𝑅0
𝑅
�
2
�1 − 3?̇?
𝑐
�  and 12𝜇𝑠ℎ𝜀 ?̇?𝑅(𝑅−𝜀), 
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respectively.  Morgan’s third contribution to the equation is in the portion of the equation 
that describes the pressure directly outside the bubble, assumed in the RPNNP as 
displayed in Equation 1.16.  However, Morgan adds that the pressure outside the bubble 
should also be affected by the elastic modulus of the shell, such that: 
 
𝑃𝐿 = �𝑃0 + 2𝜎𝑅0 + 𝟐𝝌𝑹𝟎� �𝑅0𝑅 �3𝛾 �1 − 3𝛾?̇?𝑐 � − 2𝜎𝑅 �1 − ?̇?𝑐� 
(Equation 4.2) 
 
This is somewhat perplexing, as this is assuming that pressure drop is somehow related to 
not only the Laplace pressure, but also the elastic modulus.  The effect on the equation is 
to aid acceleration of the bubble wall to return to zero when no ultrasound pressure is 
being applied as it negates the 2𝜒
𝑅
�
𝑅0
𝑅
�
2
�1 − 3?̇?
𝑐
� term when R = R0 and ?̇?= 0 (no pressure 
function).  This is important to bear in mind as it will be an important allusion to the next 
model examined, Philippe Marmottant’s modification (in the following section). 
 
4.1.2.3 Marmottant Model 
Philippe Marmottant developed his microbubble dynamic model is 2005, and is a further 
improvement inspired by the Morgan model [36].  Marmottant’s model is again rooted in 
both the Herring and RPNNP.  In addition to the terms presented in the modified Herring 
equation (Equation 3.4), Marmottant adds the effect of dilatational viscosity of the shell, 
which was originally introduced by Chatterjee in 2003 [83].  Marmottant’s original 
contribution, as alluded to in the previous section, was the effect dynamic surface tension 
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(σ(R)).  Marmottant correctly states that the surface tension of a shelled microbubble 
should not be constant, as it had previously been assumed to be, because surface tension 
is a function of the bubble surface area (and therefore the radius).  In Morgan’s model, 
the surface tension (in the Laplace pressure) is affected by the elastic modulus, χ, for all 
bubble radii.  Marmottant argues that this cannot be correct because this would assume 
that the surface tension increase as the bubble expands (when in reality it should be the 
exact opposite) [36].  Marmottant therefore defines three regimes of shelled microbubble 
oscillation; a buckled state at small radii (based on the work of Mark Borden [84]), an 
elastic state at intermediate radii, and a ruptured state at large radii.  The thresholds of 
these regimes are loosely defined as Rbuckling = 0.99*R0, and Rruptured = 
Rbuckling(1+σwater/χ)1/2 (with Relastic being anything in between).  The dynamic surface 
tension is therefore defined within these regimes as: 
 
 
 
(Equation 4.3) 
 
Within these criteria, several scenarios arise.  At very small pressure amplitudes 
(therefore small oscillations), the microbubble can stay in the elastic region with stability.  
In this case, the Morgan model would be correct (at least in terms of the addition of the 
term mentioned in the previous section).  For large pressure amplitudes, however, the 
bubble should experience all of these regimes in a single oscillation.  The surface tension 
  0   if R ≤ Rbuckling 
σ (R) =  χ� 𝑅
2
𝑅𝑏𝑢𝑐𝑘𝑙𝑖𝑛𝑔
2 − 1� if Rbuckling ≤ R ≤ Rbreak-up 
  σwater   if R ≥ Rruptured 
{ 
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will therefore vary based on the instantaneous radius between 0 and 72 mN/m (σwater).  
The Marmottant model is presented below in Equation 4.4: 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎(𝑅0)𝑅0 � �𝑅0𝑅 �3𝛾 �1 − 3𝛾?̇?𝑐 � − 2𝜎(𝑅)𝑅 − 4𝜇?̇?𝑅 − 4𝜅𝑠?̇?𝑅2 − 𝑃0
− 𝑃(𝑡)� 
(Equation 4.4) 
 
where κs is the dilatational viscosity.  The form of Marmottant’s equation is very familiar 
to those which have been presented throughout this work, with the exception of a few 
new terms (here, the dilatational viscosity and dynamic surface tension).  Since 
Marmottant himself makes comparisons to the Morgan equation, it is interesting to 
investigate their responses side by side.  Figure 4.5 displays the microbubble response 
(again in both non-dimensional radius and Mach number) of both the Marmottant 
equation (red line) and the Morgan equation (black line).  The simulations were created 
with the same Morgan model parameters as in Section 4.1.2.2, a κs of 7*10-9 N s/m, and 
incident pressure amplitudes of 100 kPa (left panels) and 500 kPa (right panels).  The 
Marmottant model proves to be more stable both in the shape of the oscillations and the 
magnitude of the oscillations.  Again, the difference in the two models is magnified at 
higher pressures.  The Marmottant model is understandably more stable with the dynamic 
surface tension, when the radius is large, damping is also at its largest (σ(R) = σwater), and 
as the bubble contracts, damping is at its smallest (σ(R) = 0). 
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Figure 4.5: Marmottant and Morgan model predictions.  The Morgan model (black line) and modified 
Marmottant model (red line) simulations are compared.  The simulations in the first column 
have an incident pressure of 100 kPa, and the second column has an incident pressure of 500 
kPa.  The first row displays the response of the non-dimensional radius (R/R0) and the second 
row displays the response of the non-dimensional wall velocity (or Mach number; (?̇?/𝑐)). 
 
 
4.2 Colloidal Approach to Microbubble Dynamics 
 
All the models aforementioned make the claim to be able to accurately predict 
microbubble oscillations.  Many of the research groups responsible for deriving these 
models prove their accuracy by taking high speed images of an oscillating microbubble 
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under an ultrasound field [29, 36, 54, 55, 85].  Most of these models are typically very 
accurate under two conditions: the incident sound pressure is relatively low (<100 kPa), 
and certain material properties are allowed to vary as fitting parameters.  These 
conditions allude to the weakness of some of these models; they break down at high 
incident pressures and they require fitting parameters (and are therefore not truly 
predictive).  From a colloid science approach, another perceived weakness of these 
models is the use of bulk material properties, such as the shell stiffness parameter (Sp), 
elastic modulus (χ), and shell viscosity (µsh).  Bulk material properties assume that the 
material in question is homogeneous throughout, whereas a microbubble is comprised of 
only a thin solid shell and larger encapsulated volume of gas.  From this perspective, 
interfacial material properties are desired, such as the surface tension (σ) and the 
dilatational viscosity (κs). 
 
The influence of the shell should be described by a well defined surface material 
property, not a bulk property.  One such appropriate property is the area expansion 
modulus, KA.  The area expansion modulus can be interpreted as the first derivative of 
surface tension with respect to area (or the second derivative of the Gibbs free energy 
with respect to area) [58]. 
 
𝐾𝐴 = �𝛿𝜎𝛿𝐴�𝑛𝑠 
(Equation 4.5) 
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where ns is the number of surfactant molecules in the monolayer.  To incorporate this 
relevant membrane phenomenological parameter into a microbubble oscillation model, 
KA must be recast in terms of a pressure drop it enacts on the interface.  By definition, KA 
is equal to the applied tension, τ, divided by the strain caused by the applied tension, αt: 
 
𝐾𝐴 = 𝜏𝛼𝑡 
(Equation 4.6) 
 
and αt is equal to the change in surface area (A) divided by the initial surface area (A0) of 
the microbubble. 
 
𝛼𝑡 =  ∆𝐴𝐴0 =  4𝜋4𝜋 (𝑅2 − 𝑅02)𝑅02 =  (𝑅2 − 𝑅02)𝑅02  
(Equation 4.7) 
 
Finally, the tension t is defined as: 
 
𝜏 =  − 12∆𝑃𝑅 
(Equation 4.8) 
 
Combining Equations 4.6, 4.7, and 4.8, KA has been rearranged as a function of pressure 
drop and can be added to an RPNNP-like equation. 
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∆𝑃 = −2 𝐾𝐴(𝑅2 − 𝑅02)
𝑅𝑅0
2  
(Equation 4.9) 
 
With the KA term identified, the remainder of the model can be easily derived from the 
energy balance, as demonstrated with Rayleigh’s equation in Chapter 1.  This new 
colloidal model also takes some insight from past modifications of Rayleigh’s equation.  
Both Poritsky and Herring’s modifications are taken into account, along with Chatterjee’s 
addition of the surface dilatational viscosity (but not Marmottant’s his dynamic surface 
tension, as discussed later in this chapter).  This new colloidal model is presented below, 
in Equation 4.10: 
 
𝑅?̈? + 32𝑅2̇ = 1𝜌��𝑃0 + 2𝜎𝑅0� �𝑅0𝑅 �3𝛾 �1 − 3𝛾?̇?𝑐 � − 2𝜎𝑅 �1 − ?̇?𝑐� − 4𝜇?̇?𝑅 − 2𝐾𝐴(𝑅2 − 𝑅𝑜2)𝑅𝑅𝑜2
−
4𝜅𝑠?̇?
𝑅2
− 𝑃0 − 𝑃(𝑡)� 
(Equation 4.10) 
 
This equation represents a step forward in microbubble dynamics equations for two 
reasons.  First, it employs only relevant surface material properties, and no bulk material 
properties.  Second, it can potentially be used as a fully predictive model (with no fitting 
parameters) by knowing only the KA of the microbubble being analyzed.  The KA is 
extensively measured in the literature for lipid bilayers, but can be measured for unique 
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samples (like microbubbles or ultrasound contrast agents) by a pipette aspiration method 
[86].  Predictions of microbubble cavitation behavior using KA will be discussed in the 
following sections. 
 
The colloidal model can be simulated in the same fashion as the aforementioned 
microbubble oscillation models.  The equation will be numerically solved using the same 
parameters as the previous models (P0 = 10130 Pa, R0 = 1 mm, σ = 51 mN/m, κs = 7*10-9 
N s /m, KA = 0.05 N/m, γ = 1.07, c = 1540 m/s, ρ = 998 kg/m3, and µ = 0.001 Pa s).  P(t) 
has the form of Figure 1.13 (4 cycle sine burst), with amplitudes of 50, 200, 500, and 
1000 kPa. 
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Figure 4.6: Colloidal model oscillation predictions.  The predictions of microbubble non-dimensional 
radius are simulated using for the colloidal model at four pressure amplitudes.  The 
simulations have incident pressure amplitudes (top left to right) or 50, 200, 500, and 1000 
kPa.  The oscillations are stable, but are already non-linear at 50 kPa. 
 
The oscillations predicted by the colloidal model are very stable, even up to 1 MPa.  The 
oscillations are slightly non-linear at 50 kPa (slightly larger peak positive pressure than 
peak negative pressure).  At greater pressure amplitude, the oscillations take on a saw-
tooth shape, and the oscillations exceed the cavitation threshold criteria of R/R0 = 2 
between 200 and 500 kPa.   In previous models, the radius is prone to increase on 
subsequent cycles.  The colloidal model predicts a slightly lower magnitude of 
oscillations in comparison with the Marmottant model.  Additionally, the Mach number 
can be simulated at the same incident ultrasound pressure with the colloidal model 
(results presented in Figure 4.7).  Similar to the other models presented in this chapter, 
the oscillations of the wall velocity become increasingly non-linear as the incident 
pressure increases, and become spikes at 1 MPa.  The Vaughan cavitation criteria (where 
the Mach number exceeds 1) is also satisfied at 1 MPa with this model. 
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Figure 4.7: Colloidal model Mach number predictions.  The predictions of microbubble non-
dimensional wall velocity are simulated using for the colloidal model at four pressure 
amplitudes.  The simulations have incident pressure amplitudes (top left to right) or 50, 200, 
500, and 1000 kPa.  The oscillations in velocity slowly become the characteristic spectrum-
like spikes at 1 MPa. 
 
 
4.3 Simulating Cavitation with the Colloidal Model 
 
As aforementioned, other studies compare their presented models for microbubble 
oscillations with high speed camera data acquired while a microbubble is oscillating 
under ultrasound.  This technique is applicable when studying the dynamic radius of a 
single bubble.  In this work, the accuracy of the proposed model will be evaluated using 
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the cavitation simulation technique described in Chapter 3.  Comparing experimental 
cavitation data with simulated cavitation profiles gives improved accuracy because it 
allows for the analysis of the behavior of an entire population of microbubbles, not just a 
single one.  This is beneficial because typically commercial contrast agents display a 
range of sizes in their microbubble populations, which is known to affect the oscillation 
dynamics.  With the cavitation comparison, a real world size distribution of microbubbles 
can be evaluated. 
 
4.3.1 Simulation Method 
Reviewing what was described earlier in Chapter 3, the simulated cavitation thresholds 
are simulated as follows.  The colloidal model (Equation 4.10) will be numerically solved 
by MATLAB (ode45, a non-stiff solver) for a series of initial radii, 0.1 – 5 µm.  At each 
R0, the solver iteratively increases the magnitude of P(t) until the given cavitation 
criterion is met (for example, R/R0 = 2).  At this point, the program records the lowest 
value of the magnitude of P(t) that satisfies the cavitation criteria, and marks it as PT0.  
The program then continues the R0 loop until it has identified a PT0 for every 
corresponding R0.  By this method, the program can generate a plot which describes the 
predicted incidence of inertial cavitation depending on the initial radius of a microbubble, 
shown here in Figure 4.8 (for the given set of constant parameters listed in the figure 
caption). 
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Figure 4.8: Prediction for the incidence of cavitation.  The blue line represents the simulated lowest 
value of PT0 which satisfies the criterion R/R0 = 2 for each of the radii examined.  The 
simulation was run with constant parameters: P0 = 10130 Pa, R0 = 1 mm, σ = 51 mN/m, κs = 
7*10-9 N s /m, KA = 0.05 N/m, γ = 1.07, c = 1540 m/s, ρ = 998 kg/m3, and µ = 0.001 Pa s. 
 
In Figure 4.8 an initial radius of 0.8 µm is shown to be the radius which requires the 
lowest pressure to inertially cavitate.  Relatively lower and higher radii require 
increasingly more pressure to reach the cavitation threshold.  To then build the cavitation 
destruction profile, the program overlays the above figure with the measured size 
distribution of the given sample, shown below in Figure 4.9 from the 95 mole% DSPC, 5 
mole% DSPE-PEG 3000 composition. 
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Figure 4.9:  Comparison of measured size distribution with “destruction distribution”.  Figure 4.8 is 
overlaid with the measured size distribution for the 95 mole% DSPC, 5 mole% DSPE-PEG 
3000 composition (green line).  At a given pressure, the fraction of size distribution under the 
blue curve is predicted to be cavitated. 
 
To build the cavitation destruction profiles, Figure 4.9 is analyzed for its overlapping 
regions at all pressures.  At low pressures below the blue line, no cavitation is predicted 
because at this pressure none of the measured sizes are ideal for cavitation.  At pressures 
above the blue line, some weighted fraction of the size distribution is predicted to be 
cavitated, because that initial size will produce oscillations greater than the threshold 
criterion.  At very high pressures (greater than 2.5 MPa), almost 100% of the measured 
size distribution is beneath the cavitation criteria line (blue) and is predicted to be 
cavitated.  The destruction profiles presented below are generated simply by equating the 
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weighted percentage of the size distribution under the blue curve to the percent of 
microbubbles destroyed. 
 
4.3.2 Cavitation Profile Sensitivity 
By changing the relevant surface material parameters, it is anticipated that any of the 
measured cavitation profiles can be fit with a simulated profile.  Altering the surface 
properties is logical as these would be the only parameters affected by a change in 
monolayer composition.  Those relevant parameters are the area expansion modulus (KA), 
the surface tension (σ), and the dilatational viscosity (κs).  Of course, building the 
minimum cavitation criteria curve (blue line in the figures above) is dependent on the 
selected inertial cavitation criterion.  First, cavitation profiles are built with the above 
method for inertial cavitation threshold criteria of R/R0 = 2, 3, 4, 6, and 8 (Figure 4.10, 
below).  This may seem excessive to classical cavitation theorists, as Leighton had 
described the threshold value to be somewhere between 2 and 2.3 [35].  However 
recently, O’Brien has used threshold values between 3.4 and 8 to describe the cavitation 
behavior of Definity [53].   
 
Figure 4.10 displays the sensitivity of the simulated cavitation profiles to changes in the 
threshold criteria.  This aids in the identification of the proper value for predicting 
cavitation profiles.  The shape of the cavitation profile remains fairly constant between 
the different cavitation criteria, however to onset of cavitation varies greatly between 0.4 
and 2.1 MPa for the range analyzed.  All other parameters except the threshold criteria 
are held constant. 
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Figure 4.10: Predicted sensitivity to cavitation threshold.  The simulated cavitation profiles are 
modeled for cavitation threshold criteria of R/R0 = 2, 3, 4, 6, and 8.  The relevant 
phenomenological constants are: σ = 51 mN/m, κs = 7*10-9 N s /m, and KA = 50 mN/m.  As 
the threshold criterion increases, the shape of the curve appears constant and the pressure 
incidence of cavitation is increased. 
 
In addition to altering the threshold, the surface material parameters from the colloidal 
model will also be varied in a physically significant way to determine the cavitation 
profiles sensitivities to them.  Figures 4.11 – 4.13 display the sensitivity of the cavitation 
profiles to changes in KA, κs, and σ, respectively.  The parameter values studied are: KA = 
5, 10, 25, 50, and 100 mN/m, κs = 3, 4, 5, 6, 7 nN s/m, and σ = 5, 10, 25, 50, 72 mN/m. 
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Figure 4.11: Predicted sensitivity to area expansion modulus.  The simulated cavitation profiles are 
modeled for area expansion moduli of KA = 5, 10, 25, 50, and 100 mN/m.  The cavitation 
threshold criterion is R/R0 = 4, and the relevant phenomenological constants are: σ = 51 
mN/m, and κs = 7*10-9 N s /m.  As the area expansion modulus increases, the growth rate of 
the curve becomes less steep and the pressure incidence of cavitation is increased. 
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Figure 4.12: Predicted sensitivity to dilatational viscosity.  The simulated cavitation profiles are 
modeled for dilatational viscosities of κs = 3, 4, 5, 6, and 7 *10-9 N s/m.  The cavitation 
threshold criterion is R/R0 = 4, and the relevant phenomenological constants are: σ = 51 
mN/m, and KA = 50 mN/m.  As the dilatational viscosity increases, the growth rate of the 
curve decreases slightly and the pressure incidence of cavitation is increased slightly. 
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Figure 4.13: Predicted sensitivity to surface tension.  The simulated cavitation profiles are modeled 
for surface tension of σ = 5, 10, 25, 50, and 72 mN/m.  The cavitation threshold criterion is 
R/R0 = 4, and the relevant phenomenological constants are: κs = 7*10-9 N s /m, and KA = 50 
mN/m.  As the surface tension increases, neither the growth rate of the curve or the 
incidence of cavitation is affected. 
 
Of these three surface material properties, variations in KA have the greatest effect on the 
cavitation profiles.  Increasing KA both decreases the growth rate of the destruction 
profile and increases the cavitation threshold pressure significantly.  Variations in κs 
influence the shape and threshold pressure in the same way, but to a lesser extent within 
the physically relevant range.  The surface tension is a well defined parameter for many 
interfaces, and is worth further discussion.  The value for an air/water interface is 72 
mN/m, and the addition of surfactants (such as the lipid shell) effectively decreases the 
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value of the surface tension.  Values for the surface tension of microbubbles have been 
estimated by previous researchers to be in the range investigated in Figure 4.13 [54, 87, 
88].  As discussed earlier in this chapter, Marmottant argues that the surface tension is 
variable between 0 -72 mN/m depending on the oscillation status of the microbubble.  
However, as shown through the simulation in Figure 4.13, values of the surface tension in 
this range make a very minimal difference in both the growth rate and cavitation 
threshold pressure in the destruction curves.  This serves as good justification for using a 
constant value for surface tension in the colloidal model. 
 
 
4.4 Predictive Model for Microbubble Cavitation 
 
Armed with the sensitivities for the variables which theoretically could be affected by a 
change in membrane composition, the colloidal model can be utilized for predicting the 
cavitation profile of microbubbles with compositional changes.  However, it is necessary 
to understand which of the variables studied above will change and by how much as a 
function of the compositional change.   
 
As described earlier, as PEG functionalization increases from 1 – 10 mole%, the 
interactions between PEG molecules changes from a regime where they do not interact 
(mushroom) to one in which they are close enough together to interact (brush).  Lin and 
Thomas report that for PEG 2000, this transition should occur at around 4 mole% PEG, 
and that the membrane should be saturated with PEG molecules at 8 mole% [26].  
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Although this is a function of PEG molecular weight, we can use these as general 
guidelines.  For example, the 1 and 2.5 mole% samples are firmly in the mushroom 
regime, while the 10 mole% samples are firmly in the brush (5 and 7.5 mole% being 
somewhere in the transition closer to brush).  This regime change brought on by 
increasing membrane surface functionalization of PEG can be described by a change in 
on the area expansion modulus, KA [62, 89, 90].  KA is a known function of the PEG 
composition, molecular weight, and interaction regime.  In the mushroom regime, the 
value of KA is insensitive to changes in molecular weight and compositional change, 
which can be seen in Figure 4.14, where all the measured cavitation profiles for 
mushroom regime compositions are plotted together (1 and 2 mole% PEG for all 
molecular weights). 
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Figure 4.14: Mushroom regime cavitation profiles.  The measured cavitation profiles for all 
mushroom regime shell compositions are plotted together (1 and 2.5 mole% PEG, all 
MWs).  All the curves overlap fairly well and have similar values for PT0, PT50, and PT100. 
 
All the cavitation profiles measured from shell compositions in the mushroom regime 
overlap, with both the same shape and inertial cavitation threshold.  This result can be 
taken that all the shell compositions in this regime have the same material parameters, 
specifically KA, which supports the earlier hypothesis.  KA0 will be considered as the 
mushroom regime value of KA, and will be determined with a fitting routine using the 
measured data.  The value of KA0 is found to be 25 mN/m, as determined by fitting curves 
to the measured data for the 99 mole% DSPC, 1 mole% DSPE-PEG 2000 shell 
composition, illustrated in Figure 4.15. 
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Figure 4.15: Mushroom regime fitted cavitation profile.  A simulated cavitation profile is compared to 
a mushroom regime measured cavitation profile (99 mole% DSPC, 1 mole% DSPE-PEG 
2000).  The simulation was generated with a cavitation threshold criterion is R/R0 = 3, and 
phenomenological parameters of: σ = 51 mN/m, κs = 7*10-9 N s /m, and KA = 25 mN/m.  In 
general, the colloidal model gives good agreement to the experimental data. 
 
This simulated profile, built using colloidal model with threshold criterion R/R0 = 3, σ = 
51 mN/m, κs = 7*10-9 N s /m, and KA0 = 25 mN/m, gives good agreement to the 
experimental data.  Since it is desired to design a predictive model, the value of KA must 
now be calculated for changes in shell composition, and then compared to other measured 
profiles.  KA in the transition or brush regime is not constant, and is a function of both the 
PEG molecular weight and mole fraction, given by Equation 4.11: 
 
𝐾𝐴 =  𝐾𝐴0 �∆ + ln (𝑋0)�85
𝑁
3
5
 
(Equation 4.11) 
 
where ∆ is the adsorption energy (normalized by kT), X0 is the mole fraction of 
PEGylated lipids in the shell, and N is the number of PEG repeat units in a PEG 
molecule.  N can simply be determined by dividing the total MW of the PEG by the MW 
of a single PEG repeat unit (44 g/mole).  The adsorption energy is somewhat more 
nebulous for these changes in shell composition, but will be held constant for the 
purposes of this work.  If the adsorption energy is set to 8.5 kT, then the predicted values 
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of KA for the studied set of PEG MW and mole fraction can be described by Figure 4.16, 
below. 
 
 
Figure 4.16: Predicted KA for various shell compositions.  This figure displays the predicted values of 
KA using Equation 4.11 for shell compositions of 1 – 15 mole% DSPE-PEG, molecular 
weights 1000 – 5000 g/mole.  The adsorption energy is assumed to be 8.5 kT.  Mushroom 
regime compositions display KA = KA0 = 25 mN/m, and brush regime compositions exhibit 
an increase in KA with both increasing PEG composition and decreasing PEG MW. 
 
It can be observed from the figure that KA is unchanged for mushroom regime shell 
compositions, but varies as a function of both X0 and N for brush regime compositions.  
In fact, KA increases with increasing PEG composition in the monolayer, but decreases 
with increasing PEG molecular weight.  While this may seem counter-intuitive, recall the 
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results of the measured inertial cavitation threshold pressures from Chapter 3.  In those 
experiments, the PT50 (peak negative pressure to destroyed 50% of a microbubble 
population) increased with PEG composition, but decreased with PEG molecular weight, 
a result which lends credence to the theory. 
 
For the combination of the colloidal model and the KA relation (Equations 4.10 and 4.11) 
to be truly predictive, experimental destruction curves from the brush regime should be 
able to be forecast by these equations.  The fitted curve to determine KA0 fits all the 
destruction profiles from the brush regime (see Figure 4.14).  A predicted curve for the 
measured cavitation data from the 90 mole% DSPC, 10 mole% DSPE-PEG 2000 is 
therefore created using the same variables as for the mushroom regime prediction, with 
the exception of a new predicted KA, determined by Equation 4.11 to be 70 mN/m.  The 
resulting predicted line is overlaid on the measured cavitation data for that shell 
composition in Figure 4.17.  The prediction (green line) provides very good agreement 
with the data, proving that the colloidal model can be used as a predictive model for 
small changes in shell composition.   
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Figure 4.17: Brush regime predicted cavitation profile.  A predicted cavitation profile is compared to 
a brush regime measured cavitation profile (90 mole% DSPC, 10 mole% DSPE-PEG 2000).  
The simulations was generated with a cavitation threshold criterion is R/R0 = 3, and 
phenomenological parameters of: σ = 51 mN/m, κs = 7*10-9 N s /m, and KA = 70 mN/m.  
The colloidal model is able to give good agreement to the experimental data by only 
altering the KA value from the mushroom regime determined KA0 and calculated from 
Equation 4.11. 
 
The use of a predictive model for determining the inertial cavitation threshold of 
ultrasound contrast agents is of obvious importance.  In this way (or by measuring the KA 
of the shell material) the onset of the negative bioeffects associated with inertial 
cavitation can be avoided.  Additionally, the full extent of cavitation can also be predicted 
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for drug delivery applications, and bubbles can be tailor made - by tuning their shell 
composition - to achieve either (or both) of these ends. 
 
 
4.5 Conclusion 
 
The focus of this chapter has been to highlight the importance and accuracy of 
microbubble dynamics equations.  Classic equations, namely the RPNNP and Herring 
equation, are analyzed along with three (of many) equations that account for the addition 
of a microbubble shell.  A new model was therefore developed based on the 
advancements put forth the RPNNP, Herring, and Marmottant equation, with the addition 
of the effect of the area expansion of the bubble.  The use of a rigorous surface property 
like the area expansion modulus allows the developed colloidal model to explain the 
cavitation profiles measured in Chapter 3.  Additionally, with the aid of an equation that 
describes the area expansion modulus as a function of shell composition, the colloidal 
model predicates its power in predicting the cavitation profiles of brush regime shell 
compositions.  
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CHAPTER 5: Resonance Frequency of Microbubbles 
 
 
5.1 Introduction to Resonance Frequency 
 
Due to their functionality as ultrasound contrast agents and drug delivery vehicles, 
shelled microbubbles have garnered significant interest over the past 20 years [9, 28, 91].  
Microbubbles which are effective in contrast and drug delivery modalities are typically 
characterized by a thin shell – often a monolayer – which coats and stabilizes a gas core.  
For ultrasound contrast applications, microbubbles rely on their ability to reflect and 
backscatter sound waves which can be detected and interpreted by a clinical ultrasound 
imager.  For this reason, microbubble stability is of importance to commercial 
manufacturers.  The most recent formulations of microbubbles are between 1 – 10 µm in 
diameter and consist of a polymer, phospholipid, or protein shell, which encapsulates a 
fluorinated heavy gas [1, 12, 92].  These microbubbles are often further stabilized by the 
addition of a covalently linked polymer, such as polyethylene glycol (PEG), to prevent 
coalescence and uptake in vivo by steric hindrance [25, 61, 74].   
 
Another phenomenon which influences microbubble stability is that of cavitation.  
Microbubbles in a sound field respond to the positive and negative pressure components 
of wave by oscillations [93].  The oscillation period is determined by the driving 
frequency of the ultrasound, while the magnitude of the oscillations is mainly driven by 
the amplitude of the sound pressure.  At relatively low pressures, below the so-called 
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cavitation threshold, microbubbles will exhibit sustained oscillations (also called stable 
cavitation).  However, above this threshold – which is accepted to be when the 
microbubble’s wall velocity exceeds the speed of sound in the media – the microbubble 
undergoes a violent collapse and implosion, termed inertial cavitation [66, 87].  Inertial 
cavitation is the unwanted outcome for a clinician (and patient) for two reasons, one 
being the destruction or fragmentation of the contrast agents themselves, and another 
being the potential for the subsequent shockwave to damage nearby  cells [40, 94].  In 
previous chapters, it was demonstrated that the inertial cavitation threshold depends on 
microbubble shell composition, namely the mole fraction and molecular weight of 
functionalized PEG.  However, given that the magnitude of microbubble oscillations is a 
function of the microbubble resonance frequency, it is hypothesized that shell 
composition driven changes in inertial cavitation threshold stem from shell composition 
driven changes in resonance frequency.  Whereas many previous studies [9, 28, 91] have 
focused mainly on the dynamics of commercially available contrast agents, it is of 
interest to test the hypothesis by investigating the resonance frequency dynamics with 
controlled variations in shell composition, both experimentally and with a well defined 
microbubble dynamics equation. 
 
 
5.2 Detection of Microbubble Resonance Frequency 
 
5.2.1  Materials 
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The phospholipid 1,2-Distearoyl-sn-glycero-3-Phosphocholine (DSPC) and Polyethylene 
Glycol (PEG) functionalized lipid 1,2-Disteroyl-sn-Glycero-3-Phosphoethanolamine-N-
[Methoxy(Polyethyleneglycol)-1000], ammonium salt (DSPE PEG 1000) were purchased 
from Avanti Polar Lipids (Alabaster, AL).  The 2000, 3000 and 5000 g/mol molecular 
weight DSPE PEG functionalized lipids were also supplied by the above.  Sulfur 
Hexafluoride (SF6) was purchased from Airgas (Allentown, PA).   All other reagents 
used were of analytical grade. 
 
5.2.2  Microbubble Preparation 
As described earlier and in previous works [52, 95], a lipid film containing various 
mole% of DSPC and a PEG functionalized lipid is deposited onto a 20 ml scintillation 
vial from stock solutions dissolved in chloroform by N2 spin drying followed by 2 hours 
in vacuum.  The dried film is then rehydrated with 5 ml of aqueous phosphate buffered 
saline (PBS) solution (pH 7.4) by sonicating the sample (Hielscher UP200S Ultrasonic 
Processor, Hielscher Ultrasonics, Teltow, Germany) for approximately 3 minutes at 20% 
amplitude.  This has the dual effect of dissolving the lipid mixture in solution and raising 
the temperature above that of the DSPC gel phase transition temperature, 55 oC.  The 
rehydrated solution is then cooled and aliquoted out into 2 ml serum vials and sealed.  
The head space air is then evacuated from the vial and replaced with the fluorinated 
heavy gas, SF6.  Finally the vials are vigorously shaken using the Vialmix shaker 
(Lantheus Medical Imaging, North Billerica, MA) in order to disperse the gas phase.  The 
resultant microbubbles are allowed to settle at room temperature for 30 minutes; long 
term storage should occur at 2-8 oC.  These techniques successfully produce stable 
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microbubbles with a 1-2 µm diameter. As mentioned in previous sections, the size 
distribution of the population of microbubbles was determined by a MATLAB 
(Mathworks, Natick, MA) image segmentation program.  Samples of the selected shell 
compositions are separately prepared by the same method listed above and diluted to aid 
the analysis of the program, since overlapping or clustered microbubbles cause 
anomalous results.  The program then detects circles imaged by an optical Carl Zeiss 
Axioskop 2+ microscope (Carl Zeiss AM, Oberkochen, Germany) and reports the 
diameter distribution of the sample.   
 
5.2.3 Resonance Frequency Measurement 
The resonance frequency detection setup, shown in Figure 5.1,  consists of two 7.5 MHz 
center frequency, 5 cm spherical focus ultrasound transducers (Olympus NDT, Waltham 
MA) positioned axially 10 cm apart with their overlapping foci inside a cylindrical steel 
sample chamber, filled with PBS, and sealed with rubber gaskets.  The transmitter is 
driven by an Inoson model MT 06013 pulser/receiver (Inoson, St. Ingbert, Germany), and 
the received signal is filtered between 1 KHz and 36 MHz and amplified by +26 dB by a 
Panametrics model 5900RR (Olympus NDT, Waltham MA), and finally digitized by an 
oscilloscope (GaGe Compuscope, Lockport IL).   
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Figure 5.1:  Resonance frequency detection setup.  The resonance frequency of lipid shelled 
microbubbles was determined by a system consisting of two 7.5 MHz center frequency 
spherically focused (5 cm) ultrasound transducers positioned axially 10 cm apart inside a steel 
cylinder, such that their foci overlap.  The transmitter is driven by an Inoson pulser/receiver, 
which emits a chirp that is attenuated inside the sample chamber by the contrast agents (and 
minimally by the PBS).  The received signal is amplified by +26 dB and band pass filtered 
between 1 kHz and 36 MHz, then finally digitized by a GaGe oscilloscope.  The data is saved 
and processed by MATLAB. 
 
The transmitted signal is defined by a chirp function, increasing in frequency from 750 
kHz to 13 MHz over a period of 25 µs (shown in Figure 5.2 A, B) with a pulse repetition 
time of 1 ms for a total of 100 pulses.  This pulse train undergoes 40 repetitions with one 
second pauses to analyze the change in frequency response over time.  The peak negative 
pressure of the ultrasound was limited to below 10 kPa to ensure that the microbubbles 
were not being destroyed during sonication and to limit nonlinear oscillations emanating 
from the microbubbles.  
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Figure 5.2:  Acoustic views of the chirp.  A The received signal waveform of a chirp emitted at 10 kPa 
with a dynamic frequency beginning at 0.75 MHz and ending at 13 MHz.  The chirp signal 
was selected because it covers a broad spectrum of frequencies in a relatively small time 
period (25 µs).  This ensures that microbubbles are not destroyed, and that a full frequency 
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response can be recorded from a population of bubbles.  B An acoustic spectrogram of 
received signal.  Here the increase in frequency within the 25 ms is easily visible.  Harmonics 
are also visible at higher power than the noise.  Both figures were acquired from the reference 
signal (PBS only). 
 
The signal travels axially through the sample chamber and interacts with the contrast 
agent population floating freely within the sample chamber at a concentration of 
approximately 15000 microbubbles per ml.  The microbubbles are prepared as described 
earlier and consist of a set of compositions encompassing PEG molecular weights of 
1000 – 5000 g/mol and PEGylated lipid shell composition of 1 – 15 mole% 
(compositions which match earlier cavitation studies).  The received signal is attenuated 
by the microbubbles depending on their concentration and resonance frequency at each 
frequency of the chirp.  The received signal is then processed by MATLAB to determine 
the attenuation amplitude in the frequency domain to determine which frequency yields 
the highest attenuation for a given sample.  The frequency spectra are normalized by a 
reference spectrum, generated with signals traveling through only PBS.   
 
 
5.3 Reference Spectrum and Concentration Calibration 
 
By this technique, spectra from samples of microbubbles of varying composition, 
concentration, or size can be analyzed.  First, a reference spectrum of the sample chamber 
devoid of microbubbles must be produced to ensure a good signal, and to compare results 
when a population of contrast agents is present inside the chamber.  As seen in Figure 
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5.3, the 7.5 MHz transducer is sufficiently broadband to generate a spectrum that has a -
20 dB bandwidth of approximately 12 MHz, ranging from 300 kHz to 12 MHz.  The 
noise floor is reached at 25 MHz at -65 dB, which will yield a high signal to noise ratio 
within the -20 dB bandwidth.  Therefore the recorded data will only be analyzed within 
the -20 dB bandwidth.  The chirp in Figure 5.2 A, B is also generated from this reference 
measurement. 
 
 
Figure 5.3:  Reference acoustic spectrum.  A spectrum is obtained while the sample chamber is devoid 
of microbubbles and contains only PBS.  The spectrum shows that the signal has a -20 dB 
bandwidth of approximately 12 MHz, ranging from 300 kHz to 12 MHz.  The noise floor is 
reached at 25 MHz, at -65 dB, which will yield a high signal to noise ratio within the -20 dB 
bandwidth.  Therefore the recorded data will only be analyzed within the -20 dB bandwidth. 
 
Now, any differences in the reference spectrum and the subsequent measured spectrum 
can be attributed to the addition of a sample into the control volume (holding all other 
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variables constant).  The resulting transmission minimum in these new normalized 
spectra is the resonance frequency of the sample.  However, there are several factors 
which influence shape of the received spectrum, but not necessarily the resonance 
frequency.  First, the size polydispersity is once again relevant.  The more monodisperse 
the population of microbubbles, the sharper the transmission minimum will be.  This is 
logical because the absolute minimum of total attenuation should be the resonance 
frequency of the highest point of the size histogram, and the breadth of the size 
distribution relates to the breadth of the transmission minimum.  Secondly, the 
concentration of the microbubbles which attenuate the transmitted sound also affect the 
shape of the curve.  As seen in Figure 5.4, increasing the concentration of microbubbles 
increases the magnitude of total attenuation, most evident around the resonance 
frequency.  Figure 5.4 shows a single composition of microbubbles (92.5 mole% DPSC, 
7.5 mole% DSPE-PEG5000), being successively diluted from the experimental 
concentration – roughly 15000 microbubble per ml – to a concentration of about 1500 
microbubbles per ml, at which point the transmission minimum is difficult to resolve. 
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Figure 5.4: Effect of microbubble concentration on resonance frequency.  The concentration of a 
sample of 92.5 mole% DSPC, 7.5 mole% DSPE-PEG 5000 microbubbles was altered within 
the sample chamber.  From top to bottom the microbubble concentration is 1500, 3000, 5000, 
7500, and 15000 microbubbles/ml.  While the magnitude of the total attenuation varies from -
2 to -30 dB over this concentration range, the frequency of the minima is consistently near 2 
MHz.  Dotted lines represent the raw data, and solid lines are a moving average. 
 
The raw acoustic data is represented by the dotted lines, where the smooth, solid curve 
was produced from an adjusted moving average of the raw data.  The moving average is 
preferable for peak determination because raw acoustic data can exhibit chaotic spikes 
which can skew the resonance frequency minimum, as seen above.   
 
It is evident from Figure 5.4 that within an optimum concentration window, determined 
here to be between 1500 – 30,000 microbubbles per ml, the developed technique gives 
reliable results for the transmission minimum, or resonance frequency, for a single 
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sample.  For the sample displayed the resonance frequency is approximately 2 MHz.  
Below 1500 microbubbles/ml, there is not sufficient attenuation by the microbubbles to 
sufficiently resolve a transmission minimum, and above 30,000 microbubbles/ml the 
microbubble field will attenuate almost all the transmitted ultrasound and the result will 
simply be the inverse of the reference spectrum.  This also serves to justify the 
experimental concentration of 15000 microbubbles/ml, shown in Figure 4.A as the 
bottommost line. 
 
 
5.4 Resonance Frequency as a Function of Shell Composition 
 
The resonance frequencies of the set of microbubble shell compositions are determined 
by the technique described in Section 5.2 above.  The attenuation of the set of 
microbubbles shell compositions is then measured by recording the response of the chirp 
when travelling through the population of microbubbles.  An example of these response 
results is shown in Figure 5.5.  Here, the received signal of a population of microbubbles 
consisting of 95 mole% DSPC and 5 mole% DSPE-PEG5000 is compared to a reference 
(from Figure 5.3), and analyzed for its mean attenuation maximum.   
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Figure 5.5:  Microbubble frequency dependent attenuation.  The received signal is analyzed for its 
attenuation, compared to a reference (as in Figure 5.3), for a population of microbubbles 
consisting of 95 mole% DSPC and 5 mole% DSPE-PEG5000.  Here, the raw data is 
represented by the dotted lines, where the smoothed line is a moving average of the raw data.  
The moving average is preferable for peak determination because raw acoustic data can have 
chaotic spikes which skew the resonance frequency.  For this population, the resonance 
frequency is determined by mean maximum of the moving average, and has a value of 2.95 
MHz.  The experiment is shown here in triplicate to demonstrate the reproducibility of the 
determined resonance frequency as well as the degree of signal attenuation. 
 
For this population, the resonance frequency is determined by mean maximum of the 
moving average, and has a value of 2.95 MHz.  The experiment is shown in triplicate to 
demonstrate the reproducibility of the determined resonance frequency (standard 
deviation of 112 kHz) as well as the degree of signal attenuation at the maximum (17.6 
dB mean maximum, 0.7 dB standard deviation).   
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Figure 5.6:  Measured microbubble resonance frequency as a function of shell composition.  The 
mean resonance frequency and standard deviation is shown for the complete set of 
microbubble shell compositions ranging from 1 – 15 mole% DSPE-PEG, and PEG molecular 
weights of 1000, 2000, 3000, and 5000 g/mol.  In general, the resonance frequency of the 
microbubble populations decreases with increasing molecular weight and also decreases with 
increasing PEG composition.  The four different molecular weights are the most similar at 
low PEG compositions, but vary afterwards, with the exception of PEG 3000 and 5000.  PEG 
2000-5000 exhibit an asymptotic decrease with increasing PEG composition, with the 
exception of a spike increase at 7.5 mole%. 
 
This approach is then repeated for the entire set of microbubble shell compositions.  
Figure 5.6 shows the mean resonance frequency and standard deviation for the complete 
set of microbubble shell compositions ranging from 1 – 15 mole% DSPE-PEG, and PEG 
molecular weights of 1000, 2000, 3000, and 5000 g/mol.  In general, the resonance 
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frequency of the microbubble populations decreases with increasing molecular weight 
and also decreases with increasing PEG composition.  The four different molecular 
weights are the most similar at low PEG compositions but vary afterwards, with the 
exception of PEG 3000 and 5000.  Samples of PEG 2000-5000 exhibit an asymptotic 
decrease with increasing PEG composition, with the exception of a spike increase at 7.5 
mole% (present in all MWs except PEG 5000). 
 
 
5.5 Simulating Resonance Frequency 
 
To describe a dynamic microbubble system as a function of shell properties, a 
modification to the RPNNP equation is employed.  In previous works, authors such as 
Church and de Jong have proposed models which include the effects of the shell into 
bubble dynamic equations [28, 91].  For the purposes of this study, an equation which 
takes into account well defined shell material properties is desired, and therefore a 
modification of Church’s equation, made by Lars Hoff, is employed [9].  The equation is 
of specific interest because it incorporates the shear modulus (GS) and shell viscosity (µS) 
into an equation that solves for the attenuation of a signal by microbubbles as a function 
of frequency and size distribution.  Hoff’s equation describing ultrasound attenuation in 
the presence of microbubbles is described below [9], 
 
𝛼(𝑎𝑒 ,𝜔) =  ∫ 𝜎𝑒(𝑎𝑒,𝜔)𝑛(𝑎𝑒)𝑑𝑎𝑒∞0                 (Equation 4.1) 
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where α is total attenuation, ω is frequency, ae is the size distribution, the integral of 
n(ae)dae is the area under the size distribution, and σe is the extinction cross section, given 
by: 
 
                                𝜎𝑒(𝑎𝑒,𝜔) = 4𝜋𝑎𝑒2 𝑐 𝛿𝑎𝑒𝜔0 Ω2(1−Ω2)2+Ω2𝛿2 ,   Ω = 𝜔𝜔0                  (Equation 
4.2) 
 
where c is the speed of sound in the media, and the damping constant δ is defined as: 
 
𝛿 = 4𝜇𝐿+12𝜇𝑆𝑑𝑆𝑒𝑎𝑒
𝜌𝐿𝑎𝑒
2𝜔0
                                                        (Equation 4.3) 
 
where µL is the media viscosity, ρL is the media density, dSe is the shell thickness, µS is 
the shell viscosity, and ω0 is described by: 
 
𝜔0 = 1𝑎𝑒 � 1𝜌𝐿 (3𝜅𝑝0 + 12𝐺𝑆 𝑑𝑆𝑒𝑎𝑒 )                                           (Equation 4.4) 
 
where κ is the polytropic coefficient, p0 is the hydrostatic pressure, and GS is the shear 
modulus.  For this set of equations, p0, ρL, µL, κ, c, and dSe are fixed by experimental 
conditions for a system of known shell material, encapsulated gas, and surrounding media 
(values of which displayed in Table 5.1).    The goal of the model will be to find good 
agreement to experimentally determined resonance frequency data by varying only the 
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shell material parameters, GS and µS.  Details of the comparison follow in the 
materials/methods section. 
 
Equation 4.1 was solved for the total attenuation by varying the frequency between 0.5 – 
15 MHz (to match the size of the chirp) and with experimental size distributions, 
measured in a previous work for each composition [52].  Shear modulus and shell 
viscosity are varied within a physically relevant range, and the remaining parameters are 
held constant, the values of which are shown in Table 5.1.   
 
Table 5.1:  Hoff equation model parameters. 
 
Hydrostatic pressure p0 10130 Pa 
Media density ρL 998 kg m
-3 
Polytropic exponent κ 1.07 
Speed of sound in media c 1500 m s-1 
Media viscosity µL 0.001 Pa s  
Shell thickness dSe 3 nm 
 
By analyzing the solution for the frequency that produces the maximum value of 
attenuation (within the relevant range of the chirp) the resonance frequency can be 
determined for each set of input parameters (GS and µS).  Alternatively, this can be 
viewed as determining where the extinction cross section is a maximum.  However, there 
is more than one set of inputs which give a specific resonance frequency solution.  
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Because of this, it is necessary to find an entire surface of solutions within the physically 
relevant range of input parameters; from these surfaces a best fit solution can be 
identified. 
 
In order to describe this system as a function of material parameters of the shell, the Lars 
Hoff model mentioned earlier is employed.  By solving this equation for the frequency 
which produces the maximum value of attenuation (within the relevant range of the 
chirp), taken from the solution to Equation 5.1, a resonance frequency can be determined 
for each set of the selected input parameters (GS and µS).  However, there is more than 
one set of inputs which give a specific resonance frequency solution.  Because of this, an 
entire surface of solutions is investigated within the physically relevant range of input 
parameters.  Theoretical resonance frequencies can be thusly determined for a range of 
input parameters – specifically, 0 – 2 Pa s in shell viscosity and 0 – 100 MPa in shear 
modulus.  The plane of solutions for the theoretical resonance frequencies is displayed in 
Figure 5.7. 
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Figure 5.7: Theoretical resonance frequencies.  The Hoff model predictions of resonance frequency are 
displayed as a function of both possible input parameters, namely shell viscosity and shear 
modulus.  General trends show that the increasing the shear modulus increases the expected 
resonance frequency, while increasing the shell viscosity decreases the resonance frequency 
slightly. 
 
To evaluate the accuracy of the Hoff model on the experimental results, the solution 
plane in Figure 5.7 should be compared to the measured resonance frequency for each 
shell composition.  A simple comparison involves taking the difference between the 
theoretical solutions and a given measured value, and finding the values of the input 
parameters which minimize the difference.  This approach is demonstrated in Figure 5.8, 
below, for microbubbles with a 95% DSPC, 5% DSPE-PEG 2000 shell.   
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Figure 5.8:  Finding best fits of resonance frequency.  The difference between the modeled resonance 
frequency and the measured resonance frequency for a microbubble population consisting of 
95% DSPC and 5% DSPE-PEG2000 is plotted on the surface of the parameters used to 
generate the modeled resonance frequencies- namely shear modulus (GS) and shell viscosity 
(µS).  Ranges for the two parameters are 0 – 2 Pa s in shell viscosity and 0 - 100 MPa in shear 
modulus.  To determine the best fit parameters, the zero crossing of the difference between 
model and measured can be obtained.  The zero crossing result, represented by the heavy 
black line, is a set of best fit parameters. 
 
Figure 5.8 shows the difference between the modeled resonance frequencies and the 
measured resonance frequency for a microbubble population consisting of 95% DSPC 
and 5% DSPE-PEG2000.  The error difference is plotted on the surface of the parameters 
used to generate the modeled resonance frequencies- namely shear modulus (GS) and 
shell viscosity (µS).  Again, ranges for the two parameters are 0 – 2 Pa s in shell viscosity 
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and 0 to 100 MPa in shear modulus.  To determine the best fit set of parameters, the zero 
crossing of the difference between model and measured can be obtained (line where the 
modeled frequency is closest to the measured frequency).  These best fit parameter lines 
can be determined for the entire set of shell compositions.   
 
 
Figure 5.9:  Modeled solutions for a set of contrast agents.  The lines of zero crossing- or so called best 
fit parameters - from the DSPC/DSPE-PEG2000 set, PEG compositions 1 – 15 mole%, 
acquired similarly to that in Figure 5.8 are displayed.  Interpolating between the lines of 
measurement (at the different PEG compositions), a plane of possible solutions to shear 
modulus and shell viscosity parameters can be drawn.  The best fit lines decrease in both 
slope and GS  intercept (on the µS v GS plane) as the PEG composition increases, again with 
the exception of 7.5 mole% PEG (x).   
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The lines of zero crossing constitute best fit parameters, which are displayed in Figure 5.9 
from the DSPC/DSPE-PEG2000 set, with PEG compositions of 1 – 15 mole%.  Between 
the best fit lines (at the different PEG compositions), a plane of possible solutions to 
shear modulus and shell viscosity parameters can be drawn.  The best fit lines decrease in 
both slope and GS intercept as the PEG composition increases, again with the exception 
of 7.5 mole% PEG (x), a phenomenon which has propagated from the measured values.   
 
 
5.6 Dependence of Cavitation Threshold on Resonance Frequency 
 
One interesting comparison is to relate these resonance frequency results with previously 
determined inertial cavitation threshold pressure results for the same set of compositions 
[52].  Recall Figure 3.10A, which displays the measured destruction profiles for a set of 
contrast agents consisting of DSPC and DSPE-PEG2000 functionalized lipid, with 
compositions ranging from 1 – 10 mole% (data represented by: 1 mole% [x], 2.5 mole% 
[o], 5 mole% [□], 7.5 mole% [∆], and 10 mole% [◊]).  No cavitation is observed at PNP 
less than 0.3 MPa for any composition, and the microbubble populations are not all 
completely cavitated by the upper limit of pressure output from the pulser.  PT50 is 
defined as the pressure required to destroy 50 percent of the microbubble population, for 
these samples ranging from 0.85 MPa and 1.2 MPa.  For these compositions, PT50 
increases with increasing PEG composition.  By this same method, the mean cavitation 
threshold was determined for the same set of compositions examined in the resonance 
frequency study.   
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Figure 5.10:  Experimental cavitation threshold and resonance frequency comparison.  The 
previously measures inertial cavitation threshold (PT50) of set of microbubble shell 
compositions ranging from 1 – 15 mole% DSPE-PEG, and PEG molecular weights of 1000, 
2000, 3000, and 5000 is plotted against the experimental results from the resonance 
frequency determination of the same set of shell compositions.  In general, as PEG 
molecular weight increases, resonance frequency decreases and cavitation threshold 
increases.  Additionally, all the points from the aforementioned data set collapse onto a 
single asymptotically decreasing curve.  The trend line is drawn as an aid to the eye. 
 
In Figure 5.10, the previously measured inertial cavitation threshold (PT50) of set a of 
microbubble shell compositions ranging from 1 – 15 mole% DSPE-PEG, and PEG 
molecular weights of 1000, 2000, 3000, and 5000 g/mol is plotted against the 
experimental results from the resonance frequency determination of the same set of shell 
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compositions.  In general, as PEG molecular weight increases, resonance frequency 
decreases and cavitation threshold increases.  Such a trend is expected and not especially 
noteworthy.  What is remarkable about the data is the fact that all of the data – from a 
wide range of compositions – fall onto a single curve.  This finding provides a key insight 
as to how shell composition influences cavitation via changes in resonance frequency, as 
discussed later. 
 
 
5.7 Effect of Shell Mass 
 
The changes in resonance frequency as a function of shell composition are likely driven 
by changes in the stiffness of the microbubble shell.  This hypothesis is supported by the 
results obtained when the measured data is plotted as resonance frequency versus PEG 
composition for each PEG molecular weight (Figure 5.6).  Several trends – albeit with a 
few exclusions – can be observed in the data.  First, increasing the PEG composition 
significantly decreases the resonance frequency for all molecular weights except PEG 
1000.  Additionally, an increase in the molecular weight also decreases the resonance 
frequency.  One explanation for these findings is trivial, namely the increase in 
microbubble mass that accompanies an increase in either PEG molecular weight or PEG 
mole fraction.  This is because resonance frequency (ωr) is directly proportional to 
stiffness (k) and inversely proportional to mass (m) [35]:   
 
𝜔𝑟
2 = 𝑘
𝑚
          (Equation 4.5) 
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Thus, a decrease in resonance frequency can potentially be explained by an increase in 
stiffness or an increase in mass or both. In this work changes in mass do not account for 
the observed changes in resonance frequency.  This can be proven simply by calculating 
the stiffness from theoretical mass and a measured resonance frequency.  Theoretical 
shell mass can be calculated simply with the following relationship: 
 
𝑚 = 𝑁𝐿
𝑁𝐴
(𝑃(𝑀𝑊𝑃) + (1 − 𝑃)(𝑀𝑊𝐿))      (Equation 4.6) 
 
where NA is Avogadro’s number, P is the mole fraction of polymer in the shell, MWP is 
the molecular weight of the polymer functionalized lipid, MWL is the molecular weight 
of the lipid, and NL is the number of lipids on a single bubble.  NL is calculated to be 
about 5 million molecules assuming an average microbubble radius of 1.1 µm (and 
therefore surface area of 3.8*10-12 m2), and the surface area of a lipid to be 7.6*10-19 m2.  
If changes in the measured resonance frequencies are due only to the change in the shell 
mass resulting from increasing PEG mole fraction and molecular weight, then a single 
calculated stiffness should predict all the experimental results.  However, as shown below 
in Figure 5.11 A, B, a single stiffness predicts higher values for the resonance frequency 
than the measured values. 
 
157 
 
 
 
Figure 5.11: Expected resonance frequency based on shell mass.  A shows the prediction of the 
microbubble resonance frequency for populations consisting of DSPC and 1 – 15 mole% 
DSPE-PEG 2000 with constant stiffness.  The stiffness calculated from the 1 mole% sample 
is applied to the remaining mole fractions (dotted line), in which it predicts values of 
resonance frequency higher than the measured values (♦).  B shows the predictions of 
resonance frequency for microbubble populations consisting of DSPC and 5 mole% DSPE-
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PEG, molecular weights 1000 – 5000 g/mole.  Again, the stiffness calculated from the PEG 
1000 sample is applied to the remaining molecular weights (dotted line), in which it 
predicts values of resonance frequency higher than the measured values (♦ ). 
 
The observed resonance frequencies are in all cases much smaller than the values 
expected based solely on changes in mass; that is, without allowing for any change in 
stiffness.  Moreover, the discrepancy between the observed values and the expected 
values - based on changes in mass alone – grows in magnitude with increasing mass.  
Taken together, these results point to changes in stiffness as the primary means by which 
PEG influences microbubble resonance frequency, with mass accounting for only a small 
portion of the decrease in resonance frequency. 
 
 
5.8  Conclusion 
 
The results of this study suggest that microbubble resonance frequency exhibits 
significant sensitivity to changes in microbubble shell composition.  Until now, similar 
studies have focused on commercially available contrast agents, and this result – while 
expected theoretically - has not been demonstrated for the given systems experimentally. 
The results can be explained by the Hoff model which quantifies resonance frequency - 
through attenuation - in terms of rigorous material properties, namely shear modulus and 
shell viscosity.  This work suggests that using shell composition to tune the microbubble 
resonance frequency to a desired value is feasible within the range of 1 – 8 MHz. 
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The ability to tune the microbubble resonance frequency is of potential significance, 
given that microbubbles emit specific non-linear signals when responding to sound close 
to their resonance frequency [28, 67, 96].  These backscattered responses contain not only 
the transmitted frequency, but harmonics as well.  For this reason, microbubbles are 
useful in harmonic imaging or phase inversion ultrasound, and provide excellent contrast 
between blood and tissue.  By tuning the resonance frequency towards the transmitted 
ultrasound frequency, one could improve the signal quality of an ultrasound contrast 
agent formulation.  This frequency matching can be of particular importance to 
ultrasound clinicians, who typically use transducers with frequencies ranging from 1 – 15 
MHz depending on the application, image location, and patient.    Additionally, it is 
likely that tuning the microbubble resonance frequency in this way could also improve 
efficacy in applications involving microbubbles as triggers for delivery vehicles as occurs 
in sonoporation and drug/gene therapy.    
 
Utilization of the microbubble resonance frequency data requires an understanding of the 
extent to which physical properties influence the value.  Therefore, several aspects of this 
work warrant further discussion.  One is the effect of microbubble size polydispersity and 
concentration within a defined composition on the shape of the attenuation profile.  While 
each case exhibits a resonance frequency value at a clearly defined maximum of total 
attenuation, the peak can be altered in amplitude and broadness.  That is, the breadth of 
the peak can be increased by increasing the polydispersity of the microbubble population 
and the amplitude can be increased by increasing the microbubble concentration.  A 
thinner peak can be obtained simply by formulating a more monodisperse microbubble 
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population, like those prepared from microfluidic techniques [78].  However, it is 
important to bear in mind that the size polydispersity (for a given average size) of a 
population of microbubbles only affects the breadth of a given microbubble attenuation 
profile but does not account for shifts in attenuation maximum value – thus the resonance 
frequency.  The same can be said of changes in microbubble concentration.  While 
increasing the concentration of microbubbles in the sample chamber increases the 
magnitude the attenuation, the maximum remains at the same frequency.  Therefore, the 
measured changes in resonance frequency must be due to some feature of the 
microbubble other than size distribution which is sensitive to compositional changes; 
most likely this feature relates to the material properties of the microbubble shell. 
 
Another trend is the anomalous increase in resonance frequency at 7.5 mole% PEG – 
relative to 5 and 10 mole% - for all molecular weights except PEG-5000, which 
subsequently leads to a sharp decrease in resonance frequency followed by a region of 
insensitivity to the PEG composition.  Note that this value of PEG mole% nearly matches 
previously published value of the saturation of PEG 2000 in PEG-lipid membranes, 8 
mole% [26, 73, 74].  At mole fractions exceeding the saturation limit, excess PEG 
functionalized lipids are thought to self-assemble into micellar structures, which would 
not be echogenic or detected by the pulse inversion technique applied in this study [79, 
80].  Between alterations in the PEG composition and molecular weight, these results 
point to changes in membrane stiffness as the primary parameter controlling the 
measured resonance frequency of a microbubble population. 
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This interpretation is tested by invoking the aforementioned Hoff modification of 
Church’s equation, which describes sound attenuation through a field of microbubbles as 
a function of shell properties.  The Hoff model operates under four important 
assumptions, however.  The model assumes that the shell viscosity and shear modulus are 
constant for a given sample, and that the microbubble oscillates isothermally.  It is 
additionally assumed that the ratio between the shell thickness and bubble radius is 
constant.  In Hoff’s work, this is a significant assumption, as the shell thickness of the 
polymer shell commercial contrast agent studied (Nycomed) has variable shell thickness.  
Because of the synthesis method of Nycomed, the shell thickness was not constant, and 
was in fact a function of the initial radius.  On the other hand, this work uses lipid 
monolayer microbubbles, which will have the same shell thickness regardless of initial 
radius (length of DSPC molecule), so the shell thickness is constant for a given DPSC-
PEG molecular weight.  The shell thickness would however change as a function of PEG 
molecular weight, as mentioned earlier.   
 
The final, more questionable assumption is that the effect of surface tension is neglected.  
The addition of surfactants will lower the surface tension below the value for air/water 
(72 mN/m).  Recent studies have shown that nonlinearities resulting from the 
microbubble shell can result in shifts in both the surface tension and resonance frequency 
[36, 85].  In Marmottant’s model, the surface tension changes non-linear into three 
regimes (buckling, elastic, and ruptured) depending on the magnitude of the microbubble 
oscillations.  Overvelde continues with Marmottant’s model to show that the value of the 
simulated resonance peak is shifted depending on which regime the current microbubble 
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oscillation is in.  However, this system operates at a very low acoustic pressure, where 
microbubble oscillations are predicted to be small exist solely in Marmottant’s elastic 
region (constant surface tension).  At 10 kPa or below, changes in surface tension are 
sufficiently small that the effect on the magnitude of the oscillation and the resonance 
peak are negligible.  Therefore, in the case of using such a low pressure, the Hoff model 
can be used with confidence. 
 
This model explicitly accounts for two properties of the shell, namely the shell viscosity 
and the shear modulus, and describes the total attenuation as a function of frequency and 
size distribution.  However, as the equation does not account directly for the resonance 
frequency of the shelled microbubble, it can be inferred by defining it as the minimum 
value of attenuation within the relevant range of the experiments (1 - 12 MHz).  As a two 
parameter model has been used to generate the theoretical resonance frequencies, a 
unique solution cannot be arrived upon for the shear modulus and shell viscosity of a 
given microbubbles composition; nevertheless, the model predictions agree with the 
experimental results using reasonable values of the shear modulus and shell viscosity.  
The lines of best fit values arrived at in Figure 4.7 can be further limited by comparing 
them with previous research on commercial contrast agents.  In Hoff’s work [9], for the 
commercial contrast agent Nycomed (Nycomed Amershan, Oslo, Norway) he finds that 
the shear modulus is between 10.6 – 12.6 MPa and the shell viscosity is between 0.39 and 
0.49 Pa s.  This range of data is supported by several of the best fit lines.   
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Another observation that can be drawn from Figure 5.9 is that each best fit line spans the 
entire range of shell viscosities input (0 – 2 Pa s) for every PEG composition of the PEG-
2000 molecular weight.  However, the best fit lines span a much smaller range of the 
input shear moduli, between 0 – 50 MPa of the input 0 – 100 MPa.  This can indicate that 
either a relatively large range has been input for the shear modulus or that the resonance 
frequency is more sensitive to changes in shear modulus than in shell viscosity.  It is 
concluded that the tunability of microbubble resonance frequency has been demonstrated 
experimentally by altering the shell composition, and experimental results agree with an 
established model of microbubble physics for this situation.  
 
The utility of this tunability in resonance frequency becomes apparent when one studies 
carefully Figure 5.10.  As noted above, all of the resonance frequency data fall onto a 
single curve, revealing that there is a unique relationship between inertial cavitation 
threshold and resonance frequency.  It is not the microbubble composition per se that 
influences cavitation behavior but rather the resonance frequency that results from that 
composition.  On the one hand, this means it is possible to prepare formulations with 
similar resonance frequencies – and thus similar cavitation thresholds – using different 
compositions (as occurs in the middle region of Figure 5.10; one can achieve similar 
results with PEGs of differing molecular weights by compensating with differing PEG 
mole fractions).  On the other hand (near the extremes of Figure 5.10), particular 
cavitation thresholds can only be achieved with particular compositions (e.g., the highest 
cavitation thresholds – those greater than 1 MPa - are only accessible with the higher 
PEG molecular weights because only these yield microbubbles which are sufficiently 
164 
 
stiff).  These findings are not only scientific interesting, they are clinically relevant. This 
is because avoiding cavitation is necessary during imaging and sonoporation applications 
so as to avoid cell (and perhaps patient) death, whereas achieving cavitation is necessary 
during drug delivery so as to achieve rupture of the microparticle that carries the drug.  
Figure 5.10 shows a simple way of achieving either of these competing requirements; one 
can either avoid or ensure cavitation simply by tuning the cavitation threshold pressure - 
with appropriate amounts of the appropriate molecular weight of PEG - to be either above 
or below the applied acoustic pressure, respectively.   
 
The effect of variations in microbubble shell composition on the microbubble resonance 
frequency is demonstrated through experiment.  Here, these variations are achieved by 
altering the mole fraction and molecular weight of functionalized polyethylene glycol 
(PEG) in the microbubble phospholipid monolayer shell, and measuring the microbubble 
resonance frequency.  The resonance frequency is measured via a chirp pulse and 
identified as the frequency at which the total attenuation of sound wave is the greatest 
while in the presence of microbubbles.  For the shell compositions utilized herein, the 
resonance frequency varies significantly from 1 – 8.15 MHz.  This change in resonance 
frequency is shown to not be a function of simply the changing mass of the microbubble 
shell, but related to some change in the shell stiffness. To further confirm the 
experimental data and explain the changes in stiffness, the measured resonance 
frequencies are compared with theory, namely through Hoff’s modification of Church’s 
equation, using shear modulus and shell viscosity as tuning parameters.  It is concluded 
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that the design and synthesis of microbubbles with a prescribed resonance frequency is 
attainable simply by tuning PEG composition and molecular weight. 
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CHAPTER 6: Co-encapsulation Ultrasound Contrast Agent 
 
 
6.1 Co-encapsulation Introduction 
 
Thinly shelled acoustic microbubbles are typically used in providing contrast to 
ultrasound images.  When insonified, these microbubbles tend to oscillate at the driving 
frequency of ultrasound, contracting during the positive pressure cycle and growing 
larger than the resting radius during the negative pressure cycle [12, 29, 65].  While the 
driving frequency of ultrasound controls the speed of these oscillations, the magnitude of 
the oscillations is controlled by the overall pressure of the sound wave.  If the peak 
negative pressure is increased sufficiently and the microbubble expands past a critical 
radius, it will implode and create a localized shockwave and increase in temperature and 
pressure [38, 65].  This so-called inertial cavitation of microbubbles has become 
increasingly interesting to contrast imaging and drug delivery researchers in a variety of 
ways [13, 25, 41, 64, 97].  The phenomenon is interesting in the imaging field as 
increasing the mechanical index (MI) of a clinical transducer above a certain threshold 
will also cause the destruction of the contrast agent, and potential cellular damage [38, 
98].  Commercial contrast agents were given the Food and Drug Administration’s black 
box label in 2007 due to a death during cardiac imaging enhanced by contrast agents [99].  
While it is uncertain whether the mortality was a direct result of the addition of contrast 
or the result of a pre-existing condition, there is merit in the development of a contrast 
agent with a safer design, by way of controlling or containing inertial cavitation. 
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The goal of this chapter is to develop a novel contrast agent taking into account the 
inherent danger of microbubble inertial cavitation.  While this idea is not new to the 
medical imaging community [20, 100], the novel aspect of this research focuses on the 
co-encapsulation of stable, solid phase, phospholipid-shelled microbubbles within the 
aqueous core of a polymer shell microcapsule.    The potential advantage of this contrast 
agent is the addition of the encapsulating polymer shell to shield the lipid shelled 
microbubbles within from the acoustic field.  By controlling the acoustic pressure (or MI) 
of the ultrasound wave, the cavitation behavior can be controlled and thus the safety of 
the contrast agent, given that microbubble inertial cavitation is the potential hazard of 
ultrasound imaging.  Additionally, the polymer shell can potentially increase the lifespan 
of a circulating microbubble as well as render it more difficult to inertially cavitate.  
Commercial contrast agents can last up to 42 minutes after synthesis in an air-enriched 
environment, or several minutes circulating through the bloodstream; however, when 
microbubbles are exposed to ultrasound at typical clinical imaging MI values, 
microbubble contrast agents can last only seconds regardless of their location [6, 101].  
The proposed contrast agent has benefit of longer lasting contrast by either shielding the 
co-encapsulated microbubbles from low pressure ultrasound waves, or trapping the gas 
within the shell to hinder gas dissolution.  Thus, by controlling the peak negative pressure 
of transmitted ultrasound, the proposed contrast agent can be used to increase both safety 
and longevity of the acoustically active microbubbles within. 
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Polymer microcapsules are not limited to contrast applications, and are more commonly 
employed in the field of drug delivery [102].  These microcapsules are favorable because 
of their size flexibility and ability to carry both a relatively large volume of encapsulated 
drug.  As mentioned earlier, inertial cavitation of co-encapsulated microbubbles may be 
used as a potential drug release trigger as well.  In tissue engineering, polymer 
microspheres have also been used to affect the mechanical properties of implants and 
biomaterials [103].  Both of these applications would potentially be bolstered by the 
ability to determine the location of the polymer microspheres by their echogenicity, 
whether in the blood or a biomaterial.  Because of the existence of a wide array of uses 
for polymer microspheres, there are potentially unforeseen applications for the 
implication of acoustically active microcapsules.  However, this chapter focuses largely 
on the application of the co-encapsulated microbubbles as a contrast agent. 
 
 
6.2 Design of Co-encapsulated Contrast Agents 
 
6.2.1 Materials 
Poly(L-lactic Acid) (PLA) and Polyvinyl alcohol (PVA) were supplied by MP 
Biomedical (Solon, Ohio).  The PLA polymer is reported to have a FW of 100,000, and 
an inherent viscosity of 1.61 dL/g.  The polyvinyl alcohol used for emulsifying has a 
molecular weight of ~27,000 g/mol and is reported to be 99% hydrolyzed.  The PVA 
used for the phantom synthesis has an average molecular weight between 85,000 and 
124,000 g/mol and is 98-99% hydrolyzed.  The lipid 1,2-Distearoyl-sn-Glycero-3-
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Phosphocholine (DSPC) and the functionalized lipids 1,2-Disteroyl-sn-Glycero-3-
Phosphoethanolamine-N-[Methoxy(Polyethyleneglycol)-5000 (and 2000)] (DSPE 
PEG5000, or 2000) were purchased from Avanti Polar Lipids (Alabaster, AL).  Sulfur 
Hexafluoride (SF6) was purchased from Airgas (Allentown, PA).  Fluorinated lipid 1,1’-
dihexadecyl-3,3,3’,3’-tetramethyl-indocarbocyanine perchlorate (DiI-C16) was 
purchased from Invitrogen Molecular Probes (Carlsbad, CA).  All other reagents used 
were of analytical grade. 
 
6.2.2 Microbubble Preparation 
Microbubbles are prepared as described earlier and in previous works [42, 63].  A lipid 
film containing 95 mole% DSPC and 5 mole% DSPE PEG 2000 (or 5000) was deposited 
onto a scintillation vial from stock solutions dissolved in chloroform by nitrogen spin 
drying followed by 2 hours in vacuum.  The dried film was then rehydrated with 5 ml of 
aqueous phosphate buffered saline (PBS) solution (pH 7.4) by sonicating the sample 
(Hielscher UP200S Ultrasonic Processor, Hielscher, Tetlow, Germany) for 3 minutes at 
20% amplitude.  This has the dual effect of dissolving the lipid mixture in solution and 
raising the temperature above that of the lipid’s gel phase transition temperature, 55 oC.  
The rehydrated solution is then aliquoted out into 2 ml serum vials and sealed.  The head 
space air is then evacuated from the vial and replaced with the heavy gas, SF6.  Finally 
the vials are vigorously shaken using the Vialmix shaker (Lantheus Medical Imaging, 
North Billerica, MA) in order to disperse the gas phase.  The resultant microbubbles are 
allowed to settle at room temperature for 30 minutes, however long term storage should 
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be at 2-8 oC.  These techniques successfully produce stable microbubbles with a 1-2 µm 
diameter, shown in Figure 6.1 A. 
 
 
Figure 6.1:  Contrast agent micrographs.  Light microscope images are presented for typical batches of: 
A Microbubbles with DSPC/ 5% DSPE PEG 2000 shell around SF6 gas, B PLA 
microcapsules, C PLA microcapsules with co-encapsulated DSPC microbubbles. 
 
6.2.3 Microcapsule Synthesis 
PLA microcapsules are prepared using the well characterized water/oil/water (W/O/W) 
double emulsion technique described previously and modified for effectiveness [104-
106].  A schematic of the W/O/W double emulsion process is detailed below in Figure 
6.2. 
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Figure 6.2: W/O/W double emulsion.  The double emulsion technique is diagramed to explain a 
successful method of encapsulating microbubbles within the aqueous core of a microcapsule.  
First, a relatively small volume of aqueous media (here, microbubbles in PBS) is added to a 
larger (10 times) volume of an organic (DCM) with dissolved polymer (PLA).  This mixture 
is homogenized for 1 minute, then added to an even larger (8 times) volume of water plus an 
emulsifier (PVA).  This mixture is homogenized for 2 minutes and the resulting emulsion is 
left to dry overnight.  This process results in polymer microspheres encapsulating the first 
aqueous phase (microbubbles in PBS), in a solution of the second aqueous phase (water with 
PVA). 
 
A solution of 0.2 ml of the above microbubbles suspended in various concentrations in 
PBS or 70 mM calcein buffer (internal water phase) is added to 2 ml of 10 mg/ml PLA in 
dichloromethane (intermediate organic phase).  This solution is then homogenized with 
the Polytron PT3100 homogenizer (Kinematica, Lucerne, Germany) for 1 minute at 
15000 rpm in order to create the primary W/O emulsion.  Quickly, 16 ml of 2% PVA in 
water is added to the solution and homogenized at 15000 rpm for 2 minutes, which will 
serve as the double emulsion W/O/W and the outer aqueous phase, W2.  After 
homogenization, an additional 32 ml of the 2% PVA is added and the mixture is moved 
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to a 400 rpm magnetic stir plate to allow the dichloromethane to evaporate for 24 hrs.  
2% PVA is a sufficient dissolved polymer concentration for emulsification.  After drying, 
the solution is washed of the PVA by centrifuging the sample at 15000 xg for 20 minutes.  
The supernatant PVA solution is siphoned off and replaced with water or PBS, and the 
sample is then centrifuge washed twice more.  This technique creates stable 
microcapsules with co-encapsulated microbubbles of diameters between 5-10 µm.  
Samples described above of microcapsules with co-encapsulated microbubbles are shown 
in Figure 6.1 C, while microcapsules prepared with their internal aqueous phase 
composed of only PBS (no microbubbles) or 70 mM calcein are shown in Figure 6.1 B.   
 
Detailed images of the microparticles can be attained from a scanning electron 
microscope (SEM) (FEI XL30, FEI, Hilsboro, OR).  For SEM imaging, the 
microparticles are first washed of all PVA solution, which is replaced with water.  The 
solution is then lyophilized.  It is necessary for the microcapsules to be in water because 
when lyophilized any dissolved polymer or salt will deposit on the microparticles.  After 
freeze drying, the microcapsules are then sputter-coated with approximately 10 nm of 
platinum, for enhancement of the SEM image.  A representative SEM image is shown in 
Figure 6.3. 
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Figure 6.3: Microcapsule SEM image.  SEM image of the double emulsion PLA microcapsules.  The 
bulk of the microcapsules are between 1 – 10 µm in diameter.  Wrinkling and other damage to 
the microcapsules is an artifact of the SEM preparation procedure.   
 
Since SEM is a surface imaging technique, it is difficult to prove that microbubbles have 
successfully been encapsulated within the aqueous core of the microcapsules.  A simple 
proof of concept experiment is therefore designed to determine whether the microbubbles 
present in the inner aqueous phase of the double emulsion have been successfully 
encapsulated.  Microbubbles are produced with 0.5 mole% DiI functionalized DSPE 
fluorescent probe, along with 4.5 mole% DSPE-PEG 2000 and 95 mole% DSPC.  This 
way, the microbubbles will be easily identifiable with fluorescence microscopy.  The 
fluorescent microbubbles are then used as the inner aqueous phase of a double emulsion, 
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as described previously.  The resultant microparticles are imaged under the Carl Zeiss 
fluorescence microscope, both under light and under fluorescence only.  The results of an 
imaged particle are shown in Figure 6.4, below. 
 
 
Figure 6.4: Encapsulation of fluorescent microbubbles within double emulsion particles.  DiI labeled 
microbubbles are encapsulated within polymer microcapsules using the double emulsion 
technique and imaged with both light and fluorescence microscopy.  The image on the left is 
of a microcapsule under white light only, while the image on the right is recorded in 
fluorescence mode.  The inner fluorescence in the right image is indicative of successfully 
encapsulated fluorescent microbubbles. 
 
A single double emulsion particle with encapsulated DiI functionalized microbubbles is 
displayed above.  The image on the left is recorded under only the microscope light.  The 
microscope light is then switched off and the fluorescent lamp is lit without moving the 
slide, as to record the response from the same microcapsule.  Under the excitation 
wavelength, the microcapsule clearly fluoresces.  This degree of fluorescence is 
indicative of successful co-encapsulation of the DiI functionalized microbubbles, 
especially because fluorescence is only present inside of the microcapsule captured in the 
light only image.  
10 µm 
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The capsules displayed in Figure 6.4 are approximately 10 µm in diameter.  For the 
purposes of this study, microcapsules of approximately 5 µm are preferable, especially 
because they are sufficiently small to fit through the size of the smallest capillary in vivo 
[16].  However, it is quite simple to synthesize microcapsules of various sizes through 
several methods.  First, increasing homogenization speed (for the second emulsion) 
decreases the size of the particles.  Additionally, increasing the hydrophobicity of the 
organic phase leads to an increase in final particle size.  While larger microcapsules 
would not be clinically relevant, they may be of some interest for purely scientific 
studies, such as studying the cavitation behavior or acoustic response of the encapsulated 
microbubbles. 
 
The concentration of microparticles was measured with a Beckmann-Coulter Z1 Particle 
Counter (Beckmann-Coulter, Brea, CA).  The Z1 particle counter measures the 
concentration of particles with a size larger than 2 µm, and shows how many are above a 
set threshold value.  For a typical batch of microparticles described above, the coulter 
counter reports a concentration of 120*106 microparticles/ml (assuming that the batch 
which started with 0.2 ml of inner phase is concentrated to a final volume of 1 ml after 
centrifugation).  From the threshold values, the coulter counter also reports that 83% of 
the total microparticles measured are between 4 – 8 µm.  Higher concentrations of 
microparticles, like those required in Section 6.5, can be attained by successive 
centrifugations of a larger batch of microparticles and subsequently concentrating them to 
the same final volume (1 ml). 
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6.3 Clinical Imaging of Contrast Agents 
 
To test the echogenicity of the contrast agent, samples are first imaged by two clinical 
ultrasound units.  The contrast agent, consisting of double emulsion microcapsules with 
co-encapsulated microbubbles, is shown to be visible in B-mode at a low MI of 0.4, while 
freely floating in a water tank, shown in Figure 6.5.  Figure 6.5 was imaged a Toshiba 
Nemio XG (Toshiba Medical Imaging Co., Tochigi, Japan) with a 12 MHz transducer.   
 
 
Figure 6.5:  Brightness mode ultrasound image of microcapsules with co-encapsulated 
microbubbles.  A 6 MHz transducer is held in a large tank of normal saline, and the sample is 
injected at the equivalent of the bottom left of the image.  The mechanical index of ultrasound 
is 0.4.  Microcapsules are observed flowing into the image from the point of injection. 
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Even from this snapshot it is evident that this co-encapsulated contrast agent formulation 
provides some contrast to the ultrasound image.  However, signal intensity is only part of 
functionality of an ultrasound contrast agent.  A successful contrast agent should also be 
evaluated for its longevity under an ultrasound field.  Because of the polymer 
microcapsule shell encapsulating the bubbles, it is logical to assume that the co-
encapsulated formula should provide some degree of protection for the bubbles 
encapsulated within.  This can either be attributed to added reflections of the incident 
sound wave of the latex/water interface of the sample chamber, or due to the inability of 
the microbubble to dissolve while entrapped within the polymer shell.  Figure 6.6 shows 
the quantified results of an experiment designed to test the longevity of the co-
encapsulated contrast agent against the current United States industry standard contrast 
agent, Definity (Lantheus Medical Imaging, North Billerica, MA), over 30 minutes of 
constant imaging with the aforementioned Toshiba machine.  The shell composition of 
the Definity contrast agent is very similar to the formulation of the microbubbles 
prepared in Section 6.2.2 (albeit a more complex mixture), such that the shell is a lipid 
monolayer with some percent of the lipids being functionalized with a stabilizing 
polymer.  Definity is further stabilized in a viscous solution (glycerin rich) and the 
encapsulated heavy gas is octafluoropropane.  
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Figure 6.6: Normalized acoustic brightness of contrast agents.  The co-encapsulated contrast agent (♦) 
and a commercial contrast agent (Definity(▲)) are imaged on a Toshiba clinical ultrasound 
unit for 25 minutes with a 12 MHz transducer.  The normalized results show that Definity has 
a higher decay rate of its acoustic brightness intensity than the co-encapsulated formula, by 
approximately a factor of 2. 
 
The results in Figure 6.6 have been normalized with their initial brightness to quantify 
their longevity.  The co-encapsulated contrast agent is shown to retain its initial 
brightness twice as well as the commercial contrast agent, Definity, over the 30 minute 
imaging window.  These results are somewhat encouraging; however Figure 6.6 does not 
provide the whole story.  The raw data (before normalization) shows that although 
Definity does have a higher decay rate of brightness than the co-encapsulated formula, 
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Definity also has higher brightness intensity initially and throughout the experiment than 
the co-encapsulated contrast agent.  The raw data is provided below in Figure 6.7. 
 
 
Figure 6.7: Raw acoustic brightness of contrast agents.  In contrast to Figure 6.6, the raw acoustic data 
is provided here for both Definity and the co-encapsulated contrast agent.  Although Definity 
has the higher decay rate, it also provides a higher degree of brightness initially and 
throughout the imaging time.  The brightness of Definity finally matches the initial brightness 
of the co-encapsulated formula after the full length of the scan, 25 minutes. 
 
To further confirm the brightness resulting from encapsulated microbubbles and not from 
reflection or scatter off the interface of the microcapsule, samples of pure microbubbles, 
double emulsion particles without co-encapsulated microbubbles, and the double 
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emulsion particles with co-encapsulated microbubbles are viewed with a phase inversion 
mode on the Siemens Acuson Antares (Siemens, Berlin, Germany).  Additionally, the 
samples are imaged within an agar gel phantom prepared with a 12 mm diameter, 10 mm 
deep cavity in the center. A 1 ml aliquot of sample is poured into the cavity and covered 
by 1 cm thick agar cylinder, and a convex 2-6 MHz transducer is positioned on top. 
Figure 6.8 A-F shows the images from the three samples immediately after transducer 
activation and 3 seconds into imaging at a frequency of 2.5 MHz, where the square 
window in the center is enhanced by tissue harmonic imaging.   
 
 
Figure 6.8:  Tissue harmonic images (THI).  THI are shown from the three samples within an agar gel 
phantom immediately after transducer activation and 3 seconds into imaging at an MI of 1.5 
and frequency of 2.5 MHz, where the square window in the center is enhanced by THI.  A 
microbubbles after a millisecond of  ultrasound, B microbubbles after 3 seconds of 
ultrasound, C microcapsules without microbubbles at 1 ms, D microcapsules after 3 s, E 
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microcapsules with co-encapsulated microbubbles at 1 ms, F microcapsules with co-
encapsulated microbubbles after 3 s. 
 
Comparing the figures it is evident that the pure un-encapsulated microbubbles (Figure 
6.8 A-B) give the strongest response, microcapsules with no microbubbles (Figure 6.8 C-
D) give the weakest or no response, and the microcapsule vehicle with microbubbles 
(Figure 6.8 E-F) gives some signal.  The difference in the overall brightness of the 
sample of microbubbles (Figure 6.8 A) compared to the sample of microcapsules with 
microbubbles (Figure 6.8 C) is expected since the concentration of overall microbubbles 
is at least 1000 times less in the sample of microcapsules with microbubbles; however an 
individual microbubble appears to give a similar brightness in both samples.  After 3 
seconds of harmonic imaging the un-encapsulated bubbles are disappearing from the 
image (Figure 6.8 B), which could be from dissolution due to high MI of imaging, 
equivalent to a peak negative pressure of 2.4 MPa.  However, the sample of microbubbles 
encapsulated within microcapsules (Figure 6.8 F) shows little change over the 3 seconds 
of ultrasound imaging.   
 
 
6.4 Acoustic Response of Contrast Agents 
 
As a method of quantifying the amount (or existence) of microbubble activity of the co-
encapsulated contrast agent, the acoustic response of a sample can be analyzed.  
Specifically, the co-encapsulated contrast agent should be compared to a sample of 
microbubbles which have not be encapsulated, as well as microcapsules which have no 
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microbubbles encapsulated.  As in Chapter 3, the acoustic response can be detected by 
the SchaumSchläger, a homemade high voltage pulser designed by Michał Mleczko, 
described earlier and in previous research [63, 66, 71], driving a 2.25 MHz, 7.5 cm focus 
ultrasound transducer (Olympus NDT, Waltham MA).  Another 2.25 MHz transducer is 
set at 90o to the transmitter and receives the acoustic response of a sample insonified by 
the transmitting transducer, such that the overlap of the foci of the two transducers is a 1 
mm3 volume.  The experiment consists of short bursts of 50 pulse trains, which are 
transmitted at a repetition frequency of 5 Hz, followed by 1 minute of rest, then repeating 
the 50 pulse train burst every 30 seconds.  The peak negative pressure of the sound is 
2.15 MPa. The sample chamber is stirred by a magnetic stir plate at 600 rpm set under the 
tank.  The received signal is filtered to reduce noise by a 5 MHz low pass filter 
(Minicircuits, Brooklyn NY) and amplified by +26 dB (Panametrics NDT, Waltham MA) 
before being digitized by an oscilloscope (Cleverscope Ltd., Auckland NZ).  The signal is 
then processed by MATLAB such that the total voltage response magnitude will be 
plotted against the overall time of the experiment.  
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Figure 6.9:  Acoustic response graphs. The responses are generated from the three contrast agent 
samples generated by a 2.25 MHz transmit/receive system.  The received voltage (in volts) is 
plotted against the experiment time (in seconds).  A Response from samples of microcapsules 
alone (■), which appears as only noise, and from microcapsules with co-encapsulated 
microbubbles (♦), which show an exponential decrease in acoustic activity. B Response from 
the sample of microbubbles only.  
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The results of the microbubble detection method are shown in Figure 6.9 A-B for 
samples of the same formulations as above.  Concentrated un-encapsulated microbubbles 
(Figure 6.9 B) again confirm the highest ultrasound response with an initial measurement 
of 9 mV, and all microbubble response is negated by either cavitation or dissolution by 
200 s.  The sample of microcapsules with no encapsulated microbubbles (Figure 6.9 
A[■]) confirms that only noise level acoustic response is present in the sample, with µV 
measurements throughout the time period of the experiment.  The sample of 
microcapsules with co-encapsulated microbubbles (Figure 6.9 A[♦]) initially shows a 
high response of 0.35 mV, but quickly returns to the noise level, indicating that any 
microbubbles present in the microcapsules have disappeared or changed so that they are 
no longer acoustically active. 
 
This simple technique for measuring the acoustic response of contrast agents can also be 
implemented to examine a range of situations.  One such study of interest is measuring 
the shelf life of contrast agents once they have been synthesized.  This can be achieved 
by measuring the acoustic response of the contrast agents over a one month period.  Since 
it is of interest to prove that the co-encapsulate formula provides some degree of 
protection for its encapsulated microbubbles, it is expected that its acoustic response will 
retain its value longer than that of un-encapsulated microbubbles.  The un-encapsulated 
microbubbles in this case are comprised of 5 mole% DSPE-PEG 2000 and 95 mole% 
DPSC, and mimic commercially available contrast agents, such as Definity or SonoVue.  
The results of the 30 day acoustic response study are shown in Figure 6.10, below. 
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Figure 6.10: Shelf life of synthesized contrast agents.  The shelf life of contrast agents is determined 
by measuring the acoustic response of the contrast agent sample over a 30 day window, and 
normalizing the results with the respective initial acoustic response value.  The co-
encapsulated contrast agent [♦] proves to retain it s acoustic response very well over the 30 
day period, losing only 40% of its initial response.  On the other hand, un-encapsulated 
microbubbles [■ ] quickly lose almost all their response (99%) only a few days after 
synthesis. 
 
The results of the study prove that in fact the co-encapsulated formula provide a 
significant increase in shelf life versus un-encapsulated microbubbles.  This is most likely 
due to the polymer shell trapping the heavy gas from dissolving or returning to the 
atmosphere.  As with the results of the brightness study undertaken in Section 6.3, these 
results have been normalized with their respective initial values of acoustic response.  In 
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this study, analysis of the raw data reveals that the total acoustic response of the un-
encapsulated microbubbles is only higher than the acoustic response of the co-
encapsulated contrast agent on day 1, than equal to each other on day 2, and finally the 
acoustic response of the microbubbles is less than that of the co-encapsulated contrast 
agent on days 3-30.  This data only serves to reinforce the previous result; by analysis of 
both normalized and raw data, the co-encapsulated contrast agent has proven to have a 
longer shelf life after synthesis than a population of microbubbles with an initially higher 
acoustic response. 
 
Another way the acoustic response can be employed is to determine the acoustic 
relationship between concentrations of microbubbles and microparticles.  A major 
challenge in relating the acoustic concentration of contrast agents is the inconsistency in 
the amount of non-linear oscillators (microbubbles) per ml of dosage.  For contrast agents 
which are simply comprised of a population of microbubbles, this is a straightforward 
calculation.  However, in complex case of the co-encapsulated contrast agent described 
here, relating the acoustic concentration of the un-encapsulated microbubbles to the same 
microbubbles which have been co-encapsulated is not simple.  Simply knowing the 
amount of microcapsules per ml is insufficient information to relate the acoustic 
concentration.  This is because the amount of microbubbles encapsulated within a given 
microcapsule is not constant from microcapsule to microcapsule.  In fact, the number is 
impossible to tell, and in some cases there may not be any microbubbles encapsulated.  
This can be attributed to the chaotic fashion in which the microbubbles are encapsulated, 
the random homogenization step of the double emulsion.  The double emulsion technique 
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results in poor loading efficiencies (reported by Kashi as 4.7% for drug molecules [107]) 
because of the interaction between the inner aqueous phase and the outer aqueous phase 
during the secondary emulsion.  Because of these factors, the acoustic concentrations of 
the aforementioned contrast agents should be determined empirically by analyzing their 
acoustic response.  In this study, various concentrations of microbubbles (un- and co-
encapsulated) are measured for their acoustic response from a 40 pulse train signal with 
PNP of 2 MPa.  The results are displayed below in Figure 6.11. 
 
 
Figure 6.11: Concentration effects on the acoustic response of contrast agents.  Various 
concentrations of un-encapsulated [■ ] and co-encapsulated [♦] microbubbles (5 mole% 
DSPE-PEG 2000, 95 mole% DSPC) are measured for their acoustic response.  The 
concentrations of un-encapsulated microbubble range from 0.1 to 200 microbubbles per ml, 
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and the concentration of co-encapsulated microbubbles ranges from 10 – 1000 µl of 
synthesized solution.  Both sample display a linear increase in the acoustic response with 
increasing concentration (although the concentration of one contrast agent cannot be 
compared to the concentration of the other directly). 
 
Figure 6.11 shows a linear increase in both contrast agent samples with increasing 
concentration.  The un-encapsulated microbubble range from concentrations of 0.1 to 200 
microbubbles per ml, and the co-encapsulated microbubbles ranges from concentrations 
of 10 – 1000 µl of synthesized solution.  Obviously, these concentration values cannot be 
directly related because of the factors discussed earlier.  In order to compare apple and 
oranges (here, un- and co-encapsulated microbubbles), more data is needed.  It is of 
interest to develop an empirical scaling factor which can “convert” the amount of 
microcapsules equaling the brightness of a microbubble.  Armed with such a conversion 
factor, future studies can adequately predict the encapsulated concentration of 
microbubbles within polymer microcapsules.  This is especially important when 
comparing the co-encapsulated formula to any other contrast agent, whether analyzing 
acoustic response, brightness, cavitation threshold, cytotoxicity, or any number of 
unforeseen studies.  This conversion factor will be explored using a more rigorous 
contrast parameter, the contrast to tissue ration. 
 
 
6.5 Contrast to Tissue Ratio  
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Although the raw acoustic response data can be used to confirm encapsulation of 
microbubbles within the aqueous core of a polymer microcapsule, a more scientific and 
clinically relevant result is desirable for studying contrast parameters.  To analyze the 
degree of contrast that an ultrasound contrast agent will provide, the brightness (or 
intensity) of the image should be compared to the brightness of some reference material 
(Equation 6.1, where Ic and It are the brightness intensities of the contrast region and 
tissue region, respectively).  For physiological relevance, this reference material should 
have similar acoustic properties to human flesh (1540 m/s speed of sound, 1400 kg/m3 
density).  While actual human flesh is somewhat difficult to legally attain, a tissue 
mocking phantom with the aforementioned acoustic properties can be easily fabricated 
without criminal repercussions.   
 
𝐶𝑇𝑅 = 20 log �𝐼𝑐
𝐼𝑡
� 
(Equation 6.1) 
 
The tissue mocking phantom is comprised of a 10 weight% PVA solution, which is 
subjected to multiple freeze thaw cycles to alter the acoustic properties, a technique 
adopted from Surry [108].  A 3 L solution of 10 w% PVA is autoclaved for 2 hours to 
fully dissolve the polymer.  After the PVA is fully dissolved, the solution is poured into 
the phantom mold, a 3.5 L steel box with a cylindrical cavity, and is left for 1 day to 
allow trapped gas to separate from the solution.  The mold is then subjected to 3 freeze 
thaw cycles such that the phantom is completely frozen (to -20 oC) and completely 
thawed (to 20 oC) in a 24 hour time period.  The freeze thaw cycles serve to realign the 
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crystal structure of the PVA such that the polymers align into tighter stacks with 
increasing freeze thaw cycles.  Acoustically, the speed of sound and density both increase 
with increasing number of freeze thaw cycles, and after 3 cycles the acoustic properties 
closely match that of flesh [108].  The phantom should be stored at 2-8 oC in deionized 
water to avoid dehydration of the cryogel phantom.  Now the contrast agent brightness 
intensity can be compared to that of the tissue mocking phantom, and a dB scale of the 
intensities can measured as a contrast-to-tissue ratio (CTR). 
 
 
Figure 6.12: Contrast to tissue ratio phantom.  To determine the CTR, the PVA phantom is insonified 
with a curved array ultrasound transducer.  The phantom has a 40 ml cylindrical cavity 
which is filled with the contrast agent solutions, held within a latex ultrasound probe cover.  
The resulting brightness of control volumes within the cavity (contrast zone) and the 
phantom (tissue zone) can be compared to calculate CTR. 
 
The contrast to tissue ratio of a given population of contrast agents is determined by 
recording brightness (B) mode and phase inversion ultrasound images and then analyzing 
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their intensities.  Samples are placed a 40 ml reservoir within a larger block of PVA 
cryogel phantom.  The reservoir is imaged from the side of the phantom with the 
Ultrasonix Sonix RP (Ultrasonix, Richmond, BC) and a 3.5 MHz curved array transducer 
(C5-2/60), the process displayed in Figure 6.12.  The resulting image is analyzed by 
comparing the intensity of a control volume within the reservoir area (contrast zone) to 
the intensity of a control volume of the phantom (tissue zone).  The experiment lasts a 
total of 10 seconds, with a one image per second frame rate, and is repeated for 6 MIs 
ranging from 0.23264 – 1.4808 in both B-mode and phase inversion mode. 
 
 
Figure 6.13:  Phase inversion mode ultrasound images of co-encapsulated contrast agent.  The 
experiment is carried out in a 40 ml reservoir within an agar gel phantom.  Progressing 
images 1-10 illustrate the change in intensity of the contrast agent over a period of 10 
seconds, with an MI of 1.4808. While the initial brightness is lost in 4 seconds, the steady 
state intensity is still higher than 0, which would be black in color. 
 
To confirm the co-encapsulation of the microbubbles within the aqueous core of the PLA 
microcapsules, the CTR of the contrast agent is examined.  Figure 6.13 shows 10 
progressive images taken during the experiment, where each image represents 1 second 
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of ultrasound (MI = 1.4808).  After approximately 4 seconds, the initial brightness has 
faded, which is indicative of some bubbles cavitation or destruction.  After 4 seconds the 
intensity stays fairly consistent for the remaining 6 seconds, however, this intensity is still 
well above the 0 value for pure water, which would be black on the image.  To further 
quantify the CTR of the co-encapsulated contrast agent, the same experiment was 
preformed with MIs ranging from 0.23264 – 1.4808, and graphed in dB versus the frame 
number in Figure 6.14 A (phase inversion mode) and Figure 6.14 B (B-mode).   
 
 
Figure 6.14:  Contrast to tissue ratio of co-encapsulated contrast agent and SonoVue.  Images of the 
contrast agents are recorded every second (1 frame per second), and the ratio of the 
intensity of the contrast agent to the intensity of the tissue (CTR), or in this case an agar gel 
phantom, is calculated for MIs between 0.23264 and 1.4808. A Shows the co-encapsulated 
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microbubbles contrast agent in phase inversion mode, and B shows the same sample in B-
mode.  The same test is preformed with SonoVue, C shows SonoVue in phase inversion 
mode, and D shows SonoVue in B-mode.  The increase in CTR between phase inversion 
and B-mode is explained by the presence of some non-linear oscillators, which in both 
cases are microbubbles.  It can also be observed that as expected an increase in MI results 
in a sharper decrease in CTR, as microbubbles are being cavitated.  Co-encapsulated 
microbubbles also show that they exhibit similar acoustic response to the commercial 
contrast agent, SonoVue. 
 
The +7 dB increase in intensity between the B-Mode and phase inversion is expected 
because of the non-linear oscillations of the microbubbles, and helps confirm their 
existence.  The highest MI in Figure 6.14 A, 1.4808, graphically represents the images in 
Figure 6.13.  Additionally, the intensity drops rapidly with increasing MI and sonication 
time.  To compare the results of the co-encapsulated contrast agent with one which is 
commercially available, the same test is preformed on SonoVue (Bracco, Milan, Italy).  
Figure 6.14 C-D show the results of CTR test on SonoVue with the same range of MIs at 
a similar concentration.  Here, SonoVue reacts similarly to the co-encapsulation CTR test 
in both its B-mode/phase inversion deviation and its trend with increasing MI. 
 
The CTR can also be used to definitively find the brightness correlation between 
microbubbles and co-encapsulated microcapsules.  In this experiment, the CTR is 
measured by the Toshiba clinical ultrasound machine mentioned earlier for both the co-
encapsulated microcapsules and the Definity ultrasound contrast agent.  It is assumed that 
Definity contains 1 billion bubbles per ml (but probably contains more) and the 
microparticle concentration is determined earlier by the Coulter Counter.  By 
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successively diluting both samples between 0 and 1 million bubbles/ml, and 0 and 120 
million particles/ml, the CTR profile of both contrast agents can be determined at an MI 
of 0.4.  Figure 6.15 displays both of these CTR profiles with respect to their respective 
concentration (Definity: top scale, co-encapsulated contrast agent: bottom scale). 
 
 
Figure 6.15: CTR of Definity and the co-encapsulated contrast agent.  The CTR of both Definity and 
the co-encapsulated contrast agent increase logarithmically with increasing concentration.  
They increase equivalently with respect to each other, separated by concentration factor of 
125 microparticles per microbubble. 
 
Overall, both Definity and the co-encapsulated contrast agent increase logarithmically by 
+18 dB with respective concentration.  More interestingly, the CTR curves of the contrast 
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agents overlap when adjusting the concentration axis by a factor of 125 microparticles 
per microbubble.  This factor is of value because it allows for a so-called acoustic relation 
between the developed co-encapsulated contrast agent and a commercially available one.  
The overlap of the curves is also encouraging, as it proves that both contrast agents are 
mechanistically responding to ultrasound in a similar fashion, albeit separated by two 
orders of magnitude. 
 
To compliment the brightness data analyzed in Section 6.3, the CTR can also be used to 
analyze the acoustic brightness of contrast agents over time.  Additionally, the CTR can 
now be normalized experimentally by utilizing the knowledge learned above, namely the 
particle/bubble conversion factor: 125.  The CTR is again monitored with the Toshiba 
unit for 30 minutes of continuous imaging, with still images captured at regular intervals 
at an MI of 0.4.  In this experiment, the CTR is compared between the co-encapsulated 
contrast agent and against home-made Definity analog microbubbles, with a shell 
composition of 95 mole% DSPC, 5 mole% DPSE-PEG 3000.  The results of the contrast 
agents’ response to clinical ultrasound imaging over time are displayed below in Figure 
6.16. 
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Figure 6.16: CTR under continuous ultrasound.  The CTR of both the co-encapsulated contrast agent 
and un-encapsulated microbubbles are compared during 30 minutes of continuous 
ultrasound imaging.  Images are captured at regular intervals during the sonication.  The co-
encapsulated contrast agent retains its contrast longer than the un-encapsulated formula at 
an MI of 0.4. 
 
This figure definitively shows that when the initial CTR is identical between the two 
studied contrast agents, the co-encapsulated contrast agent lasts longer under constant 
ultrasound imaging. While the un-encapsulated microbubbles decline steadily from the 
onset of imaging (recalling that dB is a log scale), the un-encapsulated microbubbles 
experience an initial drop of -4 dB, but retain their positive CTR value of +4 dB for the 
remainder of the experiment.  The steady drop in the un-encapsulated bubbles can be 
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attributed to the microbubbles all making eventual contact with the sound wave, and not 
yet reaching the CTR of plain water.  In the case of the co-encapsulated contrast agent, 
the contrast which is initially lost can be attributed to some percentage of the 
microbubbles within being cavitated, most likely some portion of the size distribution.  
The more resilient encapsulated bubbles are likely shielded from cavitation by the 
protection of the polymer shell.  With this result, the co-encapsulated contrast agent has 
proven to last longer under ultrasound than the commercially available ultrasound 
contrast agent, Definity. 
 
 
6.6 Cavitation Behavior of Co-encapsulated Microbubbles 
 
6.6.1 Cavitation Measurements 
Two inherent advantages of co-encapsulating microbubbles within the aqueous core of a 
polymer microcapsule are added longevity and increased patient safety.  Both of these 
potentially positive outcomes are derived from the protection of the microbubbles by the 
polymer shell.  The polymer shell is responsible for some degree of reflections from the 
incident sound wave, along with a diffusion barrier for the trapped heavy gas.  On the 
other hand, the effects of microbubbles which are potentially inertially cavitating within 
the microcapsules are retained somewhat from reaching the outside of the polymer shell.  
For example this is beneficial for the livelihood of endothelial cells which could 
potentially be killed by a nearby inertially cavitating microbubble. 
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If the mechanism of cell death is indeed inertial cavitation, then testing for the inertial 
cavitation threshold of the co-encapsulated sample versus only the microbubbles with no 
polymer shell is a logical test.  If the polymer shell increases the inertial cavitation 
threshold of a given composition of microbubble, than the co-encapsulation formula is 
inherently safer and will remain active longer in a sound field than the typical 
microbubbles studied before.  
 
A similar experimental set up as described in Chapter 3 is used to determine the 
cavitation threshold of the contrast agents, described also in previous work [52].  In this 
case, the transmitter creates pulse trains consisting of 4 pulses of 4 cycles with 80 µs 
between pulses.  Every other pulse is inverted to allow for phase inversion in signal 
processing.  The total experiment consists of 600 pulse trains, which are transmitted at a 
repetition frequency of 5 Hz.  The experiment is repeated for set peak negative pressure 
amplitudes between 50 kPa and 2 MPa.  For each new pressure amplitude, a fresh 
concentration of contrast agents is added to the sample chamber, and each composition is 
repeated in triplicate in order to ensure at least one hundred microbubbles are analyzed 
for statistical significance.  One hundred microbubbles are assured to be analyzed based 
on the assumption that the concentration of microbubbles within the sample chamber is 
0.2 microbubbles per mm3, and is well mixed.  Again, a MATLAB script will interpret 
the data, and will plot the number of destroyed microbubbles over the total number of 
detected microbubbles with increasing peak negative pressure. 
 
199 
 
 
Figure 6.17:  Inertial cavitation threshold of co-encapsulated and un-encapsulated microbubbles.  
Results shown are for microbubbles (co-encapsulated [x] and un-encapsulated [o]) with a 
bubble shell consisting of 95% DPSC and 5% DSPE-PEG 5000.  In both cases, no 
cavitation is detected until approximately 0.5 MPa peak negative pressure.  In the un-
encapsulated sample, the curve is the typical sigmoidal shape, which is fully cavitated by 
1.4 MPa.  However, the co-encapsulated sample, in which the microbubbles are shielded by 
the outer PLA shell, exhibit less cavitation at the sample peak negative pressures as the un-
encapsulated sample, and never reach complete cavitation within the maximum pressure 
which can be generated by the pulser.  
 
The inertial cavitation threshold of the co-encapsulated microbubbles is measured to 
determine the peak negative pressure they can withstand without being destroyed.  
Microbubble samples consisting of 95 mole% DSPC and 5 mole% DSPE-PEG 5000, 
both co-encapsulated in PLA and un-encapsulated, are tested for their cavitation 
threshold and shown in Figure 6.17.  While both samples exhibit no cavitation until a 
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peak negative pressure of 0.5 MPa, the co-encapsulated sample shields its microbubbles 
from cavitation at higher pressures.  The pressure at which 50% of the sample is cavitated 
for the co-encapsulated microbubbles (1.5 MPa) is almost double that of the un-
encapsulated microbubbles (0.8 MPa), and the pressure at which 100% of the sample is 
cavitated for the co-encapsulated sample cannot be determined because it exceeds the 
maximum PNP output of the pulser.  This result proves that the co-encapsulated contrast 
agent is safer and longer lasting in an ultrasound field (at PNP values above 0.5 MPa) 
than typical microbubbles, through shifting the inertial cavitation threshold to higher 
values of pressure.  In this way, a clinician is able to image at higher MIs without fear of 
the onset of inertial cavitation, therefore generating brighter images while also protecting 
the integrity of the patient’s endothelial cells. 
 
6.6.2 Modeling Co-encapsulated Oscillation Behavior 
As in Chapter 4, the behavior of microbubbles oscillating within the aqueous core of 
polymer microcapsules can be described by some modification of the colloidal model 
(Equation 4.10).  To describe the limit of the oscillations of a bubble as the bubble radius, 
R, approaches the microcapsule radius, Rcap, a drag term can be added to the colloidal 
model energy balance, highlighted in bold below in Equation 6.2 (and collected with 
Poritsky viscous damping term). 
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(Equation 6.2) 
 
The addition of the drag term drastically increases the damping of the oscillation as R 
approaches Rcap (the difference is raised to the -2 power).  The predicted oscillations as 
given in Figure 6.18, for Rcap = ∞, 3, and 4 µm (black, red, and green line, respectively).  
From the colloidal model simulations in Chapter 4, the equation is solved with 
parameters: ρ is 998 kg/m3, P0 is 10.13 kPa, σ is 0.051 N/m, γ is 1.07, µ is 0.001 Pa s, R0 
is 1 µm, KA is 50 mN/m, κs is 7 * 10-9 N s/m, and P(t) is the 4 cycle sine wave pressure 
function with an amplitude of 1 MPa.  The case where Rcap = ∞ is equivalent to response 
from the colloidal model, Equation 4.10. 
 
Figure 6.18 shows that the oscillations predicted for the co-encapsulated microbubbles 
vary from freely oscillating microbubbles (black line) only when R nears Rcap (as R 
approaches 92.5% of Rcap).  At this point, the repulsion force becomes exponentially 
stronger (power -2 from the equation), which makes sense physically as the fluid inside 
the microcapsule is being compressed by the bubble expansion and more resistant to 
further compression.  Otherwise, the oscillations remain mostly the same for all cases of 
Rcap (the lower Rcap responds slightly faster during the negative change in radius because 
the radius has already stopped expanding by the time it experiences negative pressure). 
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Figure 6.18: Oscillations predicted for co-encapsulated microbubbles.  The simulated oscillations 
predicted from Equation 6.2 for two values of Rcap, and one from the colloidal model (black 
line, infinite Rcap) are displayed.  The drag force constraint only affects the microbubble 
oscillations as it approaches R = Rcap (Rcap = 4 µm: red line, 3 µm: green line). 
 
 
6.7 Cavitation Induced Cell Death 
 
It is anticipated that the co-encapsulation of microbubbles within the aqueous core of 
polymer microcapsules will lend some increase in patient safety during contrast imaging.  
This is obviously a hot-button issue for ultrasound contrast agents due to the FDA 
restrictions mentioned previously.  One way of determining the relative safety of a 
contrast agent under ultrasound is in vitro cell viability.  While it is somewhat nebulous 
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as to the mechanism of interaction between living cells and microbubble contrast agents, 
it is a consensus that microbubble oscillations are the driving force [40, 84, 109-111].  
The polymer shell both limits the microbubble oscillations and provides a barrier between 
the microbubble and the outer fluid, both of which should prove advantageous in 
protecting nearby cells from the negative bioeffects associated with cavitation. 
 
Cell viability can be analyzed by a propidium iodide (PI) cell death assay.  In this assay, 
PI fluoresces at 550 nm (red) if excited at 488 nm in the presence of DNA.  PI’s only 
route into through the cell membrane to interact with DNA is assumed to be that of a 
sonoporated or dead cell.  First, human colon cancer cells (SW-480) cells are cultured to 
70% confluence in T75 flasks.  SW-480 cells are preferred because of their fast growth 
rate and their strong adherence to the walls of the growth chamber. SW-480 cells can be 
grown in a modified Dulbecco’s Modification of Eagle’s Medium (DMEM) with sodium 
pyruvate, non-essential amino acids and 10% fetal bovine serum (FBS).   The day before 
the experiment, the cells are trypsinated and moved to Opticells (Thermo Scientific, 
Rochester, NY), which are nearly acoustically transparent (cellulose chamber walls).  9.6 
ml of cell suspension in DMEM growth media is added to each Opticell (maximum 
volume 10 ml).  Directly before performing the experiment, 0.1 ml of 1 mg/ml PI in 
water is added to the Opticell, along with a total volume of 0.3 ml of the desired contrast 
agent concentration.  It is important to eliminate as many macroscopic air bubbles from 
the Opticell as possible to avoid acoustic reflections. 
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For a single experiment, the Opticell is placed in the focus of a spherically focused 2.25 
center frequency transducer (7.5 cm focus).  The transducer broadcasts 250 ten cycle 
pulses at a pulse repetition frequency of 5 Hz.  Twenty fluorescence micrographs are 
recorded in the focal zone of the Opticell before and after sonication.  The difference 
between the mean brightness of the images before sonication and after sonication is then 
compared (on a brightness intensity scale of 0 - 255).  Sample micrographs from before 
and after sonication of a positive cell death results from 99 mole% DSPC, 1 mole% 
DSPE-PEG 3000 (30 million contrast agents/ml concentration, 3 MPa PNP are displayed 
in Figure 6.19). 
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Figure 6.19: PI fluorescence cell death assay.  Micrographs from before (left column) and after (right 
column) cell sonication in the presence of contrast agents are displayed for microbubbles 
consisting of 5 mole% DSPC, 95 mole% DSPE-PEG 3000 (top row) and the co-
encapsulated contrast agent (bottom row).  The un-encapsulated microbubbles under 
ultrasound cause significant cell death, as shown by the difference between panels A and B, 
where difference in the co-encapsulated before and after is minimal if existent (between C 
and D). 
 
The pronounced PI fluorescence in panel B compared to panel A indicates that the 
experiment has successfully killed a significant population of the SW-480 cells in the 
experiments with un-encapsulated microbubbles, where as the insignificant difference 
between panels C and D indicate little cell death in experiments run with the co-
encapsulated contrast agent. These results prove that at similar acoustic brightness (and in 
fact higher concentration per unit contrast agent), the co-encapsulated contrast agent 
effectively shields surrounding cells from the negative bioeffects – here, cell death – 
more effectively than un-encapsulated microbubbles.  The un-encapsulated microbubbles 
used in this study are analogous to Definity or SonoVue commercial contrast agents, but 
can be produced cheaply and quickly.     
 
The results from such micrographs can be quantified by analyzing their brightness using 
a MATLAB script (imread function).  Thresholding is applied to the micrograph (as in 
Chapter 2) in order to remove the background and extraneous piece of the image which 
are not related to PI fluorescence.  Figure 6.20 shows the quantified results of 
experiments which investigate the cell death as a function of the CTR displayed by the 
given contrast agent composition.  By using the results from Section 6.5, the respective 
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contrast agent concentration of the microbubbles and microcapsules can be determined; 
however, for the purpose of this study it is more interesting to compare the contrast 
agents by normalizing their acoustic brightness (recall that 125 microparticles give the 
same brightness as 1 microbubble). 
 
 
Figure 6.20: Cell death as a function of microbubble/capsule concentration.  This chart shows the 
relative amount of cell death experienced by SW-480 cell lines in the presence of 
ultrasound and contrast agents.  In the presence of un-encapsulated microbubbles (red bars), 
cell death is proportional to CTR (therefore concentration).  However, in the presence of the 
co-encapsulated formula (blue bars), cell death is insignificantly small and insensitive in 
changes in concentration.  
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In Figure 6.20, the safety of the co-encapsulated contrast agent is proven.  The cells are 
subjected to 3 MPa peak negative pressure in the presence of both un-encapsulated and 
co-encapsulated contrast agent.  The concentrations of these contrast agents are related in 
an earlier experiment and therefore it is represented in the figure as CTR values for the 
respective concentrations of the two contrast agents.  In other words, the concentrations 
of each contrast agent which give a certain CTR value are plotted together in the figure 
above.  Predictably for microbubble contrast agents, cell death decreases with decreasing 
CTR value (and concentration).  In the case of the co-encapsulated contrast agent 
however, no significant cell death is observed even at the highest concentration (and cell 
death remains insignificant as CTR increases).   
 
In addition to cell death as a function of pressure, the same assay can be performed at 
various ultrasound pressures.  In this study, Opticells loaded with a constant 
concentration of 30 million microbubbles/ml are exposed to pressures of 50, 500, 1000, 
and 2000 kPa PNP (one Opticell per pressure).  The results of this experiment show some 
small degree of cell death at the lowest pressures (50 and 500 kPa), and a far greater 
degree of cell death at the highest pressures (1 and 2 MPa).  This result can be combined 
with the previous cavitation profile for the same microbubble composition, shown below 
in Figure 6.21. 
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Figure 6.21: Cell death and cavitation profiles.  The relative cell death profile is overlaid with the 
cavitation profile for microbubbles with a shell composition of 99 mole% DSPC, 1 mole% 
DSPE-PEG 3000.  Both graphs exhibit the same trend of a sigmoidal increase beginning at 
approximately 0.5 MPa. 
 
Overlaying these results provides a significant insight into the mechanism of cell death in 
this study.  A small degree of cell death is found at pressures below 0.5 MPa, a region 
which is associated with only stable cavitation as determined by the cavitation threshold 
for this shell composition.  At PNP above 1 MPa, the degree of cell death increases 
significantly.  These higher pressures are indentified as the inertial cavitation region for 
this shell composition.  This outcome suggests the major mechanism of cell death 
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imposed by oscillating microbubbles is mostly due to inertial cavitation (and to a lesser 
degree, stable cavitation). 
 
These results suggest that the co-encapsulated contrast agent is successfully providing a 
barrier between the inertial cavitation of the microbubbles within and the cell population 
outside the microcapsule.  The result is again bounded by the pressure range of the 
pulser/power amplifier, SchaumSchläger, but it is possible that at high enough peak 
negative pressure or with some alteration of the microcapsule composition that 
significant cell death could occur.  It is apparently that there exists some trade-off 
between the robustness of the contrast agent (CTR longevity, cell viability) and the 
ability to puncture or damage the microcapsule for potential drug delivery applications. 
 
 
6.8 Co-encapsulation Microcapsule Leakage Studies 
 
The co-encapsulated formula has an obvious application in the drug delivery field based 
on its relatively large volume of aqueous media encapsulated within the microcapsule 
along with the microbubbles.  For the contrast applications described above, the aqueous 
media was simply PBS, however this could easily be replaced with a hydrophilic drug 
solution.  The advantage of the co-encapsulated formula over microparticles with no 
encapsulated microbubbles is the use of inertial cavitation as a potential trigger for drug 
release.  Coupling this with the positioning of the transducer, the co-encapsulated 
combination could be used as a controlled and targeted drug delivery vehicle. 
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6.8.1  Calcein: self-quenching fluorophore 
To more easily analyze drug leakage from the microcapsules, the hydrophilic drug can be 
replaced by a hydrophilic fluorescent dye.  Calcein, a self-quenching fluorophore, is 
selected as the best dye for the study.  First, calcein has a relatively small molecular 
weight (622 g/mol) which allows for quicker diffusion or active leakage through the 
polymer shell.  Additionally, as a self-quenching fluorophore, at high concentrations the 
calcein molecular interactions quench the fluorescence.  This is useful for leakage 
experiments because the calcein concentration inside microparticles can be set well above 
the concentration for self-quenching, therefore not fluorescing until the dye leaks from 
the microcapsule into the larger volume of aqueous outside of the shell.   
 
To properly evaluate the leakage of calcein from the microcapsules, it is important to 
select an encapsulated concentration which provides clear fluorescence results as it leaks 
from the polymer shell.  Quantifying fluorescence intensity of an aqueous sample can be 
achieved by fluorescence spectrometry.  3 ml samples of varying concentrations of 
calcein in water will be analyzed by a fluorescence spectrometer (PTI, Birmingham NJ).  
As per the fluorescent properties of calcein, the samples are excited at 475 nm, and the 
scan reads for emissions between 490-540 nm.  Figure 6.22 shows the results of the 
calcein concentration calibration, below.  
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Figure 6.22: Calcein concentration calibration.  Calcein solutions of 0 - 70 µM are analyzed for their 
fluorescence intensity (arbitrary units) using fluorescence spectrometry.  The data shows a 
fluorescence maximum at 35 µM calcein, which is indicative of the self quenching effects 
of the fluorophore at that concentration and above.  The data is described with a 4th order 
polynomial fit. 
 
The results of the calibration show that calcein under the experimental conditions begins 
to self quench at a concentration of 35 µM.  At higher concentrations, the fluorescence 
intensity begins to decline until it ultimately reaches zero (at a concentration of 100 mM).  
Therefore, the experiment should be designed such that the concentration of calcein 
outside of the particles will be on the left side of the self-quenching point so as not to 
acquire data with an ambiguous result.  It is also favorable to have the concentration of 
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calcein encapsulated within the microcapsules to be well above this inflection point.  
Accounting for these two factors, the calcein concentration within the particles is selected 
to be 70 mM.  To calculate calcein concentration from experimental fluorescence 
spectrometry results, an empirical 4th order polynomial equation can be employed (from 
Figure 6.22).  For future reference under these experimental conditions, this relationship 
is listed below (where IF is the fluorescence intensity in arbitrary units, and Ccal is the 
calcein concentration in mM): 
 
IF = -1.505*1011(Ccal4) + 4.692*1010(Ccal3) - 4.994*109(Ccal2) + 1.980*108(Ccal) - 1.0962*104 
 (Equation 6.3) 
 
While working with calcein for these studies, it was determined that the fluorophore can 
give a false positive result (an increase in fluorescence intensity) in the presence of 
certain materials.  Examples of these materials include nitrile (as in examination gloves), 
rubber (as in the housing of the immersion cables for the transducers), and most 
significantly latex (as in the material of the sample chamber).  In light of this interaction, 
it is best to remove all such materials from the experimental procedure.  To leak dye from 
the microcapsules, it is imperative that they are sonicated in either glass or plastic (both 
of which have shown to have no interaction with calcein), and that the cable housing of 
the transducer not be submerged in the sample chamber at any point during the course of 
the experiment.  This strange and unexpected result is studied briefly below in Figure 
6.23 for the interactions of calcein specifically with the latex sample chamber several 
conditions. 
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Figure 6.23: Interactions between calcein and white latex.  A calcein solution is added to a latex 
finger cot and mixed for a period of 45 minutes, with fluorescence measurements taken at 
regular intervals.  The four samples in the figure represent: water mixed in the latex cot (♦), 
a calcein solution mixed in the latex cot (■), a calcein solution mixed in a latex cot which 
has been soaked in water for 1 week (▲), and the previous calcein solution removed from 
its old cot and added to a new one and mixed for an additional 45 minutes (x).  
 
The results of the study provide several insights about the interactions between latex and 
calcein.  First, the sample of water (♦) mixing in the latex cot shows that latex has no 
inherent fluorescent properties of its own (and neither does water).  Also, the calcein 
solution (■) mixing in the latex cot reaches a maximum of fluorescence intensity after 45 
minutes; that is to say that the interactions somehow become saturated after that time.  
The mixing of the calcein solution in a latex cot which has soaked in deionized water for 
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1 week (▲) shows that this act has no effect on the interactions between the calcein and 
latex.  Finally if the calcein solution is taken from an old latex cot after 45 minutes of 
interaction, and then added to a fresh latex cot (x), the calcein cannot interact further with 
the new cot (proven by no increase in fluorescence intensity).  In a separate experiment, a 
single latex cot is reused with new calcein solution six times.  Each time the six calcein 
solutions show the exact same growth rate and saturate at the same value of fluorescence 
intensity. 
 
Taken together, these results suggest that the latex is somehow affecting the calcein 
solution, and not the other way around; because if the calcein were entering the cot, for 
example, the intensity would again increase with the addition of a new cot.  Additionally, 
the ability for the latex to affect the calcein is seemingly limitless, and does not 
degenerate with time, water diffusion, or exposure to calcein.  While the mechanism of 
these interactions is unknown, it is important to bear in mind for ultrasound induced 
leakage experiments. 
 
6.8.2 Low Frequency Dye Leakage 
The previously prepared double emulsion microcapsules with encapsulated 1:1 
microbubble solution (microbubble concentration approximately 1 billion bubbles per 
ml) in PBS and 70 mM calcein buffer are actively leaked by ultrasound.  The 
microcapsules are effectively leaked by sonicating them with a 24 kHz probe sonicator 
for a total time of 5 minutes.  This is a somewhat trivial result for a few reasons.  First, 
low frequency ultrasound is dangerous for living tissue, as the long wavelength allows 
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the material to fully respond to the pressure amplitude, as well as nucleating and 
subsequently cavitating trapped and dissolved gasses.  Additionally, co-encapsulated 
microbubbles will be oscillating at a frequency very far from their resonance frequency 
(as discussed earlier in Chapter 4), and their effect on the polymer shell should be less 
than at their resonance frequency.  Finally, during the microcapsule synthesis process, the 
drying phase needs to be arrested after only 30 minutes in order to achieve any degree of 
leakage.  This is most likely due to the fluidity of the membrane while it still retains some 
of the organic solution.  However, the resulting studies can still provide some proof of 
concept of ultrasound induced leakage from a microcapsule with some polymer shell 
architecture.  
 
To view calcein fluorescence under a fluorescent microscope (Axioskop 2, Carl Zeiss, 
Heidenheim, Germany), it is excited at 470 +/- 20 nm, and viewed between 525 +/- 25 
nm.  Dye release from microcapsules is measured by active leakage with ultrasound 
followed by detection by fluorescence analysis. The results of the low frequency 
ultrasound (24 kHz, Misonix, Farmingdale, NY) experiment are shown in Figure 6.24 A-
D.  Here, microscope images are recorded before (Figure 6.24 A-B) and after (Figure 
6.24 C-D) ultrasound with both light (Figure 6.24 A, C) and fluorescence (Figure 6.24 B, 
D) microscopy. 
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Figure 6.24:  Fluorescent dye leakage with low frequency ultrasound.  Microscope light and 
fluorescence images of fluorescent dye loaded microcapsules before and after 5 minutes of 
continuous wave application of 24 kHz ultrasound are shown.  Fluorescent excitation light 
was at 470 +/- 20 nm, and optical filter allows viewing at 525 +/- 25 nm.  a microcapsules 
under visible light before ultrasound, b microcapsules under fluorescent light before 
ultrasound, c microcapsules under visible light after ultrasound, d microcapsules under 
fluorescent light after ultrasound. 
 
In the images before ultrasound, it is evident that most of the fluorescent dye is contained 
within the particles when the fluorescent image is recorded and compared to the phase 
inversion.  After 5 minutes of 24 kHz ultrasound, the images are retaken and it becomes 
evident that some of the dye has leaked out of the particle and into the surrounding fluid 
by the dramatic increase in the amount of fluorescence present in the media surrounding 
the microcapsules.  These fluorescence results can be quantified with the fluorescence 
spectrometer used to measure the calcein concentrations, and the results of the same 
study are displayed in Figure 6.25. 
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Figure 6.25: Active ultrasound leakage from co-encapsulated microcapsules.  A solution of co-
encapsulated microcapsules with 1:1 70 mM calcein buffer to microbubble solution is 
sonicated at 24 kHz for a total of 5 minutes.  At 1 minute intervals, the sample is tested for 
its fluorescence intensity on a fluorescence spectrometer.  The results are also subtracted 
from a control sample of co-encapsulated microcapsules which do not undergo any 
sonication (the zero line).  The results show that microcapsule exhibit some quick burst 
release in the first minute of sonication, and then plateau with increasing sonication time.   
 
In Figure 6.25, a burst release of calcein is observed from the microcapsules followed by 
a plateau in dye leakage.  The effect of passive diffusion has been subtracted from the 
dye release profile, and is a minimal contribution compared to the active leakage caused 
by ultrasound.  Although this result is encouraging, it is still not clinically relevant 
because of the use of the low frequency (24 MHz) probe transducer.  For the result to be 
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interesting for in vivo studies in drug delivery, the microcapsules need to actively leak 
the drug with a high frequency ultrasound transducer, like those found in a clinical 
environment.   
 
6.8.3 Clinical Frequency Dye Leakage 
Unfortunately, high frequency ultrasound therapy at 2.25 MHz and 3 MPa PNP is 
insufficient to cause significant dye leakage from the PLA microcapsules synthesized in 
this chapter.  This is most likely due to the rigid solid polymer shell which encapsulates 
the microbubbles.  It is yet unclear whether the polymer shell is somehow inhibiting the 
microbubbles from undergoing inertial cavitation (either by signal or oscillation 
shielding) or that microbubble inertial cavitation is not powerful enough to cause 
sufficient damage to the polymer shell for it to release any dye.  As it is well known that 
cells (with their mainly lipid/protein bilayer) can be sonoporated by inertially cavitating 
microbubbles [40], the outer shell should optimally be a lipid vesicle.   
 
However, encapsulating pre-prepared microbubbles within the aqueous core of a lipid 
vesicle is not a simple task.  Attempts to arrive a co-encapsulated vesicle through vesicle 
electroformation and microinjection were unsuccessful.  Spontaneous formation through 
either electroformation or rehydration have been unsuccessful due to the mechanism in 
which lipid films form into giant uni-lamellar vesicles (GUVs), the process of which 
shown in Figure 6.26, which is adopted from Sriram [112]. 
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Figure 6.26: Mechanism of vesicle budding from a bilayer.  This mechanism, proposed here by 
Sriram [112], shows the bilayer progression as the vesicle buds from the membrane.  In this 
way, it would be difficult for microbubbles to enter into the membrane as there are no large 
gaps in the bilayer during the budding process. 
 
The mechanism of vesicle creation proposed here is budding.  Since the bilayer buds off 
to form the vesicle, there are no windows in which a large 1 µm microbubble will be able 
to slip past the membrane into the vesicle.  This mechanism does provide insight on 
which encapsulation techniques will be successful at trapping microbubbles.  For 
example, a mechanism in which a bilayer is stretched across interface between an 
aqueous solution, and a solution with microbubbles would allow for the budding of 
vesicle into the aqueous solution from the microbubble solution, therefore having an 
inner phase with encapsulated microbubbles.  An analogous set up developed by 
Funakoshi [113] for synthesizing GUVs with encapsulated drug, is displayed in Figure 
6.27, below. 
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Figure 6.27: Pulse jet vesicle synthesis.  This diagram, adopted from Funakoshi [113], details a method 
of producing GUVs by pulse jet formation.  This technique involves pulsing a jet of the 
soon to be encapsulated solution through a planar lipid membrane in order to bud off a 
vesicle into the aqueous buffer on the other side of the bilayer. 
 
In Figure 6.27, Funakosi diagrams the design of a GUV synthesis technique involving 
jetting the encapsulated media from a nozzle at a lipid bilayer, thus forcing a vesicle to 
bud.  In Funakoshi’s case, the encapsulated material was a drug; however in the case of 
co-encapsulation, the encapsulated solution would ideally contain microbubbles and a 
drug.  This technique, along with the possibility of forming liposomes with a double 
emulsion, is a potential method of encapsulating microbubbles within the aqueous core of 
a liposome, although these experiments have not been pursued in this study. 
 
 
6.9 Conclusion 
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Given these results, the novel co-encapsulation of phospholipid microbubbles within 
polymer microcapsules shows that when exposed to an ultrasound field yields the 
expected acoustic response, along with providing successful contrast to ultrasound 
images.  As expected, the co-encapsulated contrast agent provides the added benefit of 
shielding the microbubbles within from the ultrasound wave, which is shown to 
effectively double their inertial cavitation threshold.  Additionally, the co-encapsulated 
contrast agent has shown to have an acoustic response similar to the commercial contrast 
agent, SonoVue and Definity, and in the case of higher ultrasound MIs, as seen in Figure 
6.14 A, C, the co-encapsulated contrast agent has a slightly longer lifetime than that of 
SonoVue. 
 
In addition to the potential benefits offered in contrast, the co-encapsulated formula also 
has potential benefits as a drug delivery vehicle.  The size of the PLA microcapsules (3-5 
µm), is ideal for balancing maximum loading potential of a water soluble drug while still 
maintaining a suitable size for vascular and capillary transport.  While Figure 6.24 shows 
that a hydrophilic dye can be successfully leaked from the co-encapsulated sample with 
low frequency ultrasound, it is understood that this is not a physiologically relevant result 
since low frequency ultrasound has shown to cause damage to tissue [20]; however, 
studies are underway to investigate the feasibility of leakage at higher, clinically relevant 
frequencies (1-10 MHz).  Thus far, the microbubble cavitation that is able to be generated 
with high frequency ultrasound, as in Figure 6.17, is unable to release any dye from the 
current microcapsule formula.   
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In this chapter, the acoustic response generated by the co-encapsulation of phospholipid 
shelled microbubbles within the aqueous core of polymer microcapsules is examined 
along with its feasibility as an ultrasound contrast agent.  The addition of the polymer 
shell provides the added benefit of approximately doubling the inertial cavitation 
threshold of the microbubbles contained within.  The feasibility of the utilization of the 
co-encapsulated contrast agent as a drug delivery vehicle was also investigated.  It is 
concluded that the co-encapsulated contrast agent provides contrast similar to that of un-
encapsulated microbubbles, both in acoustic response and image intensity of contrast to 
tissue. 
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CHAPTER 7: Summary and Implications 
 
 
Over the course of this dissertation, the colloidal science of contrast agents have been 
examined and hopefully better understood.  The following sections summarize the 
findings of each chapter in this dissertation and describe the potential implications and 
future of the study. 
 
 
7.1 Project Summary 
 
The size distributions of populations of microbubbles were examined with a variety of 
different shell compositions.  This set of shell compositions was laid out, which 
contained combinations of DPSC and DSPE-PEG, mole fractions between 0.01 – 0.15 
DSPE-PEG, and PEG molecular weights between 1000 and 5000 g/mole.  It was found 
that the size distributions are very similar for all the shell compositions measured; they 
contained a monomodal peak with a nearly Gaussian distribution.  The mean size of the 
microbubbles did not change significantly for the compositional changes made in this 
study.  Additionally, an image segmentation rationale was presented for measuring the 
size distribution of microbubbles. 
 
This same set of shell compositions is then analyzed for their inertial cavitation threshold 
pressure.  A high voltage pulser, the SchaumSchläger, was specifically designed, 
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synthesized, and utilized in these experiments.  A MATLAB program analyzes the 
acoustic response of the microbubbles to determine their destruction through double 
passive cavitation detection.  The experiments yielded the result that the inertial 
cavitation threshold of these microbubbles is between 0.75 and 1.25 MPa.  More 
interestingly, as PEG mole fraction increases, the inertial cavitation threshold increases 
sigmoidally.  With increasing PEG molecular weight, however, the cavitation threshold is 
shown to decrease slightly.  These results can be fit with a RPNNP like equation 
(Morgan’s equation) by numerically solving it for a cavitation criterion – here when R = 
2R0.  It is also shown that limiting the size distribution has the effect of sharpening the 
increase of the cavitation profile. 
 
With these experimental cavitation results, a predictive model is desired to explain the 
data.  Previously developed models for microbubble oscillations are examined and 
compared.  Based on the colloidal science principles, a new model for the oscillation of 
thinly shelled microbubbles is explained.  For simple microbubble compositions, a 
predictive model can be applied for calculating material parameters of the microbubble 
shell.  This equation is shown to hold for the experimental cavitation data collected 
during the course of this work. 
 
This same set of microbubble shell compositions described earlier is then analyzed for 
their resonance frequency.  This is accomplished by measuring the attenuation of a 
broadband chirp signal sent through a field of microbubbles.  The frequency where the 
attenuation is the most is that at which the microbubbles have absorbed the most energy, 
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i.e. the resonance frequency.  Again, several trends exist as a function of the shell 
composition.  As PEG mol fraction and molecular weight increase, the resonance 
frequency decreases (again sigmoidally).  The experimentally measured resonance 
frequencies can be fit with a simple model by Lars Hoff to describe sound moving 
through a field of bubbles.   
 
Using the information gathered in the previous chapters, a novel contrast agent was 
designed.  The contrast agent is comprised of lipid shelled microbubbles floating within 
the aqueous core of polymer shell microcapsules.  This combination has the benefit of 
added patient safety (through the aversion of cell death) while providing similar contrast 
to commercially available contrast agents.  The contrast agent accomplishes this by 
shielding the microbubbles from the incident sound pressure and preventing their 
expansion beyond the threshold radius.  The design of the contrast agent is also 
inherently a drug delivery vehicle which can cater to both hydrophilic and hydrophobic 
drugs. 
 
 
7.2 Implications 
 
The implications of this work can mainly be broken down into the two main sections of 
study, the physical properties of microbubbles as a function of shell chemistry and the 
design of a novel contrast agent.   
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Understanding the inertial cavitation threshold of a microbubble allows a clinician to dial 
in a certain acoustic pressure (through the MI) to avoid cavitation in imaging scenarios.  
On the other hand, in future drug delivery applications, the pressure could be raised 
above the cavitation threshold to encourage leakage.  This simple method presented can 
be used to determine these thresholds for any number of contrast agents, as only a few 
simple mixtures have been presented here.  Additionally, microbubble contrast agents 
could be designed with a specific application in mind, such as to tailor the cavitation 
threshold to the needs of a specific scan type or transducer frequency.  Knowing the 
resonance frequency of microbubbles also effects their image quality; the closer to the 
resonance frequency, the brighter the contrast and the greater the oscillations.  The 
potentially violent and damaging effects of inertial cavitation coupled with the legal 
struggles of contrast agents to gain mainstream acceptance make this technique of 
importance. 
 
With this in mind, the new contrast agent seeks to limit the microbubble’s ability to 
inertially cavitate, while still providing contrast brightness.  This has great implications in 
the aforementioned legal battle (assuming that inertial cavitation is the mechanism of the 
negative implications).  Also, the use of this contrast agent as a drug delivery vehicle 
would make it perfectly suitable as a controlled and target delivery mechanism.  The 
interactions of ultrasound and the microbubbles control when and if the drug will release 
from the microcapsule, and the physical location of the ultrasound transducer defines the 
targeted regime (focused transducers can make the target even more exact).  However, 
this work is not yet complete. 
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7.3 Future Outlook 
 
There are many potential avenues to pursue in the advancement of these studies.  First, in 
the study of the microbubble physics, there is a need for more raw data to interpret.  The 
set of shell compositions studied truly only delve into the effect of the addition of the 
stabilizing PEG to the monolayer.  It is complete in the sense that a full range of PEG 
mole percentages have been study, since above 15 mole% PEG no more PEGylated lipids 
will be able to associate into the membrane.  The effect of PEG molecular weight would 
also be difficult to explore further, but perhaps PEG molecular weights as low as 100 
g/mole can be tested in conjunction with the predictive model.   
 
To fully discover shell effects, these types of experiments would need to be performed on 
different lipids, such as dipalmitoyl phospatidylcholine (DLPC, a 16 chain saturated 
lipid) and diarachidoyl phospatidylcholine (DAPC, a 20 chain saturated lipid).  If the 
temperature were lowered below 25 oC, than lower carbon chain length lipids and 
unsaturated lipids could be tested as well (their melting temperatures are below room 
temperature).  Hydrophilic polymers other than PEG can be used as the stabilizer.  
Commercial microbubble contrast agents, like Definity, have several other degrees of 
complexity besides these.  In fact Definity has a lipid blend with a blend of PEGylated 
lipids.  Additionally it is further stabilized by a viscous liquid (more than water and PBS).  
All of these variables will have some effect on the microbubble’s oscillation behavior, 
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and therefore their cavitation profile.  In terms of the developed colloidal microbubble 
dynamic equation, it may be possible to linearize this equation in a similar approach as 
Neppiras and Morgan [30, 54], which would allow for determination of the microbubble 
resonance frequency as a function of the predictive KA parameter.  These newly 
determined resonance frequencies could be compared to experiment and perhaps provide 
a predictive model for both inertial cavitation and resonance frequency. 
 
A great deal of work can be done in furthering the development of the co-encapsulated 
contrast agent.  For the formula described above, there are many possibilities for 
improving the contrast brightness (CTR) of the microparticles.  First, the microbubble to 
microcapsule ratio should be investigated to find the optimal amount which produces the 
most brightness.  This is most likely a tradeoff between the brightness caused by the 
increase in microbubbles and the multiple scattering effects which would be present if too 
many bubbles were oscillating in near proximity (like inside the microcapsule). 
 
The co-encapsulation formula was initially developed as a drug delivery platform.  
Unfortunately the current formulation has proven to be very difficult leak using the 
microbubbles as a trigger, whether it is because the microbubbles do not oscillate enough 
or that the shell is too tough to rupture.  However, as mentioned in Section 6.7.2, the 
feasibility of leaking a drug from a liposomal carrier is much higher than from a polymer 
shell.  A lipid bilayer encapsulation shell would most probably allow for drug delivery 
applications at acoustic pressures (or MIs) above the inertial cavitation threshold, while 
providing superior contrast (over the polymer particles) at pressures below the inertial 
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cavitation threshold, thus giving it multiple functions.  The brightness would likely be 
great in a liposome because the walls of a liposome are more flexible they will reflect less 
sound.  As a glimpse of the future for this work, Figure 7.1 displays a microparticle 
which has ruptured by some artifact of SEM preparation (most likely lyophilization).  
However accidentally, this image represents the true potential of this research.     
 
 
Figure 7.1: Ruptured co-encapsulation microcapsule.  While the rupture of this microparticle is an 
artifact of SEM preparation, it shows the potential for leaking drugs from its aqueous core.  
230 
 
LIST OF REFERENCES 
 
 
[1] T. L. Szabo, Diagnostic ultrasound imaging : inside out. Amsterdam ; Boston: 
Elsevier Academic Press, 2004. 
[2] E. E. Purinton, "Simple When you Know it," The Independent, vol. 103, p. 206, 
1920. 
[3] G. Dummer, Electrical Inventions and Discoveries, 4th ed. Bristol, UK: CRC 
Press, 1997. 
[4] J. Cole, The Great American University. New York, NY: PublicAffairs, 2010. 
[5] G. A. Ferraro, F. De Francesco, C. Cataldo, F. Rossano, G. Nicoletti, and F. 
D'Andrea, "Synergistic Effects of Cryolipolysis and Shock Waves for 
Noninvasive Body Contouring," Aesthetic Plast Surg, Nov 1 2011. 
[6] A. L. Klibanov, "Targeted delivery of gas-filled microspheres, contrast agents for 
ultrasound imaging," Advanced Drug Delivery Reviews, vol. 37, pp. 139-157, 
1999. 
[7] Y. Liu, H. Miyoshi, and M. Nakamura, "Encapsulated ultrasound microbubbles: 
therapeutic application in drug/gene delivery," J Control Release, vol. 114, pp. 
89-99, Aug 10 2006. 
[8] J. Woo. (2006, Obstetric Ultrasound. A Comprehensive Review, 1.  
[9] L. Hoff, P. C. Sontum, and J. M. Hovem, "Oscillations of polymeric 
microbubbles: effect of the encapsulating shell," J Acoust Soc Am, vol. 107, pp. 
2272-80, Apr 2000. 
[10] H. Medwin, "Counting bubbles acoustically: a review," Ultrasonics, vol. 15, pp. 
7-13, 1977. 
231 
 
[11] M.-X. Tang and R. J. Eckersley, "Frequency and pressure dependent attenuation 
and scattering by microbubbles," Ultrasound in Medicine &amp; Biology, vol. 33, 
pp. 164-168, 2007. 
[12] M. Postema and G. Schmitz, "Bubble dynamics involved in ultrasonic imaging," 
Expert Review of Molecular Diagnostics, vol. 6, pp. 493-502, 2006. 
[13] Z. Gao, A. M. Kennedy, D. A. Christensen, and N. Y. Rapoport, "Drug-loaded 
nano/microbubbles for combining ultrasonography and targeted chemotherapy," 
Ultrasonics, vol. 48, pp. 260-70, Aug 2008. 
[14] R. Gramiak and P. M. Shah, "Echocardiography of the aortic root," Invest Radiol, 
vol. 3, pp. 356-66, Sep-Oct 1968. 
[15] K. W. Ferrara, M. A. Borden, and H. Zhang, "Lipid-Shelled Vehicles: 
Engineering for Ultrasound Molecular Imaging and Drug Delivery," Accounts of 
Chemical Research, vol. 42, pp. 881-892, 2009. 
[16] R. Suzuki, T. Takizawa, Y. Negishi, N. Utoguchi, and K. Maruyama, "Effective 
gene delivery with novel liposomal bubbles and ultrasonic destruction 
technology," Int J Pharm, vol. 354, pp. 49-55, Apr 16 2008. 
[17] L. Hoff, P. A. Foss, K. Dyrstad, J. Klaveness, and P. Rongved, "Stabilization of 
Gas Bubbles Released from Water-Soluble Carbohydrates Using Amphiphilic 
Compounds: Preparation of Formulations and Acoustic Monitoring of Bubble 
Lifetime," J Surfactants Deterg, vol. 14, pp. 585-593, Oct 2011. 
[18] P. A. Lewin, "Quo vadis medical ultrasound?," Ultrasonics, vol. 42, pp. 1-7, 
2004. 
[19] T. H. Marwick, "How dangerous is echocardiographic contrast?," Heart, vol. 94, 
pp. 1522-3, Dec 2008. 
[20] D. Dalecki, "WFUMB Safety Symposium on Echo-Contrast Agents: bioeffects of 
ultrasound contrast agents in vivo," Ultrasound Med Biol, vol. 33, pp. 205-13, 
Feb 2007. 
232 
 
[21] W. Nyborg, "WFUMB Safety Symposium on Echo-Contrast Agents: mechanisms 
for the interaction of ultrasound," Ultrasound Med Biol, vol. 33, pp. 224-32, Feb 
2007. 
[22] E. L. Ridley. (2011, FDA committee meeting may offer hope for US contrast. 
Aunt Minnie.  
[23] H. L. Friedman, "The Solubilities of Sulfur Hexafluoride in Water and of the Rare 
Gases, Sulfur Hexafluoride and Osmium Tetroxide in Nitromethane1," Journal of 
the American Chemical Society, vol. 76, pp. 3294-3297, 1954/06/01 1954. 
[24] D. L. Nelson and M. M. Cox, Lehninger Princinples of Biochemistry, 4th ed. New 
York, NY: W.H. Freeman and Co., 2005. 
[25] D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos, 
"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors," 
Pharmacol Rev, vol. 51, pp. 691-743, Dec 1999. 
[26] H.-Y. Lin and J. L. Thomas, "PEG-Lipids and Oligo(ethylene glycol) Surfactants 
Enhance the Ultrasonic Permeabilizability of Liposomes," Langmuir, vol. 19, pp. 
1098-1105, 2003. 
[27] N. Backmann, N. Kappeler, T. Braun, F. Huber, H.-P. Lang, C. Gerber, and R. Y. 
H. Lim, "Sensing surface PEGylation with microcantilevers," Beilstein Journal of 
Nanotechnology, vol. 1, pp. 3-13, 2010. 
[28] N. de Jong, L. Hoff, T. Skotland, and N. Bom, "Absorption and scatter of 
encapsulated gas filled microspheres: theoretical considerations and some 
measurements," Ultrasonics, vol. 30, pp. 95-103, Mar 1992. 
[29] J. E. Chomas, P. Dayton, D. May, and K. Ferrara, "Threshold of fragmentation for 
ultrasonic contrast agents," J Biomed Opt, vol. 6, pp. 141-50, Apr 2001. 
[30] E. A. Neppiras, "Acoustic cavitation," Physics Reports, vol. 61, pp. 159-251, 
1980. 
[31] L. Trilling, "The Collapse and Rebound of a Gas Bubble," Journal of Applied 
Physics, vol. 23, pp. 14-17, 1952. 
233 
 
[32] P. A. Dayton, K. E. Morgan, A. L. Klibanov, G. H. Brandenburger, and K. W. 
Ferrara, "Optical and acoustical observations of the effects of ultrasound on 
contrast agents," IEEE Trans Ultrason Ferroelectr Freq Control, vol. 46, pp. 220-
32, 1999. 
[33] J. Wu, J. P. Ross, and J. F. Chiu, "Reparable sonoporation generated by 
microstreaming," J Acoust Soc Am, vol. 111, pp. 1460-4, Mar 2002. 
[34] J. Wu, "Theoretical study on shear stress generated by microstreaming 
surrounding contrast agents attached to living cells," Ultrasound Med Biol, vol. 
28, pp. 125-9, Jan 2002. 
[35] T. G. Leighton, The Acoustic Bubble. San Diego, CA: Academic Press, 1994. 
[36] P. Marmottant, S. van der Meer, M. Emmer, M. Versluis, N. de Jong, S. 
Hilgenfeldt, and D. Lohse, "A model for large amplitude oscillations of coated 
bubbles accounting for buckling and rupture," The Journal of the Acoustical 
Society of America, vol. 118, pp. 3499-3505, 2005. 
[37] P. W. Vaughan and S. Leeman, "Sonoluminescence: Violent Light or Gentle 
Glow?," in IEEE 1986 Ultrasonics Symposium, 1986, pp. 989-992. 
[38] C. C. Church, "Frequency, pulse length, and the mechanical index," Acoustics 
Research Letters Online, vol. 6, pp. 162-168, 2005. 
[39] W. A. Dengler, J. Schulte, D. P. Berger, R. Mertelsmann, and H. H. Fiebig, 
"Development of a propidium iodide fluorescence assay for proliferation and 
cytotoxicity assays," Anticancer Drugs, vol. 6, pp. 522-32, Aug 1995. 
[40] K. Hensel, R. Haagen, G. Schmitz, A. Maghnouj, and S. A. Hahn, "Evaluation of 
subharmonic emission from encapsulated microbubbles as an indicator for 
sonoporation of cell monolayers," IEEE International Acoustics Symposium 
Proceedings, 2009. 
[41] J. R. Eisenbrey, O. M. Burstein, R. Kambhampati, F. Forsberg, J. B. Liu, and M. 
A. Wheatley, "Development and optimization of a doxorubicin loaded poly(lactic 
acid) contrast agent for ultrasound directed drug delivery," J Control Release, vol. 
143, pp. 38-44, Apr 2. 
234 
 
[42] S. P. Wrenn, S. M. Dicker, E. Small, and M. Mleczko, "Controlling Cavitation for 
Controlled Release," Proc. IEEE Int. Ultrason. Symp., 2009. 
[43] S. Ibsen, M. Benchimol, D. Simberg, C. Schutt, J. Steiner, and S. Esener, "A 
novel nested liposome drug delivery vehicle capable of ultrasound triggered 
release of its payload," Journal of Controlled Release, vol. 155, pp. 358-366, 
2011. 
[44] W. Lauterborn, "Numerical investigation of nonlinear oscillations of gas bubbles 
in liquids," The Journal of the Acoustical Society of America, vol. 59, pp. 283-
293, 1976. 
[45] L. Rayleigh, "On the Pressure developed in a Liquid during the Collapse of a 
Spherical Cavity," Phil. Mag., vol. 34, pp. 94-98, 1917. 
[46] M. S. Plesset, "The dynamics of cavitation bubbles," J. Appl. Mech., vol. 16, pp. 
277-282, 1949. 
[47] E. Neppiras and B. Noltingk, "Cavitation Produced by Ultrasonics: Theoretical 
Conditions for the Onset of Cavitation," Proc. Phys. Soc. B, vol. 64, pp. 1032-
1038, 1951. 
[48] B. Noltingk and E. Neppiras, "Cavitation produced by Ultrasonics," Proc. Phys. 
Soc. B, vol. 63, pp. 674-685, 1950. 
[49] H. Poritsky, "The Collapse or Growth of a Spherical Bubble or Cavity in a 
Viscous Fluid," Proceeding of the First US Congress in Applied Mechanics, 
ASME, pp. 813-821, 1952. 
[50] M. S. Plesset and A. Prosperetti, "Bubble Dynamics and Cavitation," Annual 
Review of Fluid Mechanics, vol. 9, pp. 145-185, 1977/01/01 1977. 
[51] A. J. Walton and G. T. Reynolds, "Sonoluminescence," Advances in Physics, vol. 
33, pp. 595-660, 1984/01/01 1984. 
[52] S. Dicker, M. Mleczko, G. Schmitz, and S. P. Wrenn, "Determination of 
microbubble cavitation threshold pressure as function of shell chemistry," Bubble 
Science, Engineering & Technology, vol. 2, pp. 55-64, 2010. 
235 
 
[53] D. A. King and W. D. O'Brien, Jr., "Comparison between maximum radial 
expansion of ultrasound contrast agents and experimental postexcitation signal 
results," J Acoust Soc Am, vol. 129, pp. 114-21, Jan 2011. 
[54] K. E. Morgan, J. S. Allen, P. A. Dayton, J. E. Chomas, A. L. Klibaov, and K. W. 
Ferrara, "Experimental and theoretical evaluation of microbubble behavior: effect 
of transmitted phase and bubble size," IEEE Trans Ultrason Ferroelectr Freq 
Control, vol. 47, pp. 1494-509, 2000. 
[55] E. Stride, "The influence of surface adsorption on microbubble dynamics," 
20080509 DCOM- 20080812. 
[56] T. D. Martz, P. S. Sheeran, D. Bardin, A. P. Lee, and P. A. Dayton, "Precision 
manufacture of phase-change perfluorocarbon droplets using microfluidics," 
Ultrasound Med Biol, vol. 37, pp. 1952-7, Nov 2011. 
[57] G. P. Raeber, M. P. Lutolf, and J. A. Hubbell, "Molecularly engineered PEG 
hydrogels: a novel model system for proteolytically mediated cell migration," 
Biophys J, vol. 89, pp. 1374-88, Aug 2005. 
[58] D. F. Evans and H. Wennerstrom, The Colloidal Domain, 2nd ed. New York, NY: 
Wiley-VCH, 1999. 
[59] S. Dicker, M. Mleczko, M. Siepmann, G. Schmitz, and S. P. Wrenn, "Influence of 
Shell Composition on the Resonance Frequency of Microbubble Contrast 
Agents," Ultrasound in Medicine & Biology, (in revision) 2011. 
[60] M. A. Borden, P. Dayton, Z. Shukui, and K. W. Ferrara, "Physico-chemical 
properties of the microbubble lipid shell [ultrasound contrast agents]," in 
Ultrasonics Symposium, 2004 IEEE, 2004, pp. 20-23 Vol.1. 
[61] M. M. Lozano and M. L. Longo, "Microbubbles coated with disaturated lipids and 
DSPE-PEG2000: phase behavior, collapse transitions, and permeability," 
Langmuir, vol. 25, pp. 3705-12, Apr 9 2009. 
[62] D. Marsh, "Elastic constants of polymer-grafted lipid membranes," Biophys J, 
vol. 81, pp. 2154-62, Oct 2001. 
236 
 
[63] S. P. Wrenn, M. Mleczko, and G. Schmitz, "Phospholipid-stabilized 
microbubbles: Influence of shell chemistry on cavitation threshold and binding to 
giant uni-lamellar vesicles," Applied Acoustics, vol. 70, pp. 1313-1322, 2009. 
[64] J. A. Kopechek, T. M. Abruzzo, B. Wang, S. M. Chrzanowski, D. A. Smith, P. H. 
Kee, S. Huang, J. H. Collier, D. D. McPherson, and C. K. Holland, "Ultrasound-
mediated release of hydrophilic and lipophilic agents from echogenic liposomes," 
J Ultrasound Med, vol. 27, pp. 1597-606, Nov 2008. 
[65] R. E. Apfel and C. K. Holland, "Gauging the likelihood of cavitation from short-
pulse, low-duty cycle diagnostic ultrasound," Ultrasound Med Biol, vol. 17, pp. 
179-85, 1991. 
[66] A. Y. Ammi, R. O. Cleveland, J. Mamou, G. I. Wang, S. L. Bridal, and W. D. 
O'Brien, Jr., "Ultrasonic contrast agent shell rupture detected by inertial cavitation 
and rebound signals," IEEE Trans Ultrason Ferroelectr Freq Control, vol. 53, pp. 
126-36, Jan 2006. 
[67] N. de Jong, A. Bouakaz, and P. Frinking, "Basic acoustic properties of 
microbubbles," Echocardiography, vol. 19, pp. 229-40, Apr 2002. 
[68] D. M. Hallow, A. D. Mahajan, T. E. McCutchen, and M. R. Prausnitz, 
"Measurement and correlation of acoustic cavitation with cellular bioeffects," 
Ultrasound Med Biol, vol. 32, pp. 1111-22, Jul 2006. 
[69] J. Wu, "Theoretical study on shear stress generated by microstreaming 
surrounding contrast agents attached to living cells." 
[70] M. Postema, N. de Jong, and G. Schmitz, "Shell rupture threshold, fragmentation 
threshold, blake threshold," in Ultrasonics Symposium, 2005 IEEE, 2005, pp. 
1708-1711. 
[71] M. Mleczko, S. M. Dicker, G. Schmitz, and S. P. Wrenn, "Determination of the 
inertial cavitation threshold of ultrasound contrast agents," Proc BMT, 2010. 
[72] S. Umchid, R. Gopinath, K. Srinivasan, P. A. Lewin, A. S. Daryoush, L. Bansal, 
and M. El-Sherif, "Development of calibration techniques for ultrasonic 
hydrophone probes in the frequency range from 1 to 100 MHz," Ultrasonics, vol. 
49, pp. 306-311, 2009. 
237 
 
[73] A. K. Kenworthy, K. Hristova, D. Needham, and T. J. McIntosh, "Range and 
magnitude of the steric pressure between bilayers containing phospholipids with 
covalently attached poly(ethylene glycol)," Biophys J, vol. 68, pp. 1921-36, May 
1995. 
[74] A. K. Kenworthy, S. A. Simon, and T. J. McIntosh, "Structure and phase behavior 
of lipid suspensions containing phospholipids with covalently attached 
poly(ethylene glycol)," Biophys J, vol. 68, pp. 1903-20, May 1995. 
[75] P. J. Frinking and N. de Jong, "Acoustic modeling of shell-encapsulated gas 
bubbles," Ultrasound Med Biol, vol. 24, pp. 523-33, May 1998. 
[76] C. Herring, "Theory of the pulsations of the gas bubble produced by an 
underwater explosion," NDRC, Division 6, 1941. 
[77] D. J. May, J. S. Allen, and K. W. Ferrara, "Dynamics and fragmentation of thick-
shelled microbubbles," IEEE Trans Ultrason Ferroelectr Freq Control, vol. 49, 
pp. 1400-10, Oct 2002. 
[78] E. Talu, M. M. Lozano, R. L. Powell, P. A. Dayton, and M. L. Longo, "Long-term 
stability by lipid coating monodisperse microbubbles formed by a flow-focusing 
device," Langmuir, vol. 22, pp. 9487-90, Nov 7 2006. 
[79] E. Evans and W. Rawicz, "Elasticity of ``Fuzzy'' Biomembranes," Physical 
Review Letters, vol. 79, p. 2379, 1997. 
[80] W. Rawicz, K. C. Olbrich, T. McIntosh, D. Needham, and E. Evans, "Effect of 
chain length and unsaturation on elasticity of lipid bilayers," Biophys J, vol. 79, 
pp. 328-39, Jul 2000. 
[81] N. de Jong, R. Cornet, and C. T. Lancée, "Higher harmonics of vibrating gas-
filled microspheres. Part one: simulations," Ultrasonics, vol. 32, pp. 447-453, 
1994. 
[82] B. C. Eatock, R. Y. Nishi, and G. W. Johnston, "Numerical studies of the 
spectrum of low-intensity ultrasound scattered by bubbles," The Journal of the 
Acoustical Society of America, vol. 77, pp. 1692-1701, 1985. 
238 
 
[83] D. Chatterjee and K. Sarkar, "A Newtonian rheological model for the interface of 
microbubble contrast agents," Ultrasound in Medicine &amp; Biology, vol. 29, 
pp. 1749-1757, 2003. 
[84] M. A. Borden and M. L. Longo, "Dissolution Behavior of Lipid Monolayer-
Coated, Air-Filled Microbubbles: Effect of Lipid Hydrophobic Chain Length," 
Langmuir, vol. 18, pp. 9225-9233, 2002. 
[85] M. Overvelde, V. Garbin, J. Sijl, B. Dollet, N. de Jong, D. Lohse, and M. 
Versluis, "Nonlinear Shell Behavior of Phospholipid-Coated Microbubbles," 
Ultrasound in Medicine & Biology, vol. 36, pp. 2080-2092, 2010. 
[86] K. B. Allen and B. E. Layton, "Determination of the forces imposed by micro and 
nanopipettes during DOPC:DOPS liposome manipulation," Chemistry and 
Physics of Lipids, vol. 162, pp. 34-52, 2009. 
[87] C. K. Holland and R. E. Apfel, "An improved theory for the prediction of 
microcavitation thresholds," IEEE Trans Ultrason Ferroelectr Freq Control, vol. 
36, pp. 204-8, 1989. 
[88] J. Wu, "Shear stress in cells generated by ultrasound," Progress in Physics and 
Molecular Biology, vol. 93, pp. 363-373, 2007. 
[89] N. Dan, "Brush adsorption from polydisperse solutions," Macromolecules, vol. 
27, pp. 2310-2312, 1994/04/01 1994. 
[90] P. G. de Gennes, "Polymers at an interface; a simplified view," Advances in 
Colloid and Interface Science, vol. 27, pp. 189-209, 1987. 
[91] C. Church, "The effects of an elastic solid surface layer on the radial pulsations of 
gas bubbles," J. Acoust. Soc. Am., vol. 97, p. 1510, 1995. 
[92] S. H. Bloch, M. Wan, P. A. Dayton, and K. W. Ferrara, "Optical observation of 
lipid- and polymer-shelled ultrasound microbubble contrast agents," Applied 
Physics Letters, vol. 84, pp. 631-633, 2004. 
[93] Y. Iida, T. Tuziuti, K. Yasui, A. Towata, and T. Kozuka, "Bubble motions 
confined in a microspace observed with stroboscopic technique," The Journal of 
the Acoustical Society of America, vol. 107, pp. 2272-80, 2000. 
239 
 
[94] R. K. Schlicher, H. Radhakrishna, T. P. Tolentino, R. P. Apkarian, V. Zarnitsyn, 
and M. R. Prausnitz, "Mechanism of intracellular delivery by acoustic cavitation," 
Ultrasound in Medicine & Biology, vol. 32, pp. 915-924, 2006. 
[95] M. A. Borden, D. E. Kruse, C. F. Caskey, S. Zhao, P. A. Dayton, and K. W. 
Ferrara, "Influence of lipid shell physicochemical properties on ultrasound-
induced microbubble destruction," IEEE Trans Ultrason Ferroelectr Freq 
Control, vol. 52, pp. 1992-2002, Nov 2005. 
[96] C.-H. Cheng, C.-C. Shen, and C.-K. Yeh, "Dual-frequency chirp imaging for 
contrast detection," Phys Med Biol, vol. 56, p. 2767, 2011. 
[97] A. Kheirolomoom, P. A. Dayton, A. F. Lum, E. Little, E. E. Paoli, H. Zheng, and 
K. W. Ferrara, "Acoustically-active microbubbles conjugated to liposomes: 
characterization of a proposed drug delivery vehicle," J Control Release, vol. 118, 
pp. 275-84, Apr 23 2007. 
[98] B. Yuan, "Ultrasound-modulated fluorescence based on a fluorophore-quencher-
labeled microbubble system," J Biomed Opt, vol. 14, p. 024043, Mar-Apr 2009. 
[99] O. A. Khawaja, K. A. Shaikh, and M. H. Al-Mallah, "Meta-Analysis of Adverse 
Cardiovascular Events Associated With Echocardiographic Contrast Agents," The 
American Journal of Cardiology, vol. 106, pp. 742-747. 
[100] P. Liu, X. Wang, S. Zhou, X. Hua, Z. Liu, and Y. Gao, "Effects of a novel 
ultrasound contrast agent with long persistence on right ventricular pressure: 
Comparison with SonoVue," Ultrasonics, vol. 51, pp. 210-214. 
[101] K. Sarkar, A. Katiyar, and P. Jain, "Growth and dissolution of an encapsulated 
contrast microbubble: effects of encapsulation permeability," Ultrasound Med 
Biol, vol. 35, pp. 1385-96, Aug 2009. 
[102] E. Brewer, J. Coleman, and A. Lowman, "Emerging Technologies of Polymeric 
Nanoparticles in Cancer Drug Delivery," Journal of Nanomaterials, 2011. 
[103] K. L. Spiller, J. L. Holloway, M. E. Gribb, and A. M. Lowman, "Design of semi-
degradable hydrogels based on poly(vinyl alcohol) and poly(lactic-co-glycolic 
acid) for cartilage tissue engineering," Journal of Tissue Engineering and 
Regenerative Medicine, 2010. 
240 
 
[104] R. A. Jain, "The manufacturing techniques of various drug loaded biodegradable 
poly(lactide-co-glycolide) (PLGA) devices," Biomaterials, vol. 21, pp. 2475-90, 
Dec 2000. 
[105] F. T. Meng, G. H. Ma, W. Qiu, and Z. G. Su, "W/O/W double emulsion technique 
using ethyl acetate as organic solvent: effects of its diffusion rate on the 
characteristics of microparticles," J Control Release, vol. 91, pp. 407-16, Sep 4 
2003. 
[106] S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer, "Controlled 
delivery systems for proteins based on poly(lactic/glycolic acid) microspheres," 
Pharm Res, vol. 8, pp. 713-20, Jun 1991. 
[107] T. S. Kashi, S. Eskandarion, M. Esfandyari-Manesh, S. M. Marashi, N. Samadi, 
S. M. Fatemi, F. Atyabi, S. Eshraghi, and R. Dinarvand, "Improved drug loading 
and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by 
solid/oil/water ion pairing method," Int J Nanomedicine, vol. 7, pp. 221-34, 2012. 
[108] K. J. Surry, H. J. Austin, A. Fenster, and T. M. Peters, "Poly(vinyl alcohol) 
cryogel phantoms for use in ultrasound and MR imaging," Phys Med Biol, vol. 49, 
pp. 5529-46, Dec 21 2004. 
[109] A. Delalande, S. Kotopoulis, C. Pichon, and M. Postema, "Sonoporation at a Low 
MI," Ultrasound in Medicine &amp; Biology, vol. 37, p. S61, 2011. 
[110] B. Krasovitski, V. Frenkel, S. Shoham, and E. Kimmel, "Intramembrane 
cavitation as a unifying mechanism for ultrasound-induced bioeffects," Proc Natl 
Acad Sci U S A, vol. 108, pp. 3258-63, Feb 22 2011. 
[111] B. Krasovitski and E. Kimmel, "Shear stress induced by a gas bubble pulsating in 
an ultrasonic field near a wall," IEEE Transactions on Ultrasonics, 
Ferroelectrics, and Frequency Control, vol. 51, pp. 973-979, 2004. 
[112] I. Sriram and D. K. Schwartz, "Line tension between coexisting phases in 
monolayers and bilayers of amphiphilic molecules," Surface Science Reports, vol. 
67, pp. 143-159, 2012. 
[113] K. Funakoshi, H. Suzuki, and S. Takeuchi, "Formation of giant lipid vesiclelike 
compartments from a planar lipid membrane by a pulsed jet flow," J Am Chem 
Soc, vol. 129, pp. 12608-9, Oct 24 2007. 
241 
 
 
 APPENDIX A: List of Abbreviations 
 
 
A-mode Amplitude mode 
B-mode Brightness mode 
CTR  Contrast to tissue ratio [dB] 
DAPC  Diarachidoyl phosphatidylcholine 
DLS  Dynamic light scattering 
DMEM Dulbecco’s Modification of Eagle’s Medium 
DPPC  Dipalmitoyl phosphatidylcholine 
DSPC  Distearoyl phosphatidylcholine 
DSPE  Distearoyl phosphotidylethanolamine 
FBS  Fetal bovine serum 
GUV  Giant uni-lamellar vesicle 
MI  Mechanical index 
MW  Molecular weight [g/mole] 
PBS  Phosphate buffered saline 
PEG  Polyethylene glycol 
PI  Propidium iodide 
PLA  Polylactic acid 
PNP  Peak negative pressure [Pa] 
PT0   inertial cavitation threshold pressure [Pa] 
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PT50 Pressure required to inertially cavitate 50% of microbubbles in a 
population [Pa] 
 
PT100 Pressure required to inertially cavitate 100% of microbubbles in a 
population [Pa] 
 
PVA  Polyvinyl alcohol 
RPNNP Rayleigh-Plesset-Neppiras-Noltingk-Poritsky (equation) 
SEM  Scanning electron microscope 
SF6  Sulfur hexafluoride 
THI  Tissue harmonic imaging 
W/O/W Water in oil in water 
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APPENDIX B: List of Symbols 
 
 
α   total attenuation [dB] 
αt   non-dimensional area difference  
χ   shell elastic modulus [N/m] 
∆  adsorption energy [J] 
δ  damping constant 
ε   shell thickness [m] 
γ  polytropic gas constant  
κs  dilatational viscosity [N s/m] 
λ  wavelength [m] 
µL   media viscosity [Pa s] 
µsh   shell viscosity [Pa s] 
ρL  media density [kg/m3] 
σ   interfacial tension [N/m] 
σe   extinction cross section [m2] 
τ  tension [N/m] 
Ω  dimensionless angular frequency 
ω   angular driving frequency [Hz] 
ω0   naked bubble angular resonance frequency [Hz] 
ωr  angular resonance frequency [Hz] 
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A  area [m2] 
A0  initial area [m2] 
ae   microbubble size distribution [m] 
c   media speed of sound [m/s] 
Ccal  calcein concentration [mM] 
dse  shell thickness [m] 
e  error 
f  frequency [Hz] 
Fe  experimental fraction destroyed at a given pressure 
Ft  theoretical fraction destroyed at a given pressure 
GS  shear modulus [Pa] 
IF  fluorescence intensity [arb] 
k  stiffness [kg/s2] 
KA  area expansion modulus [N/m] 
m  mass [kg] 
MWP  polymer functionalized lipid molecular weight [g/mole] 
MWL  lipid molecular weight [g/mole] 
N  number of PEG repeat units 
NA  Avogadro’s number [molecules/mole] 
NL  lipids per microbubble [molecules] 
P  mole fraction of polymer in shell 
P0   hydrostatic pressure [Pa] 
P(t)  incident pressure function [Pa] 
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R   bubble radius [m] 
?̇?                     bubble wall velocity [m/s] 
?̈?  bubble wall acceleration [m/s2] 
R0   microbubble resting radius [m] 
Rcap  microcapsule radius [m] 
Sp  shell stiffness parameter [N/m] 
ttravel  travel time [s] 
Vs  pulser set voltage [V] 
X0  PEG mole fraction 
Z  acoustic impedance [Rayl] 
z  object distance [m] 
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